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Abstract
During the course of this research a novel method which couples the molecular
recognition-triggered photoamplification chain in diaryl ketone adducts of dithiane with a
"turn-off" or “turn-on” fluorescence-based assay for the detection of biological targets
and ligands, regardless of their nature, through a molecular recognition event has been
developed. This research has included several key steps, the most significant being: (1)
the design of fluorophore adducts or dyads which recover fluorescence upon
photocleavage for a “turn-on” assay and the identification of fluorophores which are
quenched upon the photochemical release of a quencher for a “turn off” assay; (2)
Optimization of the photochemistry and photoamplification of dithiane adducts of
benzophenone as it applies to the development of an ultra-sensitive photoamplified
fluorescence assay; (3) implementation of the method in the design and fabrication of
chips for ultra-sensitive screening of microarrays, and (4) integration of this microchip
assay into a fluorescence based signal transducer for ultra-sensitive detection of
molecular recognition events. Proof of concept utilized biotin-avidin recognition, where
avidin is coupled to the photochemical sensitizer.
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Chapter 1: Introduction
During the past several years the Kutateladze research group has systematically
studied the photochemistry of dithiane adducts of various aldehydes and ketones. More
recently their use in applications such as the design of photolabile lipids [1,2] and
photoactive barbiturate receptors,[3] the screening of solution phase combinatorial
libraries,[4] and the design of bioanalytical molecular recognition devices has been
explored.[5] My research began with a study of the sensitized mesolytic fragmentation of
dithiane-ketone adducts [6] which supported the mechanism for adduct cleavage
previously reported [7,8] and progressed toward the major topic of this thesis - ultrasensitive photoamplified fluorescence detection of molecular recognition events.
My task was to develop a novel method which couples the molecular recognitiontriggered photoamplification chain in diaryl ketone adducts of dithiane with a "turn-off"
or “turn-on” fluorescence-based assay for the detection of biological targets and ligands,
regardless of their nature, through a molecular recognition event. This research has
included several key steps, the most significant being: (1) optimization of photochemistry
as it applies to the development of an ultra-sensitive photoamplified fluorescence turn-off
assay, (2) implementation of the method in the design and fabrication of chips for ultrasensitive screening of microarrays, and (3) integration of this microchip assay into a
fluorescence based signal transducer for ultra-sensitive detection of molecular
recognition events. Before presenting my own research it is important to understand the
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general concepts which are prevalent in it, and the work of others, both in the Kutateladze
group and outside of it, which explains the relevance and importance of this research
along with its broader impact in science.

A. Chemical Microarrays
The end goal of my research is to develop a bioanalytical amplification assay
which is compatible with high throughput screening (HTS) of small molecules on a
microarray chip. Gene arrays for HTS will not be discussed as they do not concern this
project. HTS is currently the quickest and most economical method for identifying lead
compounds in the development of new drugs.

However, the development of HTS

requires the miniaturization and automation of biological assays. This miniaturization
has lead to the search for new assays, such as those discussed in the next section, which
can be made into chemical microarrays. A key problem with developing these arrays has
been that they must screen a diverse group of compounds with different structures,
properties, and characteristics while each individual reaction is isolated in an individual
spot or well.[9] Their inability to do this leads to the need to run multiple assays for
different compound types and does not allow for the screening of compounds which
cannot be immobilized onto these microarrays. This means there is a need for assays
which can account for diverse groups of compounds being screened simultaneously.
There are currently three common classifications into which HTS microarrays for
small molecule screening fall: (1) chemical microarrays with immobilization technology
[10,11]; (2) dry chemical microarrays [12,13]; and (3) soulution-phase chemical
microarrays.[14,15] Of these three classifications only the first two have been broadly
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developed.

For example, assays of classification 2 were developed by Abbot

Laboratories™ and have been licensed by Discovery Partners International™. Assays of
classification 1 are marketed by Graffinity™ which works with several drug companies
(Elan™, AstraZeneca™, Rigel™, etc.) to provide HTS for drug discovery. On the other
hand, there are very few assays in classification 3 that have been successfully designed
and even these tend to have drawbacks.

A.1. Chemical microarray with immobilization technology
The first chemical microarrays were developed in the late 1990’s when many of
the original studies were published by Schreiber’s lab at Harvard.[10,11] These smallmolecule microarrays (SMM’s) (Figure 1.1) can utilize a diverse number of linking
techniques to immobilize ligands onto a surface such as gold or glass. Once ligands are
immobilized biological targets are applied to the surface which is then washed to prevent
non-specific and weak binding. Lead compounds are then identified by immunoassays
which rely upon fluorescence to identify the lead compounds.
While these arrays allow for the screening of thousands of compounds or
pharmacophores at once, and are useful in identifying receptors binding lead compounds,
they do have their limitations. Not only does the immobilization of a large diversified
chemical library onto the array pose a challenge, but factors which can effect target
binding - linker length and flexability, ligand orientation, spatial hindrance on the
surface, etc. - must also be optimized and may be different from one target to the next.[9]
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Figure 1.1. Small molecule microarray taken from reference. [9].
A.2. Dry chemical microarray
The dry chemical microarray (Figure 1.2) was originally designed by Abbott
Laboratories™ as a way to circumvent the limitations imposed by immobilization in the
design of SMM’s.

This process, called microarrayed compound screening

(μARCS),[12,13] arrays chemical compounds (analytes) onto dried polystyrene sheets in
DMSO which is removed by drying. The enzyme and substrate are imbedded into an
agarose gel which is applied to the array surface and a second gel is applied which
contains radioactive ATP, the substrate, which initiates a biological reaction. These
reactions can then be detected using a phosphorimager.
A major drawback of this technology is that the compounds on the surface must
be resolubilized. Because the rate of diffusion and capability for resolubilization of each
molecule varies, the outcome of the array is affected. A time differential in the rate at
which a positive binding event takes place during HTS results, making the inhibition
profiles of the compounds screened incomparable on a single array.[9]
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Figure 1.2. Dry chemical microarray taken from reference. [9].
A.3. Solution-phase chemical microarrays
One of the first attempts to create a solution-phase microarray was by Houseman
in 2002.[16] This array utilized a 384 well plate for the mixing of reagents before
applying them to a substrate chip, making it only partially a solution-phase microarray.
In 2003 Diamond’s group at the University of Pennsylvania published one of the first
successful “true” solution-phase arrays (Figure 1.3).[15] In this assay glycerol is added
to the solution of potential drug molecules to prevent evaporation from the surface of the
substrate chip, keeping the molecules in solution at all times once they are printed onto
the microarray. After the potential drugs are printed the biological targets are added by
aerosol deposition.

When a substrate is necessary to catalyze a reaction it can be

immobilized before addition of the analytes in solution are sprayed on following
application of the target. The reactions are then detected by a traditional enzyme-linked
immunosorbant assay (ELISA) techniques.
While this is a solution-phase microarray it is still designed like a traditional chip
based microarray in that the analytes are spotted onto the substrate chip in “pools” of
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solvent. There are still no walls which delineate individual pores or wells for each
reaction, which would be ideal to guarantee that there is no mixing of reaction “pools”.
Additionally, this technique and others like it require several expensive, time consuming,
and labor intensive steps, which cannot be carried out in the field, to detect binding.
Due to the drawbacks of currently developed HTS methods, such as those
described above, and because it is currently the quickest and most economical route to
the identification of lead compounds in the development of new drugs, there is a
substantial need to develop better HTS arrays. However, because the cost of replacing
old systems, such as microtiter-plate-based assays, is large it would be ideal if new
solution-phase arrays could be inexpensive and rely upon inexpensive equipment to
determine results.[9]

Figure 1.3. Solution-phase chemical microarray taken from reference. [9].
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B. Previous Developments in the Design of Bioanalytical Amplification Assays
My goal is to develop a bioanalytical amplification assay. This assay couples a
photoamplification chain with a "turn-off" or “turn-on” fluorescence-based assay for the
detection of biological targets and ligands, regardless of their nature, through a molecular
recognition event. Thus, it is important to understand previous strides in the literature
which utilize amplification for the detection of similar events.

At the same time

drawbacks of these methods will be explored to provide an understanding of why new
methods are currently needed.

B.1. The original use of amplification in bioanalytical assays
The use of amplification assays has long been an area of primary focus in
bioanalytical sciences, especially since modern methods for drug discovery require
testing of small molecules for binding to molecular targets via high throughput screening.
The first bioanalytical amplification assays, developed by A. Coons,[17,18] were based
upon antigen-antibody interactions where the amplification systems correspond to an
indirect or “sandwich” procedure for immunofluorescence detection, upon which today’s
ELISA’s are based. These assays rely upon the specific interaction between antigens and
antibodies. Generally the surface is coated with an antibody that binds to a specific
antigen in the sample. The sample is exposed to a second antibody which is covalently
attached to a florophore or enzyme that eventually relays a signal indicating detection of
the antigen. While the original techniques have been largely refined over the years to
include variations such as time resolved immunoassays, energy-transfer immunoassays,
and fluorescence polarization immunoassays, they are still restricted to screening of
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antibodies or antigens.[19] Even though current detection limits of ELISA can be below
10 ng/mL of analyte they are not applicable in the HTS of potential drug candidates,
unless coupled to other detection assays.[20-23]

B.2. Recently developed bioanalytical amplification techniques
More recent developments in bioanalytical techniques which utilize signal
amplification include PCR amplification,[24,25] the bio-bar-code based detection system
developed by C. Mirkin,[23,26] massive liquid crystal reorientation,[27] allosteric
catalysis,[28] and visible-light-polymerization based amplification.[29-32]

PCR has

become the leading amplification technique in molecular biology due to its ability to
amplify very few copies, or a specific region, of DNA into several million. The original
technique was developed in 1984 by K. Mullis [33,34] and has been modified over the
years, creating new techniques such as (A) Multiplex-PCR,[35] which allows for the
simultaneous use of multiple primers in a single PCR mixture to produce amplicons
specific to different DNA sequences, (B) Hot-start PCR,[36] which reduces non-specific
amplification at lower temperatures, and (C) Quantitative PCR,[37] which uses
fluorophore-containing DNA probes to measure the amount of amplified product as
amplification progresses. Today several microarrays based upon the use of PCR have
been created.[23,25]

These microarrays rely upon hybridization of oligonucleotides

carrying a fluorophore, pre-amplified by PCR techniques, to the immobilized ligand on a
microarray chip. After hybridization the assay can be screened by a fluorescence chip
reader. The problem with this type of amplification and screening is that it is specific to
DNA, expensive, time consuming, skilled-labor intensive, and not possible in settings
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outside of a laboratory. Thus, it cannot be applied to amplifying the signal of a positive
hit from a lead compound in a drug detection assay, nor can it be used as a portable
screening method.
The biobarcode amplification (BCA) assay (Figure 1.4) was developed by C.
Mirkin and coworkers for the detection of proteins and nucleic acids.[23,38] The original
assay used a magnetic microparticle probe (MMP) containing an antibody specific for the
target protein or antigen. After the target binds to the MMP a second nanoparticle (np) is
introduced outfitted heavily with hybridized barcode oligonucleotides and a second
antibody to recognize the antigen on the MMP. The MMP’s, bound to the barcode
containing np’s, are then collected using a magnetic field, and the barcode DNA is
dehybridized from the np’s, which are then removed. These barcode strands can be
analyzed by traditional DNA detection methods, or by PCR-less detection which was also
developed in the Mirkin lab.[38]
In 2007 Mirkin’s group introduced two new adaptations of this assay: (1) it was
adapted for use with ELISA for the detection of HIV-1, showing a detection limit which
is 100 times greater than conventional PCR assays and 150 times greater than traditional
ELISA’s[39]; (2) the BCA assay was modified for use with fluorescent probes to detect
double stranded bacterial genomic DNA with a detection limit of 2.5 fM (7.5 x 104
copies/50 uL).[40] While the BCA assays provide excellent amplification of a target
signal with very low detection limits, they are still target specific to proteins, nucleic
acids, and DNA and cannot currently be used to find lead compounds in high through-put
(HTS) drug screening assays. They also require several steps to obtain the result and, in
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some cases, rely upon PCR amplification to increase the concentration of barcode DNA
after target detection.

Figure 1.4. BCA assay developed by C. Mirkin and coworkers for the detection of
proteins and nucleic acids taken from reference. [38].
Two additional bioanalytical screening methods which employ amplification
techniques for the screening of proteins and enzymes are (A) liquid crystal reorientation
and (B) allosteric catalysis. (A) relies upon a change in the chemical or topographical
structure at an interface where, as a result of a chemical or biological species, a new
orientation of liquid crystals in contact with the surface is achieved (Figure 1.5).[27]
While the use of liquid crystals to amplify an event at an interface does seem feasible for
the detection of biomolecular binding events it does have the drawback of being target
specific. In this array, for example, the authors concluded that the liquid crystals used in
this study could be used to report the presence of phosphorylated peptides at interfaces,
which would be useful in the study of protein kinase enzymes. Although it would be
possible to screen multiple enzymes or proteins at one time, what could be adhered to the
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surface and still allow for a change in liquid crystal orientation upon binding to its target
would limit the assays’ usefulness in HTS for lead compounds.

Figure 1.5. Liquid crystal orientation reports biomolecule binding events. 4-pentyl-4’cyanobiphenyl (A). The binding of protein changes the ordering of the liquid crystal near
the interface (B). Images of samples (before and after protein binding) viewed using a
polarizing microscope (C) taken from reference. [27].
Method (B), signal amplification by allosteric catalysis (SAAC), mimics a
biological signal transduction pathway where a molecular recognition event between an
external signal and a protein receptor is allosterically transduced into catalytically
amplified chemical information via second messengers.[28] Two major areas where
SAAC is applied are biocatalysis for the detection of DNA (Figure 1.6),[41] RNA, and
ATP, and signal amplification by supramolecular and organometallic catalysis [42] to
sense halides and metal ions.[28] Although SAAC is not limited to biological targets it is
restrained by the fact that each assay is designed for a specific target, making it an
unlikely choice for HTS.
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Figure 1.6. Biocatalysis signal amplification. Binding of miRNA with the loop
sequence C allowing fluorogenic substrate to bind A, which cleaves the substrate. This
cleavage results in fluorescent products as a result of the termination of fluorescence
resonance energy transfer (FRET). The fluorescent signal intensity reflects the
concentration of the target miRNA molecules taken from reference. [28].

B.3. Visible-light-polymerization for the detection of molecular recognition events
The final amplification technique to be discussed, and the method most similar to
the one developed in this body of research, is the use of visible-light-polymerization for
the detection of molecular recognition events. In 2007 C.N. Bowman at the University of
Colorado published the original assay (Figure 1.7) showing that the use of polymeric
materials could generate an amplified response to a molecular recognition event,
specifically the binding of the biotin-avidin pair. The assay works by incubating a
surface containing the biotin-labeled species of interest with a macrophotoinitiator (a
high molecular weight copolymer of acrylic acid, acrylamide, and lysine containing one
or two pendant avidins and ~100 photoinitiator molecules) coupled to avidin. Biotin-
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avidin recognition and photoinitiation of polymerization lead to formation of a polymer,
giving a positive binding hit.[29,32]
Photoinitiation upon biotin-avidin recognition is caused by a radical initiator, (a
derivative of 2-hydroxy-2-methylpropiophenone or eosin-5-isothiocyanate) which is part
of the macrophotoinitiator (it is bound to the –COOH groups the copolymer). This
macrophotoinitiator is coupled to avidin via an amide linkage to its lysines.
Photoinitiation occurs upon the application of 365 nm UV light allowing for the
formation of white polymers which can be easily viewed under a microscope (570 um
diameter, 0.14 um thick). By using eosin, which is fluorescent, as the radical initiator the
the chips can be analyzed using a fluorescence scanner. With the use of an optical
microscope and CCD camera 0.4 attomoles of biotin have been detected on the chip.
This is approximately 10 biotinylated species per μm2. The maximum amplification
factor achieved by this assay is 107, due to non-specific interactions that limit the
sensitivity of the system.[29,32]
Unlike

the

previously

discussed

amplification

methods,

visible-light-

polymerization has the ability to detect binding events regardless of their nature. To
show the universality of this technique C.N. Bowman’s group has used it in the detection
of nucleic acids,[31] oligonucleotides,[29] and antigens.[30]

While this method is

promising for use in HTS due to its ability to detect various target types there are a few
drawbacks: (1) large spot sizes can limit the number of analytes on a chip; (2)
amplification cannot be stopped once it has begun; (3) there is no separation between the
radical polymerization and the biological analytes (they are in the same solution and
linked together) and thus the radicals can react freely with the biological sample; and (4)
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to screen various proteins in a library, all of them would have to be coupled to the
macrophotoinitiator (a large copolymer described above), which, due to its large size, is
likely to affect the proteins’ folding and its ability to bind to the analytes on the surface of
the chip more than a few small molecules.

Figure 1.7. Visible-light-polymerization for the detection of molecular recognition
events taken from reference. [32].

C. Photochemistry
The chemistry upon which this newly designed bioanalytical amplification assay
is based is photochemical and has originated in the Kutateladze laboratory.

The

following is a basic explanation of photochemistry and its importance for providing
energy to chemical reactions. Most reactions require the input of external energy in order
to overcome the activation barrier which leads to product formation. Generally this
energy is supplied by heat (thermal reactions) or light (photochemical reactions).
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Photochemical reactions differ from their thermal counterpart in several key ways: (A)
the activation energy for the reaction is provided by light in place of heat, (B) the
electronic distribution and nuclear configuration of a photochemically activated molecule
are such that the excited molecule is an electronic isomer of the ground state molecule
and differs greatly from its thermally activated form, and (C) because the molecule is in a
photoexcited state the number of products accessible to it are larger than in the groundstate of a thermally activated reaction, as the excited molecule possesses excess energy as
a result of photon absorption.
In order to compare the efficiency of these two energy types let us consider a
reaction which requires ~78 kcal/mol of energy to overcome its activation barrier (ΔG≠).
The amount of energy necessary to achieve this barrier photochemically can be found in
one mole of 365 nm light. To estimate the amount of heat required to reach this barrier in
the ground state the Eyring-Polanyi equiation was used (k = Ae-ΔG/RT, where A = kBT/h =
6x1012 s-1 at room temperature). For a reaction to proceed in a matter of minutes (τ = 100
s = 1/k, k = 0.01 s-1) the reaction would have to reach ~900 °C. It is fairly obvious that
the use of light provides the only easily accessible route to this amount of energy.
In photochemical reactions the absorption of a photon by a molecule transforms
light energy into electronic excitation energy, E = hc/λ (Table 1). The absorption of this
light excites an electron from the highest occupied molecular orbital (HOMO) to the
lowest unoccupied molecular orbital (LUMO). This excitation leads the molecule from
the ground state (S0) to its excited singlet state (S1). From the S1 state the molecule can
either (1) take part in a reaction, (2) fluoresce, (3) undergo internal conversion to return
to the grounds state, or (4) undergo intersystem crossing to the triplet state (T1). It is the
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T1 state from which most of the photochemical reactions described in this body of
research take place. If a reaction does not occur from T1 then the molecule will decay to
the ground state via phosphorescence or intersystem crossing (see Jablonski diagram
Figure 1.8).[43]
Table 1.1. Energy conversion table taken from reference [43].
λ
Region

Ultraviolet

Visable

Infrared

Microwave

Radiowave

Wavenumber

ΔE

ν

Structure and motion
involved in absorption
or emission

Å

nm

cm-1

Kcal/mol

sec-1

2,000

200

50,000

143

15 x 1015

2,500

250

40,000

114.4

12 x 1015

3,000

300

33,333

95.3

1.0 x 1015

3,500

350

28,571

81.7

8.7 x 1014

4,000

400

25,000

71.5

7.5 x 1014

4,500

450

22,222

63.5

6.6 x 1014

5,000

500

20,000

57.2

6.0 x 1014

5,500

550

18,182

52

5.4 x 1014

6,000

600

16,666

47.7

5.0 x 1014

6,500

650

15,385

44

4.6 x 1014

7,000

700

14,286

40.8

4.2 x 1014

10,000

1,000

10,000

28.6

3 x 1014

50,000

5,000

2,000

5.8

6 x 1013

100,000

10,000

1,000

2.86

3 x 1013

1.00E+09

1.00E+08

10

3 x 10-2

3 x 1011

-4

9

Electron spinprecessional motion

3 x 107

Nuclear spinprecessional motion

1.00E+11

1.00E+10

0.1

3 x 10

1.00E+13

1.00E+12

0.001

3 x 10-6
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3 x 10

Electrons-orbital
motion

Nuclei-vibrational
motion

Figure 1.8. Jablonski (state energy) diagram taken from reference [43]

C.1. Photolabile groups
Photolabile groups are commonly used as protecting groups in organic synthesis
as their removal does not require the use of a reagent(s) which interfere with other
functional groups and must be removed from the product via a purification step, thus
adding complexity to the total synthesis. By utilizing photolabile protecting groups
deprotecting reagents can be eliminated, as light causes deprotection to occur.[44] For
several photolabile protecting groups the deprotection mechanism and procedures are
well developed and understood. These groups include: (a) o-nitrobenzyl protection of
alcohols, carboxylic acids,[44,45] and thiols, (b) benzyl alcohol protection of
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amines,[46,47] and most importantly to this research (c) dithiane protection of ketones
and aldehydes.[6,7,48]

C.2. Dithiane protection of aldehydes and ketones
The addition of dithiane to aldehydes and ketones, via 2-lithio-1,3-dithiane, was
shown to have excellent yields by Corey and Seebach in 1965 (Scheme 1).[49] It has
since been shown that dithiane can be treated as a photoprotecting group for ketones and
aldehydes. Traditionally, it is deprotected via photooxidation as a dithiacetal, but in the
Kutateladze group a completely orthogonal method has been developed. They have
found that the entire dithiane group can be photocleaved via single electron transfer
(SET) initiated C-C bond fragmentation when irradiated in the presence of a sensitizer
molecule.[48]

This C-C fragmentation generally occurs when a donor molecule is

irradiated in the presence of an acceptor molecule resulting in SET leading to the
formation of a radical ion.

The radical ion can then take part in several different

reactions (cyclodimerization, isomerization, addition and elimination reactions, etc.), the
most common being hydrogen abstraction which leads to C-C bond fragmentation.[50]
Scheme 1.1. Dithiane addition

This SET initiated photocleavage of dithiane adducts (dithiane protected ketone or
aldehyde which is an electron donor) requires a triplet sensitizer (electron acceptor)
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(Scheme 2) and has a general mechanism as follows: (1) benzophenone (BP) (sensitizer)
is excited to its triplet state by irradiation with 365 nm light, (2) SET occurs from adduct
to BP forming the cation and anion radical pair, (3) hydrogen abstraction from the adduct,
by BP, leads to intramolecular electron transfer to form the O radical, (4) the formation of
the O radical induces photochemical cleavage of the adduct leading to (5) the reformation
of dithiane and a deprotected ketone or aldehyde.[6,7,48]
Scheme 1.2. Photocleavage of dithiane adducts

C.3. Utilizing dithiane protected ketones and aldehydes (adducts) as photolabile
scaffolds for molecular recognition
In recent years the use of dithiane protected ketones and aldehyde adducts as
photolabile scaffolds for molecular recognition has been explored. These molecular
scaffolds are capable of efficient photoinduced fragmentation, but only in the presence of
an external electron transfer (ET) sensitizer. The critical feature of such systems is that
they are not photolabile until an external event brings its respective parts (sensitizer and
adduct) into the proximity of each other, arming the system and making it photolabile.
Molecular recognition can be such an external event.
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In previous years the K-group has focused on the design of a photolabile system
based upon the concept of conditional photofragmentation in artificial barbiturate
receptors.[3] Photofragmentation in this system was based upon the docking of the
barbiturate carrying sensitizer (the “ligand”) to the receptor (containing adduct). The
result was photofragmentation of the adduct (Figure 1.9).
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Figure 1.9. Photoactive barbiturate receptor taken from reference. [3].
The group then applied the idea of photolabile scaffolds for molecular recognition
towards triggering an observable photochemical effect due to the molecular recognition
of the biotin-avidin pair. This research has been developed into a novel methodology for
the direct screening of solution-phase libraries encoded with photolabile tags.[4] Figure
1.10 gives a general outline for the screening of micelle-solubilized libraries of ligands L,
encoded with the tethered tags T. The receptor R is outfitted with an ET-sensitizer S, and
incubated with the library (A). The host-guest binding brings the sensitizer into the
vicinity of the adduct (B), which upon irradiation (C), triggers the release of dithiane tags
(D) into the solution, where they are analyzed revealing the identity of the lead
20

compound. The next logical question was whether such a molecular recognition event
could trigger not just one fragmentation, but set off a progression of photochemical
events (photoamplification).

Figure 1.10. Screening of micelle-solubilized solution phase libraries encoded with
photolabile tags taken from reference. [4].

C.4. Photoamplification and its use with photolabile scaffolds for molecular
recognition
Photoamplification is a unique case where the adduct used is also a masked
sensitizer. During BP (or xanthone) sensitized mesolytic fragmentations of diarylketones
(masked sensitizers) a sensitizer itself is released (Scheme 1.2, page 19, where R1 is
aromatic). This results in continued generation of sensitizer that is capable of carrying
the photofragmentation chain, which we call photoamplification. Figure 1.11 illustrates a
typical result obtained when the photoamplification is monitored. 3 mol % of 4,4dimethoxybenzophenone was added to its dithiane adduct in acetonitrile and irradiated,
while UV absorption of the solution was monitored at 360 nm. An autocatalytic curve
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was obtained, indicating that photorelease of the masked ketone accelerated this
bimolecular fragmentation.[51]

Figure 1.11. Diarylketone sensitizing its own unmasking as monitored by UV absorption
at 360 nm (Ar = MeOPh) taken from reference. [51].
We must remember though that ultimately, at a shorter wavelength, any adduct is
capable of self-cleavage.

Thus photoamplification is feasible only if, at a given

wavelength, the sensitized fragmentation is overwhelmingly more efficient than selfcleavage, i.e., εketΦsens >> εaddΦself where εket and εadd are the extinction coefficients of the
free sensitizer and its adduct, and Φses and Φself are the quantum yields of the sensitized
process and self-cleavage.

The addition of dithianes to aromatic ketones disrupts

conjugation, causing large blue-shifts in absorbance. Yet, some adducts retain significant
absorptions at irradiation wavelengths - in thioxanthones this is due to the surviving
diphenylsulfide moieties and quantum yields of self-cleavage remain rather high.[52]
The adducts of BP and xanthone which are either unsubstituted or substituted with groups
which are not electron donating, for example benzophenone-3- and xanthone-2carboxamides, generally show no detectable self-cleavage when irradiated for 5 h above
320 nm at 9.5 x 1019 photons/h. The sensitized reaction in solution is fully completed
within 1.5 h at this flux.
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Based upon this data the next logical question was whether a molecular recognition
event, could trigger not just one fragmentation, but set off a progression of photochemical
events (photoamplification), enhancing the sensitivity of detection (Figure 1.12).
Recently, this concept was tested by planting 5% of free sensitizer on polystyrene high
loading beads (PS-NH2 1.86 mmol/g, 200 μm) to emulate a small amount of the initiator,
brought in by a molecular recognition event. The rest of the surface material was the
masked sensitizer.

The beads were suspended in MeCN, purged with argon, and

irradiated with a 320 nm long pass filter, and dithiane release was monitored by GC/MS.
Figure 1.13 shows a typical release profile: dithiane concentration increases, reaching a
maximum, followed by a slow decrease due to secondary photodegradation. Control
experiments were also performed, ruling out photocleavage due to interbead sensitization
and self-cleavage.[51]

Figure 1.12. Photoamplification initiated by molecular recognition. Incubation with a
receptor, modified with a tethered sensitizer, brings the sensitizer into the vicinity of
adducts (A, red arrow). As irradiation commences, the initiator unmasks proximal
sensitizers on the surface which, in turn, can sensitize the unmasking of their neighbors
(B, red arrows) yielding more sensitizer taken from reference. [51].
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Figure 1.13. Photoamplification on beads. Release of methyldithiane, monitored by GCMS, due to photoamplification of minute amounts of free sensitizer planted with the bulk
of the masked BP taken from reference. [51].
The next question brings me to the topic of my dissertation research: can the
photoamplification of these adducts be utilized in an ultra-sensitive fluorescence assay
for the detection of molecular recognition events. In order to design such an assay the
following must be undertaken: (1) optimize photochemistry of the adduct; (2) identify
fluorophores which are quenched by one or both product(s) of photocleavage (2-alkyl1,3-dithiane and/or benzophenone) but not the adduct, and prove that photoamplification
can result in quenching of these fluorophores; (3) optimize the assay in bulk solvent
(including the optimization of the adduct for solubility); (4) design and fabricate a
microarray chip and imager for the detection of molecular recognition events; and (5)
demonstrate that the designed bioanalytical microarray works using the biotin-avidin
binding pair.
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Chapter 2: Optimization of Photochemistry for the Adducts of Dithiane with
Diarylketones
The first step in applying the photoamplification of di/tri-thiane adducts of
ketones (sensitizers) to the development of a fluorescence assay was to obtain a better
understanding of the reaction mechanism for photocleavage and optimize the quantum
yield of sensitized cleavage (Φsens). In order to increase Φsens of the adducts we utilized
an alkyl tail at R1 or R2 of dithiane (Figure 2.1.).

Figure 2.1. Dithiane which can be substituted at Carbon 2 or 5.

A. The Mechanism for Photocleavage of Dithiane Adducts of Ketones[6]1
The Kutateladze group has previously found that dithianes are extremely suitable
for use in reactions involving ET-induced fragmentations as they are easily synthesized
and cleave efficiently upon photoinduced fragmentation. The mechanism of cleavage in
these adducts has been investigated using classical physical organic methods such as
determining the Hammett substituent effect, the kinetic isotope effect,[8] and laser flash
photolysis (LFP).[7]
1

While initial mechanistic findings were in keeping with the

The research described in A has largely been taken or adapted from reference [6].
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recognized ‘Grobe-like’ mechanism it was later established, by studying photoinduced
fragmentation of the dithiane adduct of pivalaldehyde (A, Scheme 2.1.), that this
mechanism needed refinement. Adduct A cleaved to produce the expected product,
pivalaldehyde, and dithiane-2-carboxaldehyde as the major product in a 1:6.2 ratio.[53]
As the ‘Grobe-like’ mechanism could not explain this product further investigation was
undertaken, and suggested that deprotonation of the hydroxy group in the initially
generated cation radical does not result in the formation of a charge separated ‘Grob-like’
precursor. Instead it produces a neutral oxygen-centered radical (or a species behaving as
one) via intramolecular electron transfer. The O-centered radical undergoes subsequent
fragmentation in either direction and the partitioning correlates with stability of the
produced radicals (Scheme 2.2)[54]

Scheme 2.1. Photocleavage of pivalaldehyde adduct of dithiane, from reference [6].

Scheme 2.2. Proposed mechanism for cleavage of dithiane adducts which bypasses the
‘grobe-like’ mechanism’s charge separated species, from reference [6].
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The case of tert-butyl derivatives, such as A, is unique in a sense that it allowed
the Kutateladze group to discover this new channel in the mechanism of fragmentation
simply by product analysis. For dithiane adducts of aromatic aldehydes and ketones the
barrier for the aryl radical departure is prohibitively high, i.e. it is the dithiane radical
which is always departing. Therefore, it was much more difficult to ascertain whether or
not the original ‘Grob-like’ mechanism for cleavage competes with the anomalous Ocentered radical mechanism (or either one of them is operating exclusively) in the case of
aromatic adducts. Because of the presence of sulfur it is synthetically challenging, if not
impossible, to generate the O-radical from an alternative precursor, for example, a
peroxide, and study the effect of substituents on the rate of its degradation.
In order to further refine the mechanism of fragmentation in adducts of 2-alkyl
substituted dithianes with benzophenone (BP) I began my work in the lab by carrying out
an experimental and computational study of the mechanism of their photoinduced
cleavage. BP-sensitized mesolytic fragmentations, in adducts of the sensitizer itself,
result in generation of more BP and, as such, constitute its amplification. Hence, our
particular interest in this system, which I plan to utilize in developing a fluorescence
photoamplification assay.

A.1 Experimental study of adducts of 2-alkyl substituted dithianes with benzophenone
BP adducts 2a–e of unsubstituted (1a), 2-methyl- (1b), 2-ethyl- (1c), 2-hexyl (1d),
and 2-decyl (1e) dithiane (Scheme 2.3) were synthesized according to a modified Corey–
Seebach procedure,[55] and their photoinduced fragmentation was studied over a
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temperature range from -40oC to +40oC in acetonitrile upon BP sensitization.

The

driving force for the oxidative electron transfer from the dithiane moiety to the triplet
state of BP in acetonitrile is rather large; the one electron reduction potential of triplet BP
is -1.68 V (vs SCE in acetonitrile),[56] whereas various 2-substituted dithianes oxidize in
the range of +0.73 to +1.18 V in the same solvent.[57] During the course of a previously
carried out laser flash photolysis study[7] it was found that the rate of initial electrontransfer quenching of triplet BP with dithiane-benzophenone adduct in dry acetonitrile
was near the diffusion limit, 8.4 ± 0.7 × 108 M-1 s-1. During this experimental study I
determined the dependence of the quantum efficiency of fragmentation on temperature,
with the goal of determining the apparent enthalpy of activation.
Scheme 2.3. Synthesis of benzophenone adducts of 2-alkyl-1,3-dithianes taken from
reference [6].

Photolyses were carried out in a Rayonet carousel photoreactor with a Pyrex heat
exchange jacket cooled by ethanol circulating through a FTS Systems Multi-Cool
refrigeration unit. The quantum yield determinations for adduct disapearance were done
using the classic benzophenone – benzhydrol actinometer system as a standard to
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improve the accuracy of quantum yield determinations.[58] Another important parameter
determined was the percent recovery of the cleaved dithiane. Remember that both the
‘Grob-like’ mechanism and the O-radical mechanism, which Kutateladze’s group has
proposed, give the dithiane-2-yl radical as the immediate fragmentation product. The fate
of this radical is dependent upon multiple factors, including: (a) reactivity of the radical
towards oxygen; (b) dimerization; and (c) disproportionation. Thus, the recovery of
dithiane depends on the above factors and its rate of degredation due to secondary
photooxidation by benzophenone.
We found that more substituted dithianes showed better recovery. This is in
agreement with the overall trends in reactivity of the dithian-2-yl radicals (i.e.,
unsubstituted dithianyl radicals react/degrade faster) and of the final products – dithianes
(i.e.,

less

substituted

dithianes

undergo

benzophenone-sensitized

oxidative

photodegradation faster). The quantum efficiency of cleavage also steadily increases for
adducts of dithianes substituted with longer alkyl chains (Table 2.1). On the other hand,
previous LFP experiments [7] showed that the initial electron transfer quenching rate
increases with the decreased substitution, even though the adduct of unsubstituted
dithiane shows poor efficiency of cleavage.

Thus, it is difficult to determine the

partitioning (between wasteful back electron transfer (BET) and the productive
deprotonation of the adduct) of the initially formed dithiane cation radical –
benzophenone anion radical pair.
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Table 2.1. Quantum efficiencies and dithiane recovery rates at +20 oC for adducts 2b-e,
taken from reference [6].
Adduct

φ

Methyl- (2b)
Ethyl- (2c)
Hexyl- (2d)
Decyl- (2e)

0.20
0.23
0.25
0.27

Dithiane
recovery, %
32.8
35.3
41.0
47.8

Whitten makes the assumption [59] that the only temperature-dependent process
in a reaction of the geminate radical ion pair is fragmentation. Therefore we obtained the
the enthalpy of activation by plotting the data shown in Table 2.2 as ln(φ/T) vs 1/T for the
reaction of 2b and 2c (Figure 2.2). The activation enthalpies, ΔH≠, are obtained from the
slopes: 4.7 kcal/mol for the methyl derivative 2b and 1.5 kcal/mol for the ethyl derivative
2c. These values are very similar to the activation energies obtained by Whitten for the
thioindigo sensitized fragmentation in vicinal amino alcohols.[59]
Table 2.2. Quantum yields of fragmentation and % dithiane recovery as a function of
temperature, taken from reference [6].

T (oC)
-40
-20
0
20
40

Ethyl adduct 2c
Dithiane
φ
recovery, %
0.04
0.7
0.13
6.2
0.18
17.8
0.21
14.8
0.32
37.6
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Methyl adduct 2b
Dithiane
φ
recovery, %
0.01
1.5
0.05
4.3
0.10
6.2
0.15
8.7
0.25
12.5

-6

ln(φ/T) = -2155.8/T - 0.097

-6.75
ln(φ/T) = -745.8/T - 4.619

2

r = 0.97

2

r = 0.94

-7

-7.25
-8
1/T
-9
0.003

0.0035

0.004

-7.75
0.003

1/T
0.0035

0.004

Figure 2.2. 1/T dependence of fragmentation quantum yields for ethyl (2c) and methyl
(2b) adducts, taken from reference [6].
We propose that substitution at position 2 of dithiane accelerates fragmentation in
the deprotonated species, the oxygen-centered radical. Walling and Padwa[58] studied
the substitution effect in decomposition of hypochlorites of alkyldimethylcarbinols,
R-C(Me)2-O-Cl, by comparing the differences in activation energies for decomposition
and hydrogen abstraction (Scheme 2.4). They reported that while the difference was 10
kcal/mol for tert-butoxy radical (i.e. R = Me), it decreased to 1.7 for R = i-Pr, 0.7 for R =
benzyl, and was negligibly small for R = t-Bu. The absolute value for the activation
energy of fragmentation in tert-butoxy radical is 11-13 kcal/mol.[60] If we assume the
rate of hydrogen abstraction does not change much, introduction of the tert-butyl group in
place of methyl should lower the activation energy of fragmentation in these alkoxy
radicals by about 10 kcal/mol, to approx. 1-3 kcal/mol. 2-Methyl-1,3-dithian-2-yl and 2ethyl-1,3-dithian-2-yl are very stable (and bulky) radicals.

Judging by previous

observations the 2-methyldithianyl radical is more stable than tert-butyl, which in turn is
more stable than the unsubstituted dithiane-2-yl radical.[53] Thus, it is not unreasonable
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to assume that the apparent ΔH≠ of 4.7 and 1.5 kcal/mol correspond to fragmentation of
the oxygen-centered radicals, releasing methyldithianyl and ethyldithianyl radicals
respectively. These results provide evidence that the reaction takes place via the Ocentered radical mechanism and not via the original ‘Grob-like’ mechanism in the case of
adducts of benzophenone.
Scheme 2.4. Decomposition and hydrogen abstraction of alkyldimethylcarbinols.

A.2. Computational study of adducts of 2-alkyl substituted dithianes with
benzophenone
In order to support my findings from section A.1. a computational study of the
same dithiane adducts was undertaken. The computations for both the starting and
transition states were run at the DFT, B3LYP/6-31G(d), level using Gaussian 03, revision
C.02.[61] The respective oxygen centered radicals (2b•, 2c•) were generated in Chem3D
and pre-optimized at the AM1 level.

Vibrational analysis of the DFT optimized

geometries shows no imaginary frequencies for the computed ground states and only one
imaginary frequency for the transition states corresponding to the reaction coordinate (i.e.
C-C stretch).

Due to the importance of conformational considerations, the

conformational space was scanned and the relative energies of the starting alkoxy radicals
and their respective fragmentation transition states were analyzed.
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The four major

conformers are: (i) equatorial 2-alkyl with the CO bond in anti conformation to this alkyl,
denoted eMaO, i.e. equatorial Methyl anti Oxygen (the oxygen is anti to the methyl
group), and eEaO for Ethyl; (ii) equatorial 2-alkyl – gauche CO bond, eMgO/eEgO; (iii)
axial 2-alkyl – anti CO bond; aMaO/aEaO; (iv) axial 2-alkyl – gauche CO bond,
aMgO/aEgO. The other two sets of gauche conformers are enantiomers of eMgO/eEgO
and aMgO/aEgO. The relative energies of the starting oxy-radicals and their respective
transition states are listed in Table 2.3 with the calculated ΔH≠ summarized in the third
column.
Table 2.3. ZPE corrected relative energies of the starting oxy-radicals and their
transition states, taken from reference [6].

aEaO-2c•
aEgO-2c•
eEaO-2c•
eEgO-2c•

Ethyl-derivative 2c• (O-radical)
SS (kcal/mol)
TS (kcal/mol)
ΔH≠ (kcal/mol)
5.4
10.0
4.8
4.5
23.0
18.0
1.1
a
–
0.0
1.7
1.7

Methyl derivative 2b• (O-radical)
SS (kcal/mol)
TS (kcal/mol)
ΔH≠ (kcal/mol)
aMaO-2b•
3.4
8.5
5.1
aMgO-2b•
2.8
5.1
2.2
eMaO-2b•
0.9
a
–
eMgO-2b•
0.0
1.7
1.7
a
computations did not converge
The lowest energy conformations for both methyl and ethyl derivatives, the
eMgO/eEgO conformers (Figure 2.3), had the smaller alkyl substituent in the equatorial
position, whereas the bulky benzhydryl group was axial, with oxy-radical being gauche
to methyl/ethyl (that is, anti to one of sulfur atoms). These conformers have the lowest
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energies at both the ground and transition states. This is also in keeping with the
computed conformational energies of the parent alcohols that showed at least a 2
kcal/mol preference for the eRgO conformers (Table 2.4). Conversely, the lowest energy
conformer for the C-2 unsubstituted dithiane adduct of BP were those with an axial-H
(aHaO, aHgO), being more stable by approximately 3 kcal/mol.

Figure 2.3. The lowest energy conformers of the respective O-centered radicals: eMgO2b• (left) and eEgO-2c• (right), taken from reference [6].
Table 2.4. DFT relative energies for the conformers of alcohols 2a-c.

aMaO-2b
aMgO-2b
eMaO-2b
eMgO-2b

Rel. energy,
kcal/mol
3.2
3.5
2.9
0.0

aEaO-2c
aEgO-2c
eEaO-2c
eEgO-2c

5.5
1.9
3.2
0.0

aHaO-2a
aHgO-2a
eHaO-2a
eHgO-2a

0.01
0.0
3.3
2.8

Conformers
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A.3. An NMR study of adducts of 2-alkyl substituted dithianes with benzophenone
In order to confirm the structural information obtained during the computational
study in A.2. a low temperature NMR study of the adducts (parent alcohols to the oxyradical) was undertaken. Initial analysis of the 1H NMR for each of the three adducts (2a,
2b, and 2c) shows a systematic upfield shift of the dithiane's H2C(3) and H2C(5) protons
upon introduction of the methyl and then ethyl group (Figure 2.4). The downfield
multiplet corresponds to the two axial H2C(3) and H2C(5) protons and the upfield two
equatorials.

Significant differences in the conformational behavior between the

substituted and unsubstituted adducts becomes obvious when analyzing the low
temperature NMR data.

Figure 2.4. 1D proton NMR spectra of 2a-c at 25 °C.
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Figure 2.5 shows the temperature dependent changes in the 1H NMR spectra from
-22 °C to -95 °C. In the methyl and ethyl derivatives of the adduct the multiplets for the
axial and equatorial protons H2C(3) and H2C(5) split into two sets. If the rotation of the
benzhydrol group has been stopped at this temperature this would indicate that the most
stable isomer is unsymmetrical. The unsubstituted adduct does not show this divergence
of the peaks for the axial and equatorial protons H2C(3) and H2C(5), indicating that its most
stable isomer is likely symmetrical. Both of these findings are in agreement with our
DFT calculations.
In order to prove that the split signals of the equatorial and axial protons for the
ethyl and methyl derivatives belong to the same conformer, a COSY experiment was run
at -95 °C. This experiment showed definitive cross-peaks for the respective split pairs of
signals leading us to conclude that below -40 °C the equatorial (Heq-C(3) and Heq-C(5) and
axial (Hax-C(3) and Hax-C(5)) protons are not equivalent to each other. This result can only
be explained if the adducts conformation is unsymmetrical, further confirming our
computational findings.
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Figure 2.5. VT NMR data for 2a-c. The inset shows low temperature COSY spectrum
for 2c at -95oC.

While the findings in sections A.1., A.2., and A.3 do not rule out the ‘Grobe-like’
mechanism for photofragmentation they do provide further evidence that supports the
alternative oxygen-centered radical mechanism. Both the experimental studies done on
the parent adducts (alcohols), and computational studies of the oxygen centered radicals,
showed apparent enthalpies of activation for photoinduced fragmentation which were in
agreement. Additionaly an NMR study confirmed the computational results that the most
stable conformation of the ethyl and methyl adducts of BP are unsymmetrical, while that
of the unsubstituted adduct is symmetrical.
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B. Increasing Φsens for Adducts of Dithiane with a Diarylketone Through 2- and 5Alkyl Substitution in Dithianes.
Synthesis of 2-alkyl substituted dithianes is relatively straight forward and simple.
It is accomplished via the addition of 1,3-propanedithiol to an aldehyde (Scheme 2.5).
The resulting 2-alkyl-1,3-dithiane is then added to a ketone via our modified Corey–
Seebach procedure[55] to produce the desired adduct 2a-e of unsubstituted (1a), 2methyl- (1b), 2-ethyl- (1c), 2-hexyl (1d) and 2-decyl (1e) dithiane.

Scheme 2.5. Synthesis of 2-alkyl-1,3-dithianes.

Based upon the previous findings that (1) the rate of SET quenching of triplet
benzophenone with dithiane-benzophenone adduct in dry acetonitrile was near the
diffusion limit, 8.4 ± 0.7 × 108 M-1 s-1, and (2) the rate of SET is slower for more
substituted adducts due to triplet BP decaying before ET takes place, [7] one might think
the Φsens would decrease when an alkyl chain is added to position 2 of dithiane. Instead
the results from section A show the quantum efficiency of cleavage steadily increases for
adducts of dithianes substituted with longer alkyl chains at position 2 (Table 2.1., Φsens
for unsubstituted adduct is 0.12). This increase in Φsens is explained in two ways. First,
because the rates of SET and BET should be similarly affected by the size of the alkyl
group fewer adducts containing a large 2-alkyl substituent on dithiane may undergo SET
(as compared to the unsubstituted dithiane or a dithiane with smaller alkyls), even fewer
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of these adducts will participate in BET, leading to an increase in fragmentation of the
adducts.

Second, we believe that the 2-alkyl substituent sterically inhibits the

recombination of the dithiane radical with its own cleaved ketone, slowing reformation of
the oxygen centered radical. These two factors combined lead to an increase in the Φsens
for adducts of 2-alkyl-1,3-dithianes with benzophenone which is based upon the
length/size of the 2-alkyl substituent.
In order to increase adducts solubility (a topic to be discussed in more detail later)
we pursued the design of dithianes substituted at position 5 with two alkyl chains with the
hope that such substitution would either further increase or not effect Φsens. Synthesis of
5-alkyl-1,3-dithianes (3a-d, Scheme 2.6) involves a 4 step reaction, as the starting 1,3propanedithiols are not readily available. The adducts of 3a-d with benzophenone were
then synthesized via the previously mentioned modified Corey–Seebach procedure.[55]
Unfortunately, we discovered that the Φsens is lowered as a result of 5-alkyl groups. The
relative Φsens of benzophenone adducts with 3b-c to adduct 2a and 2b are 37% and 53%
respectively. We believe that this results is due to the 5-alkyl substitutents “shielding” of
the dithiane sulfurs which inhibits SET. This would be in agreement with previous
results, mentioned above, which showed that SET slows for more substituted adducts.
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Scheme 2.6. Synthesis of 5-alkyl-1,3-dithaines.

C. Experimental
C.1. General
Common solvents were purchased from Pharmco and used as is, except for THF,
which was refluxed over and distilled from potassium benzophenone ketyl prior to use.
n-BuLi (as a 1.6 M solution in hexanes), 1,3-dithiane, 2-methyl-1,3-dithiane,
benzophenone, and benzhydrol were purchased from Aldrich. 1,3-Dithiol was purchased
from Acros. Propanal, decanal, and heptanal were purchased from Alfa Aesar. All
reagents were used without purification.

1

H NMR spectra were recorded at 25 °C on a

Varian Mercury 400 MHz instrument in CDCl3 with TMS as an internal standard (unless
noted otherwise). Low temperature NMR was carried out in CD3OD using a Varian
Mercury VT system. Temperature was controlled using dry nitrogen flow through a
liquid nitrogen Dewar. Column chromatography was performed on silica gel, 70-230
mesh ASTM, using ethyl acetate-hexane mixtures as eluent. Photoreactions were carried
out in a carousel Rayonet photoreactor outfitted with a jacketed Pyrex reaction vessel
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connected to a FTS Systems Multi-Cool refrigeration unit with a peristaltic pump, using
ethanol as a coolant.
Ab initio computations were performed on a Linux workstation using Gaussian
03, Revision C.02.[61] Input geometries were created and preoptimized using a force
field geometry optimization as implemented in Chem3D (Cambridgesoft).

The

geometries were further pre-optimized at the Austin model 1, semi-emperical (AM1)
level.

Full geometry optimizations were performed using density functional theory

(DFT) at the B3LYP/6-31G(d) level of theory (the Becke three-parameter hybrid
functional combined with Lee, Yang, and Parr correlation functional).

C.2. General Method for Dithiane Preparation.
1,3-Propanedithiol (8 g, 0.07 mol) and the appropriate aldehyde (0.06 mol) were
dissolved in 250 mL CH2Cl2. BF3•Et2O (33 mL, 0.26 mol) was added to the solution.
The reaction mixture was then stirred overnight at room temperature. The mixture was
washed with NaOH (5% aq. soln.) and water.

The organic layer was dried over

anhydrous NaSO4 and the solvent was removed by rotary evaporator and the resulting
product was distilled under vacuum.

2-Ethyl-1,3-dithiane (1c): (8.7g, 59 mmol), 86%; b.p. 38 °C @ 63 mTorr;

1

H NMR

(CDCl3, 400 MHz): δ 4.0 (t, 1H, J=6.8Hz), 2.80-2.92 (m, 4H), 2.09-2.16 (m, 1H), 1.841.92 (m, 1H), 1.77-1.92 (m, 2H), 1.09 (t, 3H). (NMR tpg17001_pure)
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2-Hexyl-1,3-dithiane (1d): (5.4g, 26 mmol), 54%; b.p. 125 °C @ 72 mTorr;

1

H NMR

(CDCl3, 400 MHz): δ 4.03 (t, 1H, J=6.9Hz), 2.76-2.90 (m, 4H), 2.06-2.13 (m, 1H), 1.831.92 (m, 1H), 1.68-1.74 (m, 2H), 1.44-1.52 (m, 2H), 1.22-1.35 (m, 6H), 0.87 (t, 3H).
(NMR tpg17141_pure)

2-Decyl-1,3-dithiane (1e): (12.56g, 48 mmol, 63%; b.p. 142 °C @ 69 mTorr; 1H NMR
(CDCl3, 400 MHz): δ 4.07 (t, 1H, J=6.9Hz), 2.81-2.94 (m, 4H), 2.10-2.17 (m, 1H), 1.851.94 (m, 1H), 1.73-1.79 (m, 2H), 1.48-1.55 (m, 2H),1.25-1.33(m, 14H), 0.90 (t, 3H).
(NMR tpg17152_pure)

C.3. General method for adduct preparation.
A generic method by Corey and Seebach was modified and used to prepare the
desired dithiane-benzophenone adducts.[55]

The desired dithiane (5.1 mmol) was

dissolved in freshly distilled THF (30 mL) and placed under nitrogen. n-Butyllithium
(4.3 mL, 6.8 mmol, 1.6 M solution in hexanes) was added at room temperature upon
stirring and the resulting mixture was stirred for 10 more minutes. The appropriate
benzophenone (3.4 mmol) was dissolved in freshly distilled THF (10 mL) and added to
the anion mixture while stirring. The reaction was left for 2 hours at room temperature.
The reaction mixture was quenched with a saturated solution of ammonium chloride and
the aqueous layer was extracted twice with ethyl acetate. The organic layer was dried
over anhydrous sodium sulfate. The solvent was removed under vacuum, and the residue
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was purified by column chromatography (silica-gel, ethyl acetate/hexanes) or
recrystallization (DCM in hexanes).

(2-Methyl-[1,3]-dithian-2-yl)-diphenyl-methanol (2b): 0.80 g, 2.7 mmol, 80 %; 1H
NMR (CDCl3, 400 MHz): δ 7.85-7.87 (m, 4H), 7.21-7.30 (m, 6H), 2.82 (ddd, 2H, J= 3.5,
J=10.5, J=14.6 Hz), 2.53 (ddd, 2H, J=3.9, J=5.7, J=14.7 Hz), 1.80-1.97 (m, 2H), 1.894 (s,
3H). (NMR tpg17768_pure)

(2-Ethyl-[1,3]-dithian-2-yl)-diphenyl-methanol (2c): 0.94 g, 2.8 mmol, 93 %;

1

H

NMR (CDCl3, 400 MHz): δ 7.93-7.96 (m, 4H), 7.28-7.33 (m, 4H), 7.22-7.26 (m, 2H),
2.52 (ddd, 2H, J=4.8, J=7.0, J=14.2 Hz), 2.25 (ddd, 2H, J=4.8, J=8.1, J=13.0 Hz), 1.972.04 (m, 2H), 1.67-1.73 (m, 2H), 1.12-1.16 (m, 3H).

(NMR tpg17002_fr2 and

17002_cosy)

(2-Hexyl-[1,3]-dithian-2-yl)-diphenyl-methanol (2d): 0.61 g, 1.6 mmol, 49 %; 1H
NMR (CDCl3, 400 MHz): δ 7.91-7.94 (d, 4H), 7.20-7.31 (m, 6H), 2.49 (td, 1H, J=4.8Hz,
J=10.3Hz), 2.22 (ddd, 1H, J=5.9Hz, J=8.0Hz, J=14.1Hz), 1.91-1.96 (m, 2H), 1.60-1.73
(m, 4H),1.10-1.31(m, 6H), 0.81-0.85 (t, 3H). (NMR tpg17154_column2)

(2-Decyl-[1,3]-dithian-2-yl)-diphenyl-methanol (2e): 0.62 g, 1.4 mmol, 52 %; 1H NMR
(CDCl3, 400 MHz): δ 7.92-7.94 (dd, 4H), 7.20-7.33 (m, 6H), 2.49 (td, 2H, J=5.4Hz,
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J=14.1Hz), 2.23 (ddd, 1H, J=5.7Hz, J=8.2Hz, J=13.9Hz), 1.91-1.96 (m, 2H), 1.60-1.77
(m, 6H), 1.10-1.34 (m, 12H), 0.81-0.85 (t, 3H). (NMR tpg17153_column)

C.4. 5-alkyl-1,3-dithiane preparation.
C.4.1. General method for the preparation of diethyl 3-alkylpentanedioate.
To a suspension of NaH (1.0 g, 43 mmol) in THF (115 mL) was added diethyl
malonate (5.30 g, 33 mmol) dropwise. The mixture was stirred at room temperature for
15 min and then 1-bromoalkyl (33 mmol) was added in one portion. The reaction was
refluxed 5 hours, quenched with water (200 mL), and extracted with diethyl ether (3 x
100 mL). The organic layers were combined, dried over anhydrous sodium sulfate, and
removed under vacuum to give the product which was used without purification.

Diethyl 3-pentylpentanedioate (precursor for 3c): 5.42 g, 68 %; 1H NMR (CDCl3, 400
MHz): δ 4.14-4.22 (dq, 4H, J=7.16 Hz, J=14.19Hz), 3.29-3.32 (t, 1H, J=7.53), 1.82-1.97
(m, 4H), 1.21-1.34 (m, 10H), 1.11-1.18 (m, 4H), 0.85-0.89 (t, 3H).

(NMR

tpg27049_pure)

Diethyl 3-octylpentanedioate (precursor for 3d): 6.34 g, 64%; 1H NMR (CDCl3, 400
MHz): δ 4.16-4.21 (dq, 4H, J = 0.79, 7.07, 7.09 Hz), 3.28-3.32 (t, 1H, J = 7.56 Hz), 1.831.90 (dt, 2H, J = 7.68, 15.20 Hz), 1.24-1.28 (m, 20H), 0.85-0.88 (t, 3H, J = 6.81 Hz).
(NMR mpc24108_rm)
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C.4.2. General Method for the Preparation of Diethyl 3,3-dialkylpentanedioate.
To a suspension of NaH (0.72 g, 30 mmol) in THF (100 mL) was added the
appropriate diethyl 3-alkylpentanedioate (22 mmol) dropwise. The mixture was stirred at
room temperature for 15 min and then 1-bromoalkyl (22 mmol) was added in one
portion. The reaction was refluxed for 8 hours, quenched with water (200 mL), and
extracted with diethyl ether (3 x 100 mL). The organic layers were combined, dried over
anhydrous sodium sulfate, and removed under vacuum to give the product which was
used without purification in the next step.

Diethyl 3,3-dipentylpentanedioate (precursor for 3c): 4.55 g, 80 %; 1H NMR (CDCl3,
400 MHz): δ 4.14-4.20 (q, 4H, J = 7.16), 1.83-1.87 (m, 4H), 1.24-1.32 (m, 12 H), 1.211.25 (t, 6H, J = 7.16 Hz), 1.14-1.18 (m, 4H), 0.85-0.89 (t, 6H, J = 7.02). (NMR
tpg27051_pure)

Diethyl 3,3-dioctylpentanedioate (precursor for 3d): 6.83 g, 99 %; 1H NMR (CDCl3,
400 MHz): δ 4.14-4.19 (q, 4H, J = 7.11, 7.12 Hz), 1.83-1.87 (m, 4H), 1.21-1.25 (m, 30H),
0.85-0.89 (t, 6H, J = 6.81 Hz). (NMR mpc24112_rm)

C.4.3. General Method for the Preparation of 2,2-dialkylpropane-1,3-diol (3c-d).
LiAlH4 (1.33 g, 35 mmol) was suspended in THF (50 mL).

Diethyl 3,3-

dialkypentanedioate (15 mmol) in THF (40 mL) was added dropwise to the suspension
over 10 minutes. The mixture was refluxed with stirring for 1 h. 5% aq. HCl (150 mL)
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was added dropwise to quench the reaction, which was then extracted with ether (3x 100
mL). The organic layer was dried over anhydrous sodium sulfate and removed under
vacuum to give the product which was used without further purification.

2,2-dipentylpropane-1,3-diol (3c): 3.28 g, 100 %; 1H NMR (CDCl3, 400 MHz): δ 3.57
(s, 4H), 2.17 (s, 2H), 1.17-1.35 (m, 16 H), 0.86-0.90 (t, 6H). (NMR tpg27052_pure)

2,2-dioctylpropane-1,3-diol (3d): 3.34 g, 74 %; 1H NMR (CDCl3, 400 MHz): δ 3.57 (s,
4H), 1.22-1.27 (m, 28H), 0.86-0.90 (t, 6H, J = 6.75 Hz). (NMR mpc24110_rm)

C.4.4. General method for preparation of 3,3-bis(iodomethyl)alkanes:
To triphenylphosphine (8.65 g, 33 mmol) dissolved in benzene (50 mL), was
added pyridine (8 mL) and iodine (11.4 g, 45 mmol), in this order. Tthe reaction was
stirred for 15 minutes at room temperature. The appropriate 2,2-dialkylpropane-1,3-diol
(15 mmol) was added and the reaction was refluxed with stirring overnight.

The

precipitate was filtered off and the solvent was evaporated. The resulting residue was
purified by gel filtration (silica gel eluted with hexane:EtOAc 10:1) to give the desired
product.

3,3-bis(iodomethyl)pentane (4a): 4.17 g, 79 %; 1H NMR (CDCl3, 400 MHz): δ 3.20 (s,
4H), 1.43-1.49 (q, 4H, J = 7.5 Hz), 0.81-0.85 (t, 6H, J = 7.5 Hz).
mpc24025_DEIodo_pure)
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(NMR

3,3-bis(iodomethyl)nonane (4b): 5.2 g, 85 %; 1H NMR (CDCl3, 400 MHz): δ 3.20 (s,
4H), 1.30-1.37 (m, 8H), 1.10-1.15 (m, 4H), 0.90-0.93 (dd, 6H, J = 6.3 Hz, 13.6 Hz).
(NMR mpc24141_pure)

3,3-bis(iodomethyl)undecane (4c): 3.20 g, 82 %; 1H NMR (CDCl3, 400 MHz): δ 3.20
(s, 4H), 1.23-1.40 (3, 12H), 1.14-1.20 (m, 4 H), 0.88-0.92 (t, 6H). (NMR tpg27054_pure)

3,3-bis(iodomethyl)heptadecane (4d): 6.79 g, 87 %; 1H NMR (CDCl3, 400 MHz):
δ 3.20 (s, 4H), 1.23-1.40 (3, 22H), 1.07-1.21 (m, 2 H), 0.87-0.90 (t, 6H).

(NMR

mpc24116_rm)

C.4.5. General method for preparation of S,S’-2,2-dialkylpropane-1,3-diyl
diethanethioates:
Bis(iodomethyl)alkane (12 mmol) was dissolved in a mixture of DMF:THF (1:1)
(100 mL). Potassium thioacetate (3.1 g, 27 mmol) was added and the reaction was
refluxed with stirring for 3 hours. The mixture was poured into water, extracted with
ether (3 x 100 mL), and the organic layer was collected, dried over anhydrous sodium
sulfate, and removed under vacuum. The product was used directly in the next reaction.
S,S’-2,2-diethylpropane-1,3-diyl diethanethioate (5a): 2.77 g, 93 %; 1H NMR (CDCl3,
400 MHz): δ 2.93 (s, 4H), 2.34 (s, 6H) 1.31-1.37 (q, 4H, J = 7.5 Hz), 0.79-0.83 (t, 6H, J
= 7.5 Hz). This product was used directly to make 7a. (NMR mpc24030_DEDTrm)
47

S,S’-2,2-dibutylpropane-1,3-diyl diethanethioate (5b): 3.65 g, 100 %; 1H NMR
(CDCl3, 400 MHz): δ δ 2.93 (s, 4H), 2.33 (s, 6H) 1.24-1.28 (m, 8H), 1.16-1.22 (m, 4H),
0.87-0.91 (s, 6H). (NMR mpc24144_rm)

S,S’-2,2-dipentylpropane-1,3-diyl diethanethioate (5c): 4.14 g, 100 %; 1H NMR
(CDCl3, 400 MHz): δ 2.93 (s, 4H), 2.33 (s, 6H), 1.19-1.32 (m, 16 H), 0.85-0.89 (t, 6H).
(NMR tpg27056_rm)

S,S’-2,2-dioctylpropane-1,3-diyl diethanethioate (5d): 5.00 g, 100 %; 1H NMR
(CDCl3, 400 MHz): δ δ 2.93 (s, 4H), 2.33 (s, 6H) 1.20-1.37 (m, 24H), 0.79-0.83 (t,
6H) This product was used directly to make 7d. (NMR mpc24125_rm)

C.4.6. General method for preparation of 2,2-dialkylpropane-1,3-dithiols:
LiAlH4 (1.1 g, 28 mmol) was suspended in THF (40 mL).

S,S’-2,2-

dialkylpropane-1,3-diyl diethanethioate (12.3 mmol) dissolved in THF (40 mL) was
added to the suspension dropwise over 10 minutes. The mixture was refluxed with
stirring for 1 h. 5% aq. HCl (100 mL) was added dropwise to quench the reaction, which
was extracted with ether (3x 100 mL). The organic layer was dried over anhydrous
sodium sulfate and removed under vacuum to give pure product.

48

2,2-dibutylpropane-1,3-dithiol (6b): 2.44 g, 90 %; 1H NMR (CDCl3, 400 MHz): δ 2.512.53 (d, 4H, J = 8.5 Hz), 1.27-1.33 (m, 8H), 1.07-1.15 (m, 4H), 0.90-0.93 (t, 6H, J = 7.2
Hz). (NMR mpc24148_rm)

2,2-dipentylpropane-1,3-dithiol (6c): 2.83 g, 93 %; 1H NMR (CDCl3, 400 MHz):
δ 2.51-2.53 (d, 4H), 1.11-1.35 (m, 16H), 1.06-1.11 (t, 2H, J=8.57 Hz), 0.87-0.91 (t, 6H).
(NMR tpg27057_pure)

C.4.7. General method for preparation of 2,2-dialkylpropane-1,3-dithianes:
A solution of dimethoxymethane (1.24 mL, 14 mmol) and 2,2-dialkylpropane1,3-dithiol (11.4 mol) were dissolved in CH2Cl2 (100 ml). BF3●Et2O (7.22 ml, 57 mol)
was slowly added and stirred overnight at room temperature. The reaction was quenched
with 30% aq. NaOH (20 ml, added slowly), washed with 5% aq. NaOH (200 mL), and
H2O (100 ml). The organic layer was collected and dried over anhydrous NaSO4. The
solvent was removed under vacuum and the residue was purified by gel filtration (silica
gel eluted with 10:1 Hexane:EtOAc) to give the desired product which was used to make
the adducts of benzophenone as per C.3 above. The benzophenone adducts containing
these dithianes will be reported in Chapter 4.

2,2-diethylpropane-1,3-dithiane (7a): 5a (59 mmol) and concentrated HCl (48 mL)
were added to formaldehyde (466 mL, 36% aq. solution stabilized by 10-15% MeOH)
and refluxed overnight with stirring. The reaction mixture was brought to neutral pH
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with saturated aqueous sodium bicarbonate, extracted with DCM (2 x 100 mL), and the
organic layer was collected and removed under vacuum to give the product (7.49 g, 72
%). 1H NMR (CDCl3, 400 MHz): δ 3.64 (s, 2H), 2.57 (s, 4H), 1.57-1.63 (q, 4H, J = 7.5
Hz), 0.79-0.82 (t, 6H, J = 7.5 Hz). (NMR mpc24033_4)

2,2-dibutylpropane-1,3-dithiane 7b): 8.77g, 64 %; 1H NMR (CDCl3, 400 MHz): δ 3.64
(s, 2H), 2.56 (s, 4H), 1.32-1.35 (m, 8H), 1.13-1.19 (m, 4H), 0.91-0.94 (t, 6H). (NMR
mpc24150_53)

2,2-dipentylpropane-1,3-dithiane (7c): 11.83 g, 77 %; 1H NMR (CDCl3, 400 MHz):
δ 3.63 (s, 2H), 2.57 (s, 4H), 1.50-1.55 (m, 4H), 1.25-1.34 (m, 8H), 1.14-1.21 (m, 4H),
0.87-0.91 (t, 6H). (NMR tpg27058_wup)

2,2-dioctylpropane-1,3-dithiane (7d): To a solution of S,S’-2,2-dioctylpropane-1,3-diyl
diethanethioate (6.88 mmol) in ethanol (20 mL) dimethoxymethane (1.2 g, 15.5 mmol)
was added. HCl (3.0 mL, 4.0 M in Dioxane) was then added dropwise and the reaction
was refluxed overnight. The solvent was removed, the residue was dissolved in DCM
(100 mL) and washed with 5% aq. NaOH (2 x 100 mL). The organic layer was collected,
dried over anhydrous sodium sulfate, and removed under vacuum to give the product.
(13.8 g, 68 %). 1H NMR (CDCl3, 400 MHz): δ 3.64 (s, 2H), 2.58 (s, 4H), 1.25-1.34 (m,
22H), 1.09-1.22 (m, 2H), 0.87-0.90 (t, 6H). (NMR mpc24136_33)
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Chapter 3: Identification of Fluorophores for a “Turn On” or “Turn Off”
Photoamplification Assay
The purpose of this research is to develop a novel method which couples the
molecular recognition-triggered photoamplification chain in diaryl ketone adducts of
dithiane with a "turn-off" or “turn-on” fluorescence-based assay for the detection of
biological targets and ligands, regardless of their nature, through a molecular recognition
event.

Integral to this assay are three components to the development of a new

photoinduced methodlology for an ultra-high sensitivity fluorescence “turn-on” or “turnoff” assay: (1) the fluorophore, (2) the masked sensitizer (adduct), and (3) the solvent.
All of these components have to be optimized, both independently and in combination,
for use with this new methodology. Before (2) and (3) can be optimized a fluorophore(s)
must be identified.
Both the fluorescence “turn-on” and “turn-off” assays have advantages and
disadvantages which are unique to themselves. A fluorescence turn-on assay will provide
a better signal to noise ratio, as it is easier to locate one bright spot in a field of black than
to locate one dark spot in a field of light. The difficulty with this type of assay (turn-on)
is identifying a fluorophore that will be quenched when incorporated as part of an adduct
but not inhibit the adducts photoamplification.

If the adduct cannot participate in

photoamplification then the “turn-on” assay becomes more complex, as an adduct which
can carry the photoamplification chain must be added separately. On the other hand, our
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1,3-dithiane adducts of benzophenone are known to participate in photoamplification and
might be ideal for a fluorescence turn-off assay due to the release of two potential
quenchers – 1,3-dithiane and benzophenone.

A. Towards the Development of a Fluorescence Recovery (“turn-on”) assay.
I have considered three approaches to the design of a fluorescence “turn-on” assay
(Figure 3.1). First, we could utilize a fluorescent diaryl ketone to which 1,3-dithiane can
be added via the modified Corey-Seebach addition.[49] This should effectively mask the
fluorophore by disrupting the conjugation at the core of the fluorophore’s π-system via
the formation of a covalent C-C bond, leading to quenching of fluorescence. Upon
photocleavage of the dithiane, conjugation is restored and fluorescence is recovered.
Second, a fluorescent dye could be attached to an adduct which contains a quencher.
When the fluorophore and quencher are held in close proximity, as part of the adduct,
fluorescence should be significantly diminished. Upon photocleavage of the adduct the
quencher would be released and fluorescence will recover. The third option is to identify
an organic dye that self quenches when in close proximity to itself. Utilizing trithiane a
bis or tris adduct of this dye could be synthesized, giving a product with a significantly
lowered fluorescence intensity as the dyes are held in close proximity.

Once

photocleavage takes place the dye would be released into solution leading to fluorescence
recovery.
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Figure 3.1. Three approaches to the design of a fluorescence “turn-on” assay. (1) A
fluorophore masked with dithiane which recovers fluorescence upon cleavage. (2) A
fluorophore conjugated to an adduct carrying a quencher which upon cleavage releases
the quencher allowing for fluorescence recovery. (3) An adduct carrying self quenching
fluorophores that recover fluorescence upon their release due to photocleavage.
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A.1. Fluorescence recovery by photocleavage of 1,3-dithaine adduct
In addition to the fluorophore meeting the requirements inherent in the three
requirements above for a “turn on” assay , it must also meet the following requirements:
(1) The quantum yield of fluorescence (ФF) must be high, or if low offset by a high
extinction coefficient (ε). This is because ФF*ε is a quality parameter which describes
how efficient a fluorophore is. If ФF is low but the ε is high then the fluorophore is
absorbing most of the light that is put into it, which may allow it to overcome its low ФF.
On the other hand if the ФF is high but the ε is low then the fluorophore may not absorb
enough light to be useful. (2) Irreversible photobleaching must not occur when the
adduct is irradiated for photocleavage (λ from 340 nm to 375 nm). (3) The fluorophore
must not interfere with photofragmentation in dithiane adducts and therefore should not
absorb light considerably at the irradiation wavelength – 365 nm. (4) Both product(s) of
photocleavage (2-alkyl-1,3-dithiane and/or benzophenone) must not quench the
fluorophore.
Initial research had shown that the fluorescence of 2-amidothioxanthones (Figure
3.2) were effectively quenched by two orders of magnitude upon addition of 1,3-dithiane
to form an adduct. Upon photocleavage of these adducts fluorescence of thioxanthone
(TX) is recovered (Figure 3.3).[52] Unfortunately, there is one significant problem with
the use of TX adducts, they are self-cleavable systems (Φself ≥ Φsens), making them
inappropriate for a photoamplification assay where Φself should not exist or be <<< Φsens.
As this rendered adducts of TX unusable for this application I explored the use of
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alternative fluorescent ketones in which the fluorophore’s π-system could be disrupted
via the formation of a covalent C-C bond with dithiane.

Figure 3.2. 2-Amidothioxanthones and their adducts for which fluorescence recovery
takes place upon photofragmentation. ΦF, λex, λem are all in acetonitrile. Adapted from
reference. [52].

Figure 3.3. Fluorescence monitoring of release of dithiane from ATX adduct bound to
tantagel beads: (a) overall curve of fluorescence recovery in 20 mg of TantaGel beads
irradiated with a U-360 nm broad band filter, arbitrary units; (b) pseudocolor image of
the beads (excited at 405 nm), adapted from reference. [52].
Two well known diaryl ketones, which also fluoresce, are fluorenones (3a λex =
293 nm, λem = 470 nm, 3c λex = 312 nm, λem = 450 nm, all λ measurements taken in
ethanol) and 10-methyl-9-acridone (5) (Figure 3.4). The dithiane adducts of both ketones
were prepared via the previously described Corey-Seebach addition[49] to give 4a-c and
6. Fluorenone adducts 4a-c did not fluoresce and cleavage of the adduct, when irradiated
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with a senstizer (BP @ 365 nm or anthraquinone at 405 nm), was confirmed by 1H NMR.
When fluorenones 3a-c were used as the sensitizer it was not possible to photoamplify
the release of fluorenone. This is probably because the excitation of fluorenone is πÆπ*,
not nÆπ*, making it incapable of sensitizing photocleavage. The inability of the adducts
to photoamplify did not alone rule out there use. It is possible to add a photoamplifiable
adduct which could release BP capable of fragmenting the fluorenone adduct. During
fluorescence studies there was no fluorescence recovery upon cleavage of the adduct. It
was found that fluorenone is quenched, at a diffusion controlled rate, by dithiane adduct
which is in solution in bulk ([adduct] > 10 mM).
While we were able to form the acridone adduct 6 it did not undergo sensitized
fragmentation in the presence of acridone, benzophenone, or anthraquinone, but rather
underwent self cleavage when irradiated at either 365 or 405 nm. This is likely due to
stabilization of the charge on acridone after C-C bond fragmentation by the N
heteroatom.

Because diaryl ketones with a heteroatom containing a lone pair in

resonance with the cleavable C-C bond have a high tendency to undergo self cleavage we
decided to direct our efforts in a different direction.

Figure 3.4. Fluorenones and acridone used to design fluorescence recovery adducts.
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A.2. Intramolecular quenching of a fluorophore by linkage to a quencher containing
dithiane adduct
Knowing that coumarins are highly fluorescent, biologically compatible, readily
available or easily synthesized fluorescent tags, they seemed to be excellent choices for
use as fluorescent markers in this application. In addition they have been shown to be
quenched by donors with oxidation potentials less positive than 1.0 V and more positive
than 1.50 V vs. SCE.[62] This led us to believe that dithiane itself might quench
coumarin as its oxidation potential is between 0.73 to 1.18 V vs. SCE.[57], resulting in
the synthesis of coumarin directly coupled to dithiane (Figure 3.5) which unfortunately
showed no decrease in fluorescence intensity as compared to the parent coumarin. As a
result a plan to incorporate a quencher into the adduct itself was devised.

Figure 3.5. N-(3-(1,3-Dithian-2-yl)propyl)-7-(diethylaminocoumarin)-3-carboxamide
To design such an adduct an appropriate quencher had to be identified which (1)
can be linked to the adduct and (2) would not interfere with linking the adduct to the
fluorophore (example in Figure 3.6). Aniline is noted in the literature as a commonly
available quencher of coumarins which works via an electron transfer from aniline to the
coumarin dye.[63]
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Figure 3.6. An example of a fluorophore linked to a quencher containing dithiane
adduct.
Because the synthesis of 2-alkyl-1,3-dithianes is relatively straightforward, it was
decided to incorporate the quencher as part of the alkyl tail of dithiane resulting in 13
(Scheme 3.1). 13 was then added to 4-carboxybenzaldehyde via the previously described
Corey Seeback addition[49] to give the adduct which was turned into its Nhydroxysuccinamide (NHS) ester (16) and coupled to 1,6-diaminohexane extended 7diethylaminocoumarin-3-carboxylic acid (15) to give 8 (Scheme 3.2).

A control

coumarin (17), which is coupled to formylbenzoic acid NHS ester (18) was also
synthesized.
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Scheme 3.1. Synthesis of dithiane with an aniline containing 2-alkyl tail (13).

Scheme 3.2.
Synthesis of 8, 7-diethylaminocoumarin-N-(6-(4-(hydroxy(2-(10(methyl(phenyl)amino)decyl)-1,3-dithian-2-yl)methyl)benzamido)hexyl)-3-carboxamide.

The Stern-Volmer quenching constant (KSV) for quenching of the control
coumarin with dithiane 8 was experimentally determined to be 14,000 M-1s-1. When the
fluorescence of 7 was compared to the control coumarin there was no difference in
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intensity, indicating that the attached aniline was not acting as a quencher. Additionally,
7 showed no evidence of photofragmentation to release dithiane under both self and
sensitized cleavage condition. To confirm that the distance between aniline and the
coumarin was not leading to ineffectual quenching 19 was prepared (Figure 3.7).
Fluorescence results for 19, when compared to the coumarin control, did not exhibit a
difference in fluorescence intensity.

Figure 3.7. 7-(Diethylaminocoumarin-N-(3-(methyl(phenyl)amino)propyl)-chromene-3carboxamide (19).

A.3. Trithiane adducts of self quenching fluorescent dyes
The final effort to prepare a fluorescence recovering adduct was to use highly
fluorescent well known dyes that self quench while also meeting our previously noted
requirements. For this we chose to use Cy3 and coumarin dyes which could be coupled to a
trithiane adduct (Figure 3.8 and Figure 3.9). While both dyes do have a small amount of
absorption at 365 nm (the excitation wavelength for the sensitizer BP) they do not interfere with
cleavage of dithiane adducts when present in solution.
quenching at concentrations above 10-5 M
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In addition they both showed self
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Figure 3.8. Excitation and emission spectra, in DCM, for 20, 2-((1E,3E)-3-(3,3dimethyl-1-propylindolin-2-ylidene)prop-1-enyl)-1-carboxyhexyl-3,3-dimethyl-3Hindolium chloride salt
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Figure 3.9.
Excitation and emission spectra, in DCM, for 21, N-butyl-7diethylaminocoumarin-3-carboxamide
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The trithiane adduct (22, Scheme 3.3) was designed with three free amines to
which the dyes could be coupled. Once prepared both tris adducts of trithiane, containing
Cy3 (23 confirmed by NMR analysis Figure 3.10) or coumarin (24), showed little to no
decrease in fluorescence intensity compared to the free dye. It is possible that the dyes
are too far apart to self quench, but when synthesis of the dye triads was attempted
without the glycine spacer coupling did not take place. In addition the adducts showed
little evidence of cleaving the C-C bond of the trithane adduct. It is possible that the dyes
shield the adduct from triplet benzophenone preventing sensitization and consequently
photocleavage.

Scheme 3.3. Trithiane adduct for attachment of Cy3 and coumarin dyes.
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Figure 3.10. NMR identification of 23.
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B. Towards the Development of a Fluorescence Quenching (“Turn-off”) Assay:
While the “turn-on” assay requires the use of a quenched fluorophore which
recovers fluorescence upon cleavage of the adduct, the “turn-off” assay requires a
fluorophore which is fluorescent until a quencher is introduced to, or produced within,
the assay. In our case the adduct cleaves into two parts upon photofragmentation, BP and
dithiane. If one or both of these parts is capable of quenching the fluorophore, which is
separate from the adduct in solution, this could constitute a fluorescence “turn-off” event.
If this event can be utilized to detect a molecular recognition event then a “turn-off”
assay has been developed.
The requirements for a fluorophore to be used in a fluorescence quenching “turnoff” assay are similar to those for the “turn on” assay and are as follows: (1) the quantum
yield of fluorescence (ФF) must be high; (2) irreversible photobleaching must not occur
when irradiated for photocleavage (λ from 340 nm to 375 nm); (3) the fluorophore must
not interfere with photofragmentation in dithiane-ketone adducts and therefore should not
absorb light considerably above 340 nm; (4) one or both product(s) of photocleavage (2alkyl-1,3-dithiane and/or benzophenone), but not the adduct (i.e. masked benzophenone),
must quench the fluorophore. There are two approaches which can be taken to this type
of “turn-of” methodology - quenching of the fluorophore via energy transfer (dexter
quenching) or quenching of the fluorophore by a reaction which leads to photobleaching.
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B.1. Identifying a fluorophore quenched by energy transfer2
Initial experiments towards the development of the “turn-off” assay utilized
fluorene due to its high ФF of 0.68 and a fluorescence lifetime τF of 10 ns in non-polar
solvents.[3]

Initial studies (Figure 3.11) showed benzophenone to be a very good

quencher for fluorene (KSV = 1100 M-1s-1 in CH2Cl2). Unfortunately the adduct proved to
be an even more efficient quencher (KSV = 2300 M-1s-1), rendering it unsuitable because
the fluorophore τF is too long for this application. We then looked for a fluorophore with
a shorter lifetime (less prone to quenching by the masked sensitizer) and focused on poligophenylenes (Figure 3.12),[65] particularly p-terphenyl (ΦF = 0.84, tf = 0.95 ns),
which strongly absorbs at λmax ~ 280nm (ε ~ 3.5 × 104) with no absorption beyond
330nm, and p-quaterphenyl (ΦF = 0.81, tf = 0.92 ns).
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Figure 3.11. Stern-Volmer plot for fluorescence quenching of fluorene (10-5 M), in
CH2Cl2, by benzophenone, benzhydrol, 2-methyl-1,3-dithiane, and 2-methyl-1,3-dithiane
benzophenone adduct (MDT BP Adduct) to determine KSV for each quencher taken from
reference. [5].
2

Much of the data presented in this section has been taken or adapted from references [5] and [64]
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Figure 3.12. Spectral properties of p-oligophenylenes, taken from reference. [65]
p-Oligophenylenes are well known as durable fluorophores, and commonly used
as a dye in dye lasers due to their resistance to photobleaching,[66,67] a desirable
characteristic for this application. Quenching results for p-terphenyl (p-TPh) and pquaterphenyl (p-QPh) show them to be very efficiently quenched by benzophenone (pTPh: KSV = 3000 M-1s-1 in DCM, 1100 M-1s-1 in t-BuPh; and p-QPh: KSV = 1250 M-1s-1 in
DCM, 1100 M-1s-1 in t-BuPh) whereas the effect of the adduct, 2-methyl-1,3-dithiane
benzophenone adduct (MDT BP adduct) is significantly smaller (KSV = 80 M-1 s-1, 40 M-1
s-1 in t-BuPh) and only relevant at low concentrations (< 10 mM). Quenching by free
alkyl dithianes was found to be insignificant. Compared to p-TPh (in DCM λex max = 280
nm, λem max = 345 nm) the excitation and emission of p-QPh (in DCM λex max = 297 nm,
λem

max

= 376 nm) has a bathochromic shift, with some emission in the visible region

(Figure 3.12). For this reason p-QPh was chosen as the best fluorophore to test a
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fluorescence “turn-off” assay via collisional quenching. We found that the optimum
fluorescence of p-QPh is achieved at a concentration of 2x10-5 M (Figure 3.13).
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Figure 3.13. Determination of the concentration of p-QPh to achieve maximum
fluorescence intensity.
The next step was to verify that enough benzophenone can be produced during
photoamplification to effectively quench the fluorescence of p-QPh. At first a 1H NMR
experiment was run containing equimolar concentrations of p-TPh and BP to rule out a
reaction between the two molecules. NMR’s before and after irradiation at 365 nm
showed no changes. A second 1H NMR experiment was run to show that the production
of BP, as a result of photocleavage, takes place in the presence of p-TPh (Figure 3.14).
The NMR samples contained 1x10-5 M p-TPh, 10 mM MDT-BP adduct, and 1x10-6 M
BP (the concentrations of pTPh and BP are too low to detect by NMR). This experiment
verified that the fluorophore does not interfere with photocleavage of the adduct, nor does
it react with the adduct or any products produced during the cleavage reaction.
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Figure 3.14. 1H NMR of 1x10-5 M p-TPh, 10 mM MDT-BP adduct, and 1x10-6 M BP in
CD3CN (the concentrations of pTPh and BP are too low to detect by NMR) before and
after irradiation.
In order to prove that the assay works it was necessary to show that fluorescence
quenching occurs due to photocleavage of the adduct. A solution containing 30 mM DTBP adduct, 10-5 M BP, and 10-5 M p-QPh was prepared in DCM along with a matching
solution lacking BP. The solutions’ fluorescence intensities were recorded and they were
irradiated using an in house built 365 nm LED reactor. The results, for each sample,
were normalized to their initial fluorescence intensity and plotted to show an
autocatalytic curve for fluorescence quenching which is typical of photoamplification
(Figure 3.15), proving that the use of p-QPh in a photoamplified fluorescence turn off
assay is possible.
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Figure 3.15. Autocatalytic curve for the quenching of p-QPh due to photoamplified
release of BP from DT-BP adduct in DCM. 30 mM DT-BP adduct + 10-5 M BP + 10-5 M
p-QPh (blue), 30 mM DT-BP adduct + 10-5 M p-QPh (red)

B.2. Identifying a fluorophore quenched via a chemical reaction with benzophenone
While quenching of fluorescence generally refers to either the Dexter or Förster
resonance energy transfer mechanisms it can also be applied to any situation where the
fluorescence of a fluorophore is turned off. In coumarins it is well documented that
electron transfer reactions, when coumarins are one half of a donor-acceptor pair, not
only take place but also result in the dealkylation of the diethylamino group.[62,68,69]
In the case of this assay fluorescence is quenched via a reaction of the fluorophore, 3(benzo[d]thiazol-2-yl)-7-diethylaminocoumarin, commonly known as coumarin 6 (C6),
catalyzed by BP, which leads to de-ethylation of C6 to give a secondary fluorophore that
photobleaches quickly upon formation. The two possible reaction mechanisms are shown
in Scheme 3.4 and Scheme 3.5.

Both reactions give the same product, 3-

(benzo[d]thiazol-2-yl)-7-ethylaminocoumarin (25).
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Scheme 3.4. Mechanism 1 for the de-ethylation of Coumarin 6 sensitized by
benzophenone.

Scheme 3.5. Mechanism 2 for the de-ethylation of Coumarin 6 sensitized by
benzophenone.
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The dealkylation reaction of diethylaminocoumarins was verified by 1H NMR
(Figure 3.16) experiments using 7-diethylaminocoumarin-3-(N-butyl)-carboxamide. The
1

H NMR shows both the appearance of acetaldehyde and the loss of one ethyl group,

while the coumarin itself remains intact. Upon isolation of the dealkylated product its
emission was compared with that of the starting coumarin (Figure 3.17) and found to
have a relative ΦF (ethyl/diethyl) of 1.60. This was determined by the following formula
ΦF=[(Astd*PAunk)/(Aunk*PAstd)]*ΦF

std

(see list of abbreviations for definition of

variables). Unfortunately, further investigation of the dealkylated coumarin showed that
its fluorescence was quenched within 20 minutes upon its direct irradiation or its
irradiation with 10-5 BP using 365 nm light (the wavelength at which the
photoamplification reaction takes place).

As a result we decided to utilize this

dealkylation reaction to develop a second fluorescence “turn-off” assay, as the
diethylamino starting coumarin retains more than 80% of its fluorescence after irradiation
at 365 nm for 1 h, but in the prescence of 10-5 M BP it fluorescence is quenched by >
50% in less than 20 minutes.
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Figure 3.16. NMR of dealkylation reaction of 7-diethylaminocoumarin-3-(N-butyl)carboxamide (20) to give 7-ethylaminocoumarin-3-(N-butyl)-carboxamide (25).

550
Intensity (a.u.)
500

Diethylaminocoumarin Ex

450

Diethylaminocoumarin Em

400

Ethylaminocoumarin Ex
Ethylaminocoumarin Em

350
300
250
200
150
100
50
Wavelength (nm)

0
225

275

325

375

425

475

525

575

625

Figure 3.17. Excitation and emission spectra comparison for 7-diethylaminocoumarin-3(N-butyl)-carboxamide (20) and its dealkylated product 7-ethylaminocoumarin-3-(Nbutyl)-carboxamide (25)
72

The final step was to verify 7-diethylaminocoumarins as suitable fluorophores for
this fluorescence “turn-off” assay by showing that photoamplification of benzophenone
does result in its quenching, and that the fluorophore does not interfere with
photoamplification. Coumarin 6 became the preferred fluorophore to carry out these
experiments as its excitation and emission maxima are shifted farther into the visible
range than its carboxamide counterparts (Figure 3.18).

Additionally, its extinction

coefficient at 365 nm (the irradiation wavelength for photochemistry) is lower than for
the coumarin carboxamides.
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Figure 3.18. Excitation and emission spectra of coumarin 6.
A 30 mM solution of DT-BP adduct containing 10-6 M BP, and 10-6 M C6 was
prepared in DCM and 0.05 M PBS (pH7.5) was added. A matching solution lacking BP
was also prepared. The solutions’ fluorescence spectra were recorded (λex = 450 nm) and
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they were irradiated using an in house built 365 nm LED reactor. In Figure 3.19 the
decrease in emission over an irradiation time of 35 min can be seen.
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Figure 3.19. Fluorescence decline over 35 minutes for a sample containing 30 DT-BP
adduct + 10-6 M BP + 10-6 M C6 in DCM under 0.05 M PBS (pH7.5).
The fluorescence intensity at 495 nm for the scan at each irradiation interval was
normalized to the starting intensity at time zero and plotted to show an autocatalytic
curve for fluorescence quenching which is typical of photoamplification (Figure 3.20).
The resulting autocatalytic curve verifies that the fluorescence quenching is due to the
photoamplification of benzophenone from cleavage of DT-BP adduct which sensitizes
the dealkylation of C6 to its quickly photobleached counterpart. In addition 1H NMR
results showed no interference by coumarin in the photocleavage reaction. These results
lead us to believe that coumarin 6 would be a second acceptable fluorophore for this
fluorescence “turn-off” assay. The next step in this assays design was to find conditions
to achieve the lowest possible detection limit.
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Figure 3.20. Autocatalytic curve for the quenching of C6 due to photoamplified release
of BP from DT-BP adduct in DCM under 0.05 M PBS (pH7.5). 30 mM DT-BP adduct +
10-6 M BP + 10-6 M C6 (blue), 30 mM DT-BP adduct + 10-6 M C6 (red).

C. Experimental
C.1. General
Common solvents were purchased from AAper Alcohol and used as is, except for
THF and hexanes. THF was refluxed over and distilled from potassium benzophenone
ketyl prior to use. Hexanes was distilled over calcium hydride before use. All reagents
for which a synthesis is not referenced in the text or described here were purchased from
Alfa Aesar, TCI America, Fisher Scientific, AK Scientific, ChemImpex, or Aldrich. All
reagents were used without purification unless otherwise noted. NMR spectra were
recorded at 25 °C on either a Varian Mercury 400 MHz instrument, or a Bruker Biospin
500 MHZ instrument, in CDCl3 with TMS as an internal standard (unless noted
otherwise). Column chromatography was performed on silica gel, 32-63μ mesh, and the
eluent is noted in the procedure.
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C.2. General Information regarding photoreactions
Photoreactions were carried out using an in house built 365 nm five LED reactor
outfitted with a 300-400 nm long pass filter. For each photoreaction discussed a bulk
solution of fluorophore and adduct was prepared and divided to the appropriate number
of samples. Benzophenone was added to each sample, from a stock solution, at the
appropriate concentration. The concentrations of each reagent in the photoreactions are
stated in the text where the reaction is presented. All bulk solution photoreactions were
carried out in quartz fluorescence spectroscopy cells from NSG precision cells.

C.3. General method for the synthesis of dithiane adducts
A generic method by Corey and Seebach was modified and used to prepare the
desired dithiane adducts.[55] Dithiane (5.1 mmol) was dissolved in freshly distilled THF
(30 mL) and placed under nitrogen. n-Butyllithium (4.3 mL, 6.8 mmol) was added at
room temperature with stirring and the resulting mixture was stirred for 10 minutes.
Benzophenone (3.4 mmol) was dissolved in freshly distilled THF (10 mL) and added to
the anion mixture while stirring. The reaction was left 2 hours at room temperature. The
reaction mixture was quenched with a saturated solution of ammonium chloride and the
aqueous layer was extracted twice with ethyl acetate. The combined organic layer was
dried over anhydrous sodium sulfate. The solvent was removed under vacuum, and the
residue was purified by column chromatography (silica-gel, ethyl acetate/hexanes) or
recrystallization (DCM in hexanes).

76

C.4. Synthetic methods
N-butyl-9-oxo-9H-fluorene-2-carboxamide (3b):

A mixture of 9-fluorenone-2-

carboxylic acid (0.40 g, 1.8 mmol), N-hydroxysuccinimide (0.311 g, 2.7 mmol), and
EDC (1-(3-(dimethylamino)propyl)-3-ethylcarbodiimide hydrochloride, 0.414, 2.2 mmol)
was dissolved in CH2Cl2 (20 mL) and stirred for 24 hours. n-Butylamine (0.27 mL, 2.7
mmol) and NEt3 (5 drops) were added to the mixture which was refluxed for 6 hours.
The solution was left overnight with stirring at room temperature. It was washed with
water (40 mL) and saturated NaHCO3 (40 mL) followed by NaCl (20 mL). The organic
layer was dried over anhydrous sodium sulfate and removed under vacuum.

The

resulting solid was purified using column chromatography (silica gel with 20 % ethyl
acetate in Hexane increased to 40 % ethyl acetate in hexane as the eluent) giving the
product (0.380 g, 76% yield). 1H NMR (CDCl3, 400 MHz): δ 8.06-8.08 (d, 1H), 7.91 (s,
1H), 7.69-7.71 (d, 1H), 7.57-7.62 (t, 2H), 7.51-7.55 (dt, 1H, J=1.1, 7.4Hz), 7.34-7.38 (dt,
1H, J=1.2, 7.4Hz), 6.15 (s, 1H), 3.45-3.50 (dt, 2H, J=5.7, 7.2Hz), 1.58-1.66 (td, 2H,
J=7.4Hz, J=14.8Hz), 1.39-1.48 (qd, 2H, J=7.2, 14.3Hz), 0.95-0.99 (t, 3H, J=7.34 Hz).
(NMR tpg17390_pure)

N-(9-oxo-9H-fluoren-2-yl)butyramide (3c): 2-amino-9-fluorenone (0.50 g, 2.1 mmol),
butyrylchloride (0.41 mL, 3.8 mmol) and a catalytic amount of NEt3 were combined in
dichloromethane and stirred overnight. The organic layer was washed with water, dried
over sodium sulfate, and removed under vacuum. The resulting solid was recrystallized
in toluene to give the desired product (150 mg, 27 %). 1H NMR (CDCl3, 400 MHz): δ
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7.89-7.92 (d, 1H), 7.61-7.64 (d, 1H), 7.58-7.63 (s, 1H), 7.46-7.48 (m, 3H), 7.26-7.27 (m,
1H), 2.35-2.38(t, 2H), 1.75-1.80 (dd, 2H, J=7.32, 14.88Hz.), 1.00-1.04 (t, 3H, J=7.37
Hz). (NMR tpg17384_rc)

9-(2-methyl-1,3-dithian-2-yl)-9H-fluoren-9-ol (4):

To a solution of 2-methyl-1,3-

dithiane (1.34 mL, 11.2 mmol) in freshly distilled THF (10 mL) was added nbutyllithium (1.6M solution in hexanes, 5.3 mL, 8.4 mmol). The resulting mixture was
stirred 10 minutes at room temperature. 9-Fluorenone (0.50 g, 2.8 mmol) in freshly
distilled THF (25 mL) was added slowly. The mixture was stirred overnight at room
temperature.

The reaction was quenched with a saturated solution of ammonium

chloride, extracted with dichloromethane (30 mL) and dried over anhydrous NaSO4. The
mixture was washed with hexane to remove dithiane giving the product (0.161g, 20%
yield) . 1H NMR (CDCl3, 400 MHz): δ 8.04-8.06 (d, 2H, J=7.6 Hz ), 7.56-7.58 (d, 2H,
J=7.5 Hz), 7.35-7.40 (t, 2H, J=7.5Hz, J=11.6Hz), 7.23-7.27 (t, 2H, J=7.5Hz), 3.26-3.29
(m, 2 H), 2.82-2.89 (m, 3H), 1.95-2.07 (m, 2H), 1.23 (s, 3H). (NMR tpg17361_pure)

10-methyl-9-(2-methyl-1,3-dithian-2-yl)-9,10-dihydroacridin-9-ol (6): To a solution of
2-methyl-1,3-dithiane (0.67 mL, 5.6 mmol) in freshly distilled THF (10 mL) was added
n-butyllithium (1.6M solution in hexanes, 2.6 mL, 4.2 mmol) and the reaction was stirred
at room temperature for 10 minutes.. 10-methyl-9-acridone (0.30 g, 1.4 mmol) in freshly
distilled THF (25 mL) was slowly added. The mixture was left overnight at room
temperature.

The reaction was quenched with a saturated solution of ammonium
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chloride, extracted with dichloromethane (30 mL) and dried over anhydrous NaSO4.
Trituration with hexane was utilized to remove dithiane giving the product (0.161g, 20%
yield) 1H NMR (CDCl3, 400 MHz): δ 7.92-7.95 (d, 2H, J=7.8 Hz ), 7.34-7.38 (dd, 2H,
J=7.24, 8.26 Hz), 7.06-7.11 (t, 2H), 6.96-6.98 (d, 2H, J=7.25Hz), 3.46 (s, 1 H), 2.89-2.95
(m, 2H), 2.64-2.71 (m, 2H), 1.86-1.92 (m, 2H), 1.27 (s, 3H). (NMR tpg17362_pure)

N-(3-(1,3-dithian-2-yl)propyl)-7-(diethylaminocoumarin)-3-carboxamide

(7):

Triethylamine (0.20 mL) and DMAP (catalytic) were added to a solution of (14) (0.30 g,
0.84 mmol) and 3-(1,3-dithian-2-yl)propan-1-amine (0.163 g, 0.92 mmol) in
dichloromethane and stirred for 5 hours while the reaction was monitored by TLC. The
reaction mixture was washed with water which was extracted with dichloromethane (100
mL).

The organic solvent was concentrated, gel filtration was carried to remove

remaining dithiane using hexane and then 10% ethyl acetate in hexane (0.230 g, 65 %
yield).

1

H NMR (CDCl3, 400 MHz): δ 8.79-8.81 (t, 1H, J=5.9Hz), 8.69 (s, 1H), 7.41-

7.43 (d, 1H, J=8.97 Hz), 6.3-6.65 (dd, 1H, J=2.5Hz, J=8.9Hz), 6.49 (d, 1H, J=2.20 Hz),
4.06-4.09 (t, 1H, J=6.40 Hz), 3.43-3.47 (q, 4H, J=7.3Hz, J=14.29 Hz), 2.80-2.90 (m, 4H),
2.07-2.13 (m, 1H), 1.82-1.90 (m, 5H). (NMR tpg17501_082406)

(11-bromoundecyl)(tert-butyl)dimethylsilane (9): 11-Bromoundecanol (10.0 g, 40
mmol) and t-butyldimethylsilyl chloride (TBDMSCl) (7.84 g, 52 mmol) were dissolved
in THF (125 mL). Triethylamine (20 mL) and a catalytic amount of DMAP were added
and the reaction was stirred at room temperature overnight. The reaction mixture was
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washed with 5% aq. HCl (100 mL) and water (100 mL). The organic layer was collected,
dried over anhydrous sodium sulfate, and removed under vacuum.

The excess

TBDMSCl was removed by using a high vacuum pump to give (11-Bromo-undecyloxy)tert-butyl-dimethyl-silane (12.78 g, 87% yield).

1

H NMR (CDCl3, 400 MHz): δ 3.58-

3.61 (t, 2H, J=6.6Hz), 3.38-3.58 (t, 2H, J=6.9Hz), 1.82-1.89 (m, 2H), 1.80-1.91 (m, 2H),
1.38-1.55 (m, 4H), 1.45-1.55 (m, 4H), 1.27-1.32 (m, 12H), 0.89 (s, 9H), 0.05 (s, 6H).
(NMR tpg17609)

(11-(1,3-dithian-2-yl)undecyl)(tert-butyl)dimethylsilane (10): To a solution of 1,3dithiane (3.8 g, 32 mmol) in freshly distilled THF (100 mL), at 0 °C and under nitrogen
atmosphere, was added n-butyllithium (1.6M solution in hexanes, 21 mL, 34 mmol). The
resulting mixture was stirred 15 min at 0 °C and then the temperature was lowered to -70
°C. (9) (6.40 g, 17.0 mmol) in THF (40 mL) was added and the reaction was slowly
warmed to room temperature and kept overnight. The reaction mixture was then poured
into saturated aq. NH4Cl (100 mL), extracted with ethyl acetate (100 mL), and washed
with brine (40 mL). The organic layer was collected, dried over anhydrous sodium
sulfate, and removed under vacuum to give the product (13.6 g with dithane present).1H
NMR (CDCl3, 400 MHz): δ 4.02-4.06 (t, 1H, J=6.9Hz, J=13.8Hz), 3.57-3.61 (m, 2H,
J=6.6Hz, J=13.3Hz), 2.78-2.91 (m, 4H), 2.08-2.15 (m, 1H), 1.80-1.91 (m, 1H), 1.70-1.77
(m, 2H), 1.46-1.60 (m, 4H), 1.26-1.30 (s, 14H), 0.89 (s, 9H), 0.05 (s, 6H). (NMR
tpg17613_B
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11-(1,3-dithian-2-yl)undecan-1-ol (11): To (10) (6.39 g, 17 mmol) in THF was added
TBAF (5.91 g, 19 mmol) and the reaction was stirred overnight. The reaction was poured
into NH4Cl (100 mL), extracted with EtOAc (100 mL), and washed with water (25 mL).
The organic layer was dried over anhydrous sodium sulfate and removed under vacuum.
High vacuum was used to remove the silyl group and the product was purified by column
chromatography (silica gel eluted with 10% EtOAc in hexane to remove dithiane and
45% EtOAc in hexane to remove the product) giving 11-[1,3]Dithian-2-yl-undecan-1-ol
(7.86 g, 68% yield starting from 11-bromoundecanol). 1H NMR (CDCl3, 400 MHz): δ
4.02-4.06 (t, 1H, J=6.9, 13.8Hz), 3.62-3.65 (t, 2H, J=6.2, 12.6Hz), 2.79-2.91 (m, 4H),
2.07-2.17 (m, 1H), 1.80-1.91 (m, 1H), 1.71-1.76 (m, 2H), 1.44-1.60 (m, 4H), 1.23-1.36
(s, 14H). (NMR tpg17614_column)

2-(11-Bromo-undecyl)-1,3-dithiane (12): (11) (7.83 g, 27 mmol) and carbon
tetrabromine (10.7 g, 32 mmol) were dissolved in THF (200 mL). Triphenylphosphine
(8.5 g, 32 mmol) was added and the reaction was stirred overnight. The precipitate was
filtered and washed with hexane. The solvent was removed under vacuum and the
resulting residue was dissolved in hexane. The solid was subsequently filtered and
washed with hexane and the solvent was removed under vacuum to give the desired
product with PPh3 present (13.12 g) which was used in the next step. 1H NMR (CDCl3,
400 MHz): δ 4.02-4.06 (t, 1H, J=6.9, 13.8Hz), 3.38-3.41 (t, 2H, J=6.9, 13.8Hz), 2.79-2.91
(m, 4H), 2.07-2.14 (m, 1H), 1.79-1.92 (m, 3H), 1.71-1.76 (m, 2H), 1.34-153 (m, 4H),
1.27-1.31 (s, 12H). (NMR tpg17616_rm)
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N-(11-(1,3-dithian-2-yl)undecyl)-N-methylaniline

(13):

To

a

solution

of

N-

methylaniline (3.33 g, 31 mmol) in freshly distilled THF (30 mL) at -20 °C, under
nitrogen atmosphere, was added n-butyllithium (1.6M solution in hexanes, 21.4 mL, 34
mmol). The resulting mixture was stirred 20 min at this temperature and then crude (12)
(6.56 g, 19 mmol) in THF (20 mL) was added and the reaction was allowed to warm to
room temperature with stirring overnight. The reaction mixture was then pured into 5%
HCl (100 mL), extracted with dichloromethane (50 mL), and washed with aq. sodium
bicarboate (40 mL). The organic layer was collected, dried over saturated sodium sulfate,
and removed under vacuum to give a yellow oil. The product was purified using column
chromatography (silica gel eluted with 5%EtOAc in hexane) to give the product (6.7 g,
67% yield from 11-[1,3]Dithian-2-yl-undecan-1-ol).

1

H NMR (CDCl3, 400 MHz): δ

7.19-7.24 (dd, 2H, J=7.2, 8.9Hz), 6.64-6.70 (m, 3H), 4.02-4.06 (t, 1H, J=6.9Hz), 3.273.31 (m, 2H, J=7.5, 15.1Hz), 2.91 (s, 3H), 2.79-2.89 (m, 4H), 2.08-2.15 (m, 1H), 1.801.91 (m, 1H), 1.71-1.77 (m, 2H), 1.46-1.60 (m, 4H), 1.26-1.30 (s, 14H). 13C NMR
(CDCl3, 400 MHz): δ 149.55, 129.33, 115.96, 112.26, 53.03, 47.91, 38.51, 35.70, 30.73,
29.86, 29.77, 29.72, 29.59, 29.46, 27.42, 26.86, 26.84, 26.30. (NMR tpg17612_pure and
tpg17583_13C)
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7-diethylaminocoumarin-3-carboxylic acid (26): A mixture containing ethanol (20
mL), 4-diethylamino salicylaldehyde (5.0 g, 26 mmol), Meldrum's Acid (3.7 g, 26
mmol), piperidine (0.40 mL), and acetic acid (0.80 mL) was allowed to react at room
temperature for 30 min and then refluxed for 4 hours. The mixture was cooled to room
temperature and chilled in an ice bath for 1.5 h to precipitate the product, a bright orange
solid. The solid was filtered and washed with ice cold ethanol to give pure coumarin
(5.10 g, 75% yield).

1

H NMR (CDCl3, 400 MHz): δ 8.66 (s, 1H), 7.44-7.46 (d, 1H,

J=9.08 Hz), 6.69-6.72 (dd, 1H, J=2.48, 9.03 Hz), 6.53 (d, 1H, J=2.47 Hz), 3.46-3.51 (q,
4H, J=7.16, 14.30 Hz), 1.24-1.28 (t, 6H, J=7.15 Hz). (NMR tpg17472)

7-diethylaminocoumarin-3-carboxylic acid N-hydroxysuccinamide ester (14): (26)
(1.0 g, 3.8 mmol) was dissolved in dichloromethane (50 mL), N-hydroxysuccinimide
(0.66 g, 5.7 mmol) and EDC (0.87 g, 4.6 mmol) were added. The reaction mixture was
stirred overnight at room temperature. The solution was dilluted with water (30 mL),
extracted with ethyl acetate (2 x 30 mL), washed with sodium bicarbonate solution (2x30
mL), and brine (30 mL). The organic layer was collected and evaporated under vacuum
to give a bright yellow solid (1.41 g, 99% yield). 1H NMR (CDCl3, 400 MHz): δ 8.58 (s,
1H), 7.36-7.38 (d, 1H, J=9.04 Hz), 6.62-6.64 (dd, 1H, J=2.5, 9.0Hz), 6.46 (d, 1H, J=2.42
Hz), 3.44-3.51 (q, 4H, J=7.14, 14.29 Hz), 2.88 (s, 4H), 1.55 (s, 4H), 1.24-1.28 (t, 6H,
J=7.15 Hz). (tpg17497_082406)
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tert-butyl 6-(7-diethylaminocoumarin-3-carboxamido)hexylcarbamate (27): N-boc1,6-diaminohexane (0.814 g, 3.8 mmol) was dissolved in DMF(15 mL), triethylamine (1
mL) was added and the mixture was stirred for 5 minutes. (14) (1.0 g, 2.7 mmol) in DMF
(25 mL) and a catalytic amount of DMAP were added the reaction which was stirred
overnight at room temperature.

The reaction mixture was poured into sodium

bicarbonate (50 ml), extracted with ethyl acetate (2 x 40 mL), and washed with brine (50
mL). The organic layer was dried over anhydrous sodium sulfate and removed under
vacuum. The resulting solid was purified on a silica gel column (80% EtOAc:20%
hexane as eluent) to give pure product (0.85 g, 69 % yield).

1

H NMR (CDCl3, 500

MHz): δ 8.78 (s, 1H), 8.70 (s, 1H), 7.41-7.43 (d, 1H, J=8.96 Hz), 6.63-6.65 (dd, 1H,
J=2.49, 8.49), 6.49-6.50 (d, 1H, J=2.40 Hz), 4.54 (s, 1H), 3.40-3.48 (m, 4H), 3.08-3.12
(m, 4H), 1.58-1.64 (q, 2H, J=7.09, 14.03Hz), 1.35-1.51 (m, 15H), 1.22-1.25 (t, 6H,
J=7.13 Hz). (NMR tpg17475_081406)

N-(6-aminohexyl)-7-diethylaminocoumarin-3-carboxamide (15): (27) (0.85 g, 1.8
mmol) was dissolved in dichloromethane (25 mL) and trifluoroacetic acid (2.11 mL, 18.5
mmol) was added. The reaction was stirred overnight and then poured into water. The
water was made basic and extracted with ethyl acetate. The organic layer was removed
under vacuum to give the product (0.453 g, 70% yield). 1H NMR (CDCl3, 500 MHz): δ
8.79 (s, 1H), 8.70 (s, 1H), 7.42-7.44 (d, 1H, J=8.9 Hz), 6.63-6.65 (dd, 1H, J=2.4, 9.0 Hz),
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6.49-6.50 (d, 1H, J=2.4 Hz), 3.41-3.47 (m, 6H), 2.69-2.73 (t, 2H, J = 6.84 Hz), 1.58-1.65
(m, 2H), 1.35-1.51 (m, 6H), 1.22-1.25 (t, 6H, J=7.13 Hz). (NMR tpg17493_082106)

4-(hydroxy(2-(11-(methyl(phenyl)amino)undecyl)-1,3-dithian-2-yl)methyl)benzoic
acid (28): To a solution of (13) (1.0 g, 2.7 mmol) in freshly distilled THF (40 ml), under
nitrogen, was added n-butyllithium (1.6M solution in hexanes, 2.2 mL, 3.5 mmol). The
solution was stirred at room temperature for 15 min. to generate the anion.
Formylbenzoic acid (0.210 g, 1.4 mmol) in THF (20 mL) was added and the reaction
was continued at room temperature for 20 min. before quenching with 5% aq. HCl (20
mL). The reaction mixture was extracted with dichloromethane (50 mL), washed with
NaHCO3 (10 mL) and brine (30 mL). The organic layer was collected, dried over
anhydrous sodium sulfate, and removed under vacuum . The orange oil was purified
using column chromatography (silica gel with an eluent of 7% EtOAc in hexane to
remove dithiane and 45% EtOAc in hexane to remove the product) giving the product
(0.50 g, 68 % yield). 1H NMR (CDCl3, 400 MHz): δ 8.04-8.06 (d, 2H, J=8.5Hz), 7.637.65 (d, 2H, J=8.4Hz), 7.19-7.24 (dd, 2H, J=7.2, 8.9Hz), 6.66-6.72 (m, 3H), 5.24 (s, 1H),
3.36 (s, 1H), 3.26-3.30 (m, 2H, J=7.5, 15.2 Hz), 3.18-3.25 (ddd, 1H, J=2.8, 11.9, 14.5Hz),
3.01-3.09 (ddd, 1H, J=2.6, 11.9, 14.5Hz), 2.91 (s, 3H), 2.66-2.78 (tdd, 2H, J=3.3, 14.2,
18.3 Hz), 2.11-2.20 (m, 1H), 1.83-1.96 (m, 1H), 1.73-1.81 (ddd, 1H, J=4.8, 12.1, 14.4
Hz), 1.43-1.56 (m, 3H), 1.13-1.31 (m, 16H).
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13

C NMR (CDCl3, 400 MHz): δ 172.02,

149.51, 144.25, 129.33, 129.26, 129.08, 129.06, 116.24, 112.55, 73.28, 59.35, 53.15,
38.60, 34.71, 30.18, 29.81, 29.74, 29.72, 29.69, 29.58, 27.39, 26.77, 25.67, 24.48, 24.31
(NMR tpg17621_pure and tpg17624_13C)

4-(hydroxy(2-(11-(methyl(phenyl)amino)undecyl)-1,3-dithian-2-yl)methyl)benzoic
acid N-hydroxysuccinamide ester (16): (28) (0.50 g, 0.944 mmol) was dissolved into
dichloromethane (25 mL) and N-Hydroxysuccinimide (0.163 g, 1.4 mmol) and EDC
(0.217 g, 1.1 mmol) were added. The reaction mixture was stirred overnight at room
temperature. The solution was dilluted with water (30 mL) extracted with ethyl acetate
(2 x 30 mL), washed with sodium bicarbonate solution (2x30 mL), and brine (30 mL).
The organic layer was evaporated under vacuum to give the desired product (0.50 g, 84%
yield). 1H NMR (CDCl3, 400 MHz): δ 8.08-8.10 (d, 2H, J = 8.52 Hz), 7.67-7.69 (d, 2H, J
= 8.45 Hz), 7.19-7.23 (m, 2H), 6.64-6.69 (m, 2H), 5.24 (s, 1H), 3.48 (s, 1H), 3.26-3.30
(m, 2H), 3.15-3.25 (t, 1H, J = 11.91 Hz), 2.98-3.11 (t, 1H, J = 11.93 Hz), 2.91 (m, 7H),
2.64-2.79 (t, 2H, J = 14.90, 18.97 Hz), 2.15-2.19 (m, 1H), 1.84-1.94 (m, 1H), 1.71-1.79
(m, 1H), 1.45-1.60 (m, 5H), 1.05-1.35 (m, 14H). (NMR tpg17643)

7-diethylaminocoumarin-N-(6-(4-(hydroxy(2-(10-(methyl(phenyl)amino)decyl)-1,3dithian-2-yl)methyl)benzamido)hexyl)--3-carboxamide (8): (15) (0.440 g, 0.70 mmol)
was added to a solution of (16) (0.302 g, 0.84mmol) and NEt3 (3 mL) dissolved in DMF
(25 mL), then a catalytic amount of DMAP was added.

The mixture was stirred

overnight. The reaction mixture was decanted into saturated aq. bicarbonate solution,
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washed with brine, and extracted with EtOAc.

The organic layer was dried over

anhydrous sodium sulfate and removed under vacuum to give an orange residue which
was purified by column chromatography (silica gel eluted with EtOAc) to give 8 (100
mg, 17.4 % yield). 1H NMR (CDCl3, 400 MHz): δ 8.80-8.20 (t, 1H, J = 5.42 Hz), 8.66
(s, 1H), 7.75-7.77 (d, 2H, J = 8.24 Hz), 7.57-7.59 (d, 2H, J = 8.22)7.38-7.40 (d, 1H, J =
8.95 Hz), 7.19-7.23 (dt, 2H, J = 8.65, 7.33, 1.36 Hz), 6.67-6.69 (d, 2H, J = 7.91 Hz),
6.62-6.65 (m, 2H), 6.49 (d, 1H), 6.38-6.41 (t, 1H, J = 5.82 Hz), 5.20 (s, 1H), 3.40-3.47
(m, 10H), 3.26-3.30 (m, 2H), 3.16-3.22 (t, 1H, J = 11.90 Hz), 2.99-3.05 (t, 1H, J = 12.17
Hz), 2.91 (s, 3H), 2.65-2.73 (ddt, 2H, J = 18.13, 14.96, 3.67 Hz), 2.12-2.15 (m, 1H), 1.731.92 (m, 2H), 1.62-1.65 (m, 5H), 1.45-1.56 (m, 8 H), 1.17-1.28 (m, 16H).

13

C NMR

(CDCl3, 400 MHz): δ 167.48, 163.33, 162.97, 157.74, 152.64, 149.51, 148.17, 141.52,
134.40, 131.28, 129.27, 129.02, 126.04, 115.88, 112.20, 110.49, 110.09, 108.53, 96.69,
73.48, 59.32, 52.96, 45.23, 39.84, 39.36, 38.44, 34.77, 30.18, 29.78, 29.70, 29.66, 29.60,
27.35, 26.79, 26.73, 26.50, 25.63, 24.50, 24.32. (NMR tpg17647_pure, tpg17647_13C,
and tpg17647_cosy)
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Cosy for (8).
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7-Diethylaminocoumarin-3-carboxylic

acid

[6-(4-formyl-benzoylamino)-hexyl]-

amide (17): (15) (0.094 g, 0.26 mmol), (18) (0.065 g, 0.26 mmol), NEt3 (0.20 mL) and
DMAP (catalytic) were put into DMF and stirred at room temperature overnight. This
solution was poured over ice and made basic. The water was then extracted with DCM
and the organic solvent was dried over anhydrous sodium sulfate. The solvent was
removed under vacuum to give pure product (60 mg, 47% yield). 1H NMR (CDCl3, 400
MHz): δ 10.06 (s, 1H), 8.81-8.83 (t, 1H), 8.62 (s, 1H), 8.14-8.17 (s, 1H), 7.99-8.00 (d,
2H, J=7.83 Hz), 7.93-7.95 (d, 2H, J=8.17 Hz), 7.36-7.38 (d, 1H, J=8.95), 6.62-6.64 (m,
1H), 6.49 (s, 1H), 3.43-3.49 (m, 8H), 1.62-1.67 (dt, 4H, J=6.6, 13.8Hz), 1.37-1.52 (m,
4H), 1.22-1.25 (t, 6H, J=7.23 Hz). (NMR tpg17493_082106)

Formylbenzoic acid N-Hydroxysuccinamide ester (18): Formylbenzoic acid ( 0.5 g,
3.33 mmol), N-hydroxysuccinimide (0.57 g, 4.9 mmol), and EDC (0.48 g, 4.0 mmol)
were dissolved in amixture of DCM:THF (1:1) and stirred overnight. The solution was
washed with water (30 mL), NaHCO3 (30 mL) and brine (30 mL). The organic layer was
dried over anhydrous sodium sulfate and removed via vacuum filtration to give the
product formylbenzoic acid N-Hydroxysuccinamide ester (0.550 g, 68% yield). 1H NMR
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(CDCl3, 500 MHz): δ 10.20 (s, 1H), 8.33-8.34 (dt, 2H, J = 3.43, 0.95 Hz), 8.18-8.19 (dt,
2H, J = 3.08, 1.01 Hz), 2.94 (s, 4H). (NMR tpg17480_081406)

7-Diethylaminocoumarin-3-carboxylic

acid

[3-(methyl-phenyl-amino)-propyl]-

amide (19): To a solution of N-(3-aminopropyl)-N-methylaniline (0.28 g, 1.7 mmol) in
DMF (25 mL) was added triethylamine (2 mL), (14) (0.5 g, 1.1 mmol) and DMAP
(catalytic amount). The reaction was stirred overnight at room temperature. The mixture
was poured over ice and extracted with ethyl acetate (3 x 30 mL), washed with brine (25
mL), dried over anhydrous sodium sulfate, and removed under vacuum to give the
product containing the starting amine.

The residue was purified by column

chromatography (silica gel eluted with ethyl acetate) to give the product (0.360 g, 63%
yeild). 1H NMR (CDCl3, 400 MHz): δ 8.86-8.89 (t, 1H, J = 5.68 Hz), 8.70 (s, 1H), 7.427.44 (d, 1H, J = 8.97), 7.21-7.25 (m, 2H), 6.72-6.74 (dd, 2H, J = 0.93, 8.83 Hz), 6.666.70 (m, 1H), 6.63-6.65 (dd, 1H, J = 2.54, 9.04 Hz), 3.39-3.51 (m, 8H), 2.95 (s,3H), 1.881.95 (m, 2H, J = 7.14, 14.25 Hz), 1.22-1.26 (t, 6H, J = 7.12 Hz). (NMR tpg17662_rm)

Synthesis of cyanine dye (20):

2,3,3-trimethyl-1-propyl-3H-indolium

bromide:

A

mixture

of

2,3,3-

trimethylindolenine (2.0 mL, 13.0 mmol) and 1-bromopropane (1.42 mL, 16 mmol) in
1,2-dichlorobenzene (10 mL) was heated in a pressure vessel at 110 °C with stirring for
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24 h.

The solution was cooled to room temperature, chilled in the fridge (4 °C)

overnight. The solvent was decanted, and the glassy red/brown residue which remained
was dissolved in methanol. Methanol was removed under vacuum to give the crude
product which was purified by column chromatography (silica gel eluted with 10:1
DCM:MeOD) to give pure product (2.06 g, 52% yield). 1H NMR (CD3OD, 500 MHz): δ
7.87-7.91 (m, 1H), 7.77-7.80 (m, 1H), 7.64-7.68 (m, 1H), 4.48-4.52 (m, 2H), 2.15-2.16
(dq, 2H, J = 7.94, 7.96, 15.87 Hz), 1.62 (s, 6H), 1.30 (s, 3H), 1.08-1.12 (t, 3H, J = 7.42
Hz). (NMR tpg27025_fr30)

(E)-3,3-dimethyl-2-(2-(N-phenylacetamido)vinyl)-1-propyl-3H-indolium bromide: A
mixture of N,N-diphenylformamidine (0.59 g, 3.0 mmol) and 3,3-dimethyl-2-methylene1-propylindoline (0.7 g, 2.5 mmol) was refluxed in acetic anhydride (10 mL) for 30 min.
The solution was cooled to room temperature and the solvent was removed to give an
impure product which was used in the next step.

1-(5-carboxypentyl)-2,3,3-trimethyl-3H-indolium bromide: A mixture of 2,3,3trimethylindolenine (6.0 mL, 39 mmol) and 1-bromohexanoic acid (9.36 g, 48 mmol) in
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1,2-dichlorobenzene (50 mL) was heated in a pressure vessel at 110 °C with stirring for
72 h. The solution was cooled to room temperature, chilled in a fridge (4 °C) 2 h, and
then the solvent was decanted, and the residue which remained was dissolved in ethanol.
Ethanol was removed under vacuum to give the crude product which was purified by
column chromatography (silica gel eluted with 10:1 DCM:MeOD) to give pure product
(9.79 g, 57%yield). 1H NMR (CDCl3, 500 MHz): δ 7.71-7.73 (m, 1H), 7.56-7.61 (m, 3H),
4.68-4.72 (t, 2H), 3.15 (s, 3H), 2.42-2.46 (t, 2H, J=6.92 Hz), 1.98-2.07 (td, 2H, J=16.26,
8.33 Hz), 1.70-1.78 (m, 2H), 1.65 (s, 6H), 1.58-1.63 (m, 2H). (NMR tpg27228, 11)

1-(5-carboxypentyl)-2-((1E,3E)-3-(3,3-dimethyl-1-propylindolin-2-ylidene)prop-1enyl)-3,3-dimethyl-3H-indolium chloride (20 abbreviated Cy3): A mixture of 2Methyl-3-(3-carboxyhexyl) benzooxazole Iodine salt (1.3 g, 3.5 mmol), acetanilide
derivative (1.52 g, 2.96 mmol), and dry triethylamine (1 mL) in absolute ethanol (90 mL)
was refluxed for 2 h. The solvent was removed under vacuum and the crude product was
purified twice by column chromatography using silica gel (column 1; 7%MeOD in DCM,
column 2: 20% Hexane in EtOAc then 7% MeOD in DCM) to give the pure product
(0.72 g, 40 % yield). 1H NMR (CDCl3, 500 MHz): δ 8.55-8.61 (t, 1H, J = 13.46 Hz), 7.93
(s, 1H), 7.56-7.58 (dd, 2H, J = 2.16, 7.14 Hz), 7.45-7.49 (t, 2H, J = 8.16), 7.37-7.40 (dd,
2H, J = 4.42, 7.92 Hz), 7.32-7.36 (t, 2H, J = 7.48 Hz), 4.14-4.20 (dt, 4H, J = 7.62, 11.91
Hz), 2.33-2.36 (t, 2H, J = 7.28 Hz), 1.86-1.96 (m, 4H), 1.78 (s, 12H), 1.70-1.76 (m, 2H),
1.52-1.58 (m, 2H), 1.09-1.12 (t, 3H, J = 7.42 Hz). (NMR tpg27293_column1, 60)
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N-butyl-7-diethylaminocoumarin-3-carboxamide (21): (14) (0.30 g, 0.84 mmol) was
added to a solution of n-butylamine (0.11 mL, 1.1 mmol) and NEt3 (0.15 mL) in
dichloromethane (15 mL). The reaction was left overnight at room temperature before
being poured into 5% aq. HCl (25 mL), extracted with dichloromethane (2 x 30 mL), and
washed with saturated aq. NaHCO3 (25 mL). The organic layer was collected, dried over
anhydrous sodium sulfate, and removed under vacuum to give the product (0.20 g, 75%
yield). 1H NMR (CDCl3, 500 MHz): δ 8.79-8.83 (t, 1H, J = 5.86 Hz), 8.73 (s, 1H), 7.457.46 (d, 1H, J = 8.95 Hz), 7.29 (s, 1H), 3.44-3.53 (m, 6H), 1.60-1.66 (m, 2H), 1.41-1.48
(dq, 2H, J = 7.31, 7.35, 14.66 Hz), 1.25-1.28 (t, 6H, J = 7.13 Hz), 0.96-0.99 (t, 3H, J =
7.36 Hz).

13

C NMR (CDCl3, 400 MHz): δ 163.20, 162.98, 157.63, 152.63, 148.14,

131.25, 110.78, 110.07, 108.61, 96.78, 45.25, 39.58, 31.85, 20.44, 14.00, 12.63. (NMR
tpg17714_pure and tpg17714_13C)

Synthesis of trithiane adduct (22)

N-benzylidene-1,1,1-trimethylsilanamine: To the solution of hexamethyl disilazane (46
mL, 0.22mol) in THF (150 mL), BuLi (1.6 M, 125 mL, 0.2mol) was added at 0 °C and
stirred for 1h at this temperature. Then benzaldehyde (20 mL ) was added at 0 °C and
stirred for 10h at 20 °C. Distilled Me3SiCl (25 ml) was added, the formed precipitate was
filtered off, the solvents were removed, the residue was distilled on a high vacuum pump
to give the product (30 g, 77% yield) 1H NMR (CDCl3, 400 MHz): δ 8.98 (s, 1H), 7.797.81 (m, 2H), 7.40-7.47 (m, 3H), 0.26 (s, 9H). (NMR mpc24166_disfrac)
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(1,3,5-trithiane-2,4,6-triyl)tris(phenylmethanamine): To a suspension of 1,3,5trithiane (2.0 g, 14.4 mmol) in 20 mL THF, t-BuLi (1.7 M in pentane, 34 mL, 57.8 mmol)
was added at -20°C and allowed to stir at this temperature for 1 hour. N-trimethylsilyl
imine (8.46 g, 47.7 mmol) solution was then added and the reaction mixture was allowed
to stirr for 3 hours at room temperature. The reaction was quenched with saturated NH4Cl
solution, the organic layer was separated and the compound was extracted with DCM.
The organic layer was washed with 10% aq. HCl. The organic layer was removed and
the aqueous layer was made basic with 20% NaOH and washed with CH2Cl2. The
organic layer was extracted, dried, and removed to give the product. (Yield: 5.5 g, 84 %)
1

H NMR (Acetone, 400 MHz): δ 7.22-7.39 (m, 15H), 4.56-4.74 (m, 3H), 4.21-4.24 (m, 3

H), 3.22-3.30 (m, 6H). (NMR mpc24168_rm)

NHBoc
HN

O
S

O
BocHN

S

NH
S
O

NHBoc

N
H

tert-butyl-(2,2',2''-(1,3,5-trithiane-2,4,6-(riyl)tris(phenylmethylene)tris(azanediyl)
tris(2-oxoethane-2,1-diyl)tricarbamate: Boc-Gly-OH (1.35 g, 7.72 mmol), EDC-HCl
(1.48 g, 7.72 mmol), 1-Hydroxy-benzotriazole hydrate (1.04 g, 7.72 mmol) were added to
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a solution of trithiane adduct (1.0 g, 2.20 mmol) in DMF (30 mL) and allowed to stir
overnight at room temperature. DMF was removed under vaccum, the compound was
extracted with ethyl acetate, washed with 5% aq. NaOH solution and brine. The organic
layer was dried over anhydrous Na2SO4 and concentrated. The compound purified by
column chromatography. (Yield 1.55 g, 76 %) 1H NMR (CD3OD, 400 MHz): δ 7.53 (s,
3H), 7.20-7.30 (m, 15H), 5.31-5.32 (t, 3H, J = 5.74 Hz), 4.67-4.71 (m, 3 H), 3.66-3.74
(m, 6H), 1.40 (s, 27H). (NMR mpc24170_68)

N,N',N''-(1,3,5-trithiane-2,4,6-triyl)tris(phenylmethylene)tris(2-aminoacetamide)
(22): To N-Boc protected (1,3,5-trithiane-2,4,6-triyl)tris(phenylmethanamine) (1.1 g,
1.12 mmol), HCl (12 mL, 4.0 M in dioxane) was added and stirred for 30 min at room
temperature. The reaction mixture was quenched with 5% aq. NaOH solution. Compound
was extracted with EtOAc, dried over anhydrous Na2SO4 and concentrated to give the
product (Yield: 0.711 g, 93 %). 1H NMR (DMSO, 400 MHz): δ 8.45 (s, 3H), 7.27-7.32
(m, 15H), 5.22-5.23 (m, 3H), 4.95-5.10 (m, 3H), 3.29 (s, 6H), 3.07-3.12 (m, 6H). (NMR
mpc24179_rm)

1,1',1''-(6,6',6''-(2,2',2''-(1,3,5-trithiane-2,4,6-triyl)tris(phenylmethylene)tris(azanediyl)tris(2-oxoethane-2,1-diyl))tris(azanediyl)tris(6-oxohexane-6,1-diyl))tris(2((1E,3E)-3-(3,3-dimethyl-1-propylindolin-2-ylidene)prop-1-enyl)-3,3-dimethyl-3Hindolium) chloride (23): (20) (0.243 g, 0.47 mmol) and DIEA (0.175 mL, 1.0 mmol)
were dissolved in DMF (6 mL). PyBOP (0.27 g, 0.52 mmol) was added in one portion
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and the reaction mixture was stirred for 5 min at room temperature. A solution of (22)
(0.100 g, 0.16 mmol) in DMF (1 mL) was added and the reaction was left overnight with
stirring. The mixture was diluted with chloroform (50 mL), washed with water (2 x 40
mL) and brine (40 mL), dried over anhydrous Na2SO4, and the solvent was removed
under vacuum. Ethanol (10 mL) was used to dissolve residue, diethyl ether was added
(15 mL) to precipitate the product. This was repeated twice. Diethyl ether (10 mL) was
then added, the mixture was heated to boiling, and the solid was decanted. The solid was
then purified by column chromatography (silica gel eluted with ethanol in chloroform
gradient 0-8%) to give the pure reddish product which was dried under high vacuum (100
mg, 10 % yield). 1H NMR (CDCl3, 500 MHz) 8.52-8.57 (t, 3H, J = 13.52 Hz), 7.93 (s,
3H), 7.53-7.57 (t, 6H, J = 8.23 Hz), 7.41-7.48 (dt, 6H, J = 19.24, 7.87 Hz), 7.21-7.35 (m,
27H), 6.45-6.52 (m, 6H), 5.29-5.35 (m, 3H), 4.80-4.86 (m, 3H), 4.05-4.16 (m, 12H),
3.84-3.88 (m, 6H), 2.27-2.31 (ddd, 6H, J = 10.23, 7.10, 2.85 Hz), 1.80-1.88 (m, 12H),
1.76 (s, 36 H), 1.70-1.74 (m, 6H), 1.49-1.56 (m, 6H), 1.03-1.06 (td, 9H, J = 7.36, 7.32,
1.07 Hz). (NMR tpg27307_column1, 50, and tpg27307_cosy)

N,N',N''-(2,2',2''-(1,3,5-trithiane-2,4,6-triyl)tris(phenylmethylene)tris(azanediyl)
tris(2-oxoethane-2,1-diyl))tris(7-diethylaminocoumarin-3-carboxamide) (24):
(26) (0.173 g, 0.66 mmol) and DIEA (0.24 mL, 1.3 mmol) were dissolved in DMF (3
mL). PyBOP (0.345 g, 0.66 mmol) was added in one portion and the reaction mixture
was stirred for 5 min at room temperature. A solution of the 4-fluorophenyl version of
(22) (0.15 g, 0.22 mmol) in DMF (1 mL x 2) was added and the reaction was left
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overnight with stirring.

The mixture was poured over ice and a yellow solid was

collected by vacuum filtration. The solid was then purified by column chromatography
(silica gel eluted with ethanol in chloroform gradient of 0 to 6%) to give pure product
(0.140 g, 15% yield) 1H NMR (CDCl3, 500 MHz): δ

9.30-9.33 (t, 1H, J = 5.90 Hz),

9.25-9.27 (t, 2H, J = 5.42 Hz), 8.62-8.67 (m, 3H), 7.42-7.46 (m, 3H), 7.23-7.30 (m, 6H),
6.91-6.95 (td, 3H, J = 3.89, 8.54, 8.56 Hz), 6.86-6.89 (t, 3H, J = 8.61 Hz), 6.63-6.68 (ddd,
3H, J = 2.90, 7.70, 9.02 Hz), 6.48-6.51 (dd, 3H, J = 2.11, 11.90 Hz), 5.42-5.44 (dd, 1H, J
= 5.94, 8.27 Hz)., 5.32-3.39 (m, 2H), 4.71-4.72 (d, 1H, J = 5.09 Hz), 4.66-4.68 (t, 2H, J =
5.41 Hz), 4.07-4.38 (m, 6H), 3.44-3.53 (m, 12H), 1.13-1.39 (td, 18H, J = 2.77, 7.04, 7.05
Hz). (NMR tpg27363_column, 10, and tpg27363_cosy)

97

Cosy of (24):
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Chapter 4: Optimizing a Fluoresence “Turn-off” Assay
In Chapter 3 two fluorophores were identified for use in this assay: p-QPh and
C6. The next step in developing this new photoinduced methodology for an ultra-high
sensitivity fluorescence “turn-off” assay is to optimize the other two integral components:
(1) the masked sensitizer (adduct) and (2) the solvent. What is important to understand
about these optimizations is that they are an iterative process, meaning that to optimize
one we must optimize the other.
To choose a dithiane-benzophenone adduct we must always consider two factors,
solubility and purity. As far as the solvent is concerned we know that the assay works in
DCM. While DCM is an excellent solvent from a reactivity and solubility standpoint it is
not ideal in regards to evaporation, with a boiling point of 40 °C. But, before the adduct
can be modified to improve solubility some requirements for the solvent must be laid out.
The solvent should: (1) be hydrophobic with a high boiling point and low viscosity; (2)
dissolve the masked sensitizer (a dithiane adduct of benzophenone) which will be used;
(3) allow for the use of an adduct which can be choromatographed or crystallized to high
purity; (4) allow for high quantum yields of fragmentation; (5) not interfere with
photochemistry or emission of the fluorophore; (6) be immiscible with aqueous
physiological buffers which will hold the target (“receptor”); and (7) allow for
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benzophenone to diffuse through solution with a diffusion coefficient similar to DCM
(1.5 x 10-5 cm2 s-1).

A. Improving Solubility of the Masked Sensitizer (Adduct)
Before we can improve the adducts solubility we must consider the solvent
requirements to determine the types of solvent into which the adduct must dissolve. The
solvent should be hydrophobic with a high boiling point and low viscosity.

The

requirement for hydrophobicity is mandated by the need for high quantum yields of
fragmentation.

The use of hydrophobic solvents increases the quantum yield of

sensitized fragmentation (Φsens). In non-polar/hydrophobic solvents the rate of electron
transfer (ET) is slower than in polar/hydrophilic solvents. This also means that the rate of
back electron transfer is slowed, meaning that once electron transfer occurs there is more
time for the sensitizer and adduct to diffuse away from one another before BET takes
place. The result is an overall increase in Φsens. A hydrophobic solvent will also be
immiscible with aqueous physiological buffers which will hold the target (“receptor”).
Because the final application of this assay is a chip, the solvent needs to be high
boiling in order to prevent rapid evaporation at room temperature. In order to be high
boiling and hydrophobic it is likely that the ideal solvent will be an alkane, such as
decane, or incorporate an alkane chain into its structure.

Contradictory to this

requirement of a high boiling solvent is the need for low viscosity. Viscosity is an issue
as the solvent must allow for benzophenone to diffuse through solution with a diffusion
coefficient similar to DCM (1.5 x 10-5 cm2 s-1). The experimentally determined diffusion
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coefficients for 4-trifluoromethylbenzophenone, which I measured by

19

F NMR in

several solvents, either purchased or synthesized, are shown in Table 4.1.
The first step in determining which solvent to move forward with was to design
and synthesize adducts which would be soluble in more hydrophobic solvents such as
decane and pristane. If we are to follow the principle that like dissolves like then the
adduct itself must be made more hydrophobic. To implement this we can substitute the
adducts protons at R1, R2, R3, or R4 with an alkyl tail (Figure 4.1). In Chapter 2 I
reported that the Φsens for DT-BP adduct is 0.12, and that by introducing an alkyl chain as
R1 (2-alkyl-1,3-dithiane benzophenone adduct) Φsens can be increased to ≥ 0.23
depending on the length of the alkyl chain.[6] It was found that such adducts undergo
small amounts of ground state cleavage (thermally induced) and unsensitized cleavage,
and are therefore not suitable. Thioxanthone adducts undergo thermal cleavage at 30
Kcal/mol which will result in the production of nanomolar amounts of thioxanthone in
minutes at room temperature. This is most likely due to the increased steric effect placed
upon the cleaving C-C bond when a substituent is present. This rules out modification at
R1.

Figure 4.1. 2-Alkyl-1,3-dithaine adduct of BP showing all possible modification points
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Table 4.1. Diffusion coefficients of 4-trifluoromethylbenzophenone in various solvents
measured by 19F PFG NMR
Solvent

Diffusion Coefficient (cm2s-1)

Adiponitrile

1.26E-06

Dichloromethane

1.50E-05

Ethyl Acetate
Pristane
(2,6,10,14-tetramethylpentadecane)
t-Butyl Benzene

1.48E-05
4.30E-06

Tetradecane

8.14E-06

2,2,4,4,6,8,8-heptamethylnonane

6.00E-06

2-Phenylethyl Priopionate

2.34E-06

3-Phenylpropyl Acetate

2.04E-06

Propionic acid 2-ethyl-2propionyloxymethyl-butyl ester (2b)

1.55E-06

2,2-Dimethyl-propionic acid 2,2dimethyl-propyl ester (10)

4.65E-06

Propionic acid 2-methyl-3-propionyloxy2-propionyloxymethyl-propyl ester (4)

9.09E-07

Butyric acid 2-butyl-2-butyryloxymethylhexyl ester

8.59E-07

Propionic acid 2,2-bis-bromomethyl-3propionyloxy-propyl ester (3b)

2.32E-07

Acetic acid 3-acetoxy-2,2-bisbromomethyl-propyl ester (3a)

1.49E-07

Propionic acid 2-bromo-1,1-bisbromomethyl-ethyl ester (5)

2.02E-07

Propionic acid 3-chloro-2,2-dimethylpropyl ester (9)

2.75E-06

2,2-diethylpropane-1,3-diyl bis(2,2,3,3,3pentafluoropropanoate) (6)

1.92E-06

Tetrahexylammonium
bis(trifluoromethanesulfonyl)imide (16)*

1.20E-06

1-Hexyl-3-methylimidazolium
bis(trifluoromethanesulfonyl)imide (15)*

1.28E-06

Methyltrioctylammonium
bis(trifluoromethanesulfonyl)imide (11)*

9.07E-07

6.50E-06

*Ionic Liquid
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The second option was to prepare adducts modified with Cn (alkyl) tails at R2, R3,
and R4 (refer to Figure 4.1). Adducts 1b, have a Cn substituent at R4, n = 2, 4 or 8.
Adducts 1c, have a Cn substituent at R2 or R3, n = 2,3,4,5,6,8, or 12, and adducts 1d, have
a Cn substituent at R2 n=8 and R4, n=4, or 5. Adducts substituted with alkyl chains at both
R2 and R3 were also created, but they did not further improve solubility. Before testing
these adducts for solubility their ability to take part in a sensitized photofragmentation
reaction was evaluated. The Φsens range from 0.12 for adducts 1b (adducts modified at
R4) to 0.18 for adducts 1c (adducts modified at R2 or R3). Additionally, no unsensitized
cleavage was detected by 1H NMR when irradiated at 365 nm for up to 4 hours.
Next the solubility of these adducts was tested in three hydrophobic, high boiling
solvents – decane, dodecane, and pristane (Table 4.2).[64] From these results a direct
correlation between the length of the Cn tail, on the adducts, and its solubility in higher
alkanes can be made. In Table 4.2 there is also a column indicating whether the adduct is
recrystallizable or not. This has to do with purification of the adduct which will be
discussed in the next section of this chapter.
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Table 4.2. Representative results for the solubility of adducts (Figure 4.1). Rn = R
substituted on the adduct and Cn = tail length. If the adduct eventually crystallized from
the solvent the time for this to occur is indicated.

Rn

Cn

Recrystallizable

n/a*
n/a
1
1
1
2
1
6
1
10
2
1
2
2
2
4
2
5
2
6
2
8
2
10
2
12
4
4
2,4
5,8
2,3
2
*Unsubstituted DT-BP Adduct

y
y
y
n
n
y
y
n
n
n
n
n
n
n
n
y

DCM

Decane

Dodecane

Pristane

y
y
y
y
y
y
y
y
y
y
y
y
y
y
y
y

n
n
n
n
y
n
n
5 days
5 days
y
y
y
y
n
y
2 days

n
n
n
n
n
n
n
5 days
y
y
y
y
y
n
y
2 days

n
n
n
n
n
n
n
7 days
y
y
y
y
y
n
y
2 days

B. Increasing the Purity of the Masked Sensitizer (Adduct)
Initially purity of the adducts was determined by 1H NMR. It was realized that
this was not a good measure of purity when the crude synthesized adduct showed no BP
to be present and the fluorescence assay results, at this time in DCM, were not
reproducible from one batch of the adduct to the next. We found the assay we were
developing to be more sensitive to the presence of trace amounts of BP (less than 10-5 M
or 1.82 ppm) than NMR, and thus, had to rely upon it (the assay being developed) to
determine the purity of each batch of adduct and the overall detection limit of BP.
Because there currently is no method to differentiate between a minute impurity of BP
and very small amounts of direct (unsensitized) cleavage of the adduct we cannot
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determine whether the BP present is truly an impurity or if it is a product of cleavage and
therefore will always determine our detection limit.
In Table 4.2 the ability of the adduct to be recrystallized is noted. The adducts
can be purified by one of two methods, recrystallization or column chromatography with
silica gel. Recrystallization is generally accepted as a better method for purification
when possible. This is because silica gel can catalyze minute degradation of the product
being purified. In our case, it is highly likely that silica gel, which is acidic in nature, can
cause very small amounts of cleavage of the adduct. The result would be that the same
purity achieved during recrystallization cannot be achieved as a trace amount of BP, not
detectable by NMR, is always produced during chromatographic purification. Therefore,
the method by which purification takes place has a large effect on the detection limit of
the assay.
Initial studies were done in DCM, as the recrystallizable adducts were all soluble
in it. A solution containing 2x10-5 M p-QPh and 30 mM DT-BP adduct recrystallized 8
times was prepared and divided into 3 samples. The sensitizer, BP, was added to samples
1 and 2 at 10-6 and 10-7 M respectively. The third sample did not contain any added
sensitizer. The initial fluorescence intensity of each sample was recorded and then they
were all irradiated at 365 nm using a carousel reactor. The fluorescence intensity of each
sample was recorded at regular intervals to give the results in Figure 4.2.
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Figure 4.2. Normalized fluorescence emission to determine the detection limit for
photoamplified fluorescence quenching of p-QPh by benzophenone in DCM using
recrystallized DT-BP adduct.
The adducts must have alkyl substituents to afford solubility in the best
hydrophobic solvents. In decane (bp = 174 °C) it takes 2-3 hours to evaporate from a
capillary chip at room temperature, while in pristane (bp = 68 °C @ 0.001 mmHg) it
takes ˃5 hours to evaporate from a capillary chip.

This means that adducts which are

soluble in higher boiling alkanes will require purification by column chromatography, as
they have an alkyl substituent(s) present.
achieved in pristane.

The best results for these adducts were

The samples were prepared, and the experiment carried out,

identical to the experiment described in DCM. The results are shown in Figure 4.3.
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Figure 4.3. Normalized fluorescence emission to determine the detection limit for the
photoamplified fluorescence quenching of p-QPh by benzophenone in pristane using
column purified DT-OBP adduct.
The detection limit in DCM (10-7 M BP – 18 ppb, 18 μg/L), using the
recrystallized adduct is clearly much lower than that for pristane (10-6 M BP – 180 ppb,
180 μg/L) where a column purified adduct was used. The maximum difference in
normalized fluorescence intensity between a sample with 10-6 M BP and no BP in DCM
is 0.84 while in pristane it is 0.23. Although both results are reproducible, within 20% of
those shown, they are clearly better in DCM. This is especially true when one considers
that 10-7 M BP is reproducibly detectable in DCM with an intensity difference of 0.61,
but that it is not detectable in pristane. Thus, the conclusion is drawn that in order to
achieve higher sensitivity a recrystallizable adduct should be used.
I must point out that the assay being developed is an amplified assay, meaning
that a small amount of analyte produces a large response as the presence of BP is
photoamplified. In the case of DCM (Figure 4.2 above) 10-7 M BP (18 ppb) was
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reproducibly detected. This translates into a 100,000 fold amplification of the original
sensitizer. This estimate is determined by the fact that there is 30 mM adduct in solution,
and that at least 33% of this adduct undergoes photocleavage to produce benzophenone
during the irradiation period, producing the maximum difference in fluorescence
intensity. The result is the generation of minimum of 10 mM BP, giving us 100,000
times its starting concentration. This is significant as chemical preamplification takes
place before the use of scientific instrumentation/hardware, such as spectrophotometers
or chip readers, to “read” the results. This signal amplification affords scientists the
ability to detect a wide range of molecular binding events. It not only improved the
signal strength from those events which are already detectable at reasonable limits, but
also affords one the ability to identify binding events which, without this amplification,
would be difficult to detect or undetectable.

C. Towards Implementation onto a Microarray Chip – Finding the Right Solvent.
The end product of this research will be a chip which is easy to use. Thus, it
would be ideal to utilize a solvent that is more resistant to evaporation than DCM but
offers a better detection limit than pristane. To do this the reaction was studied in various
solvents to identify a solvent “type” which may allow for the use of a recrystallizable
adduct. The results of these studies (Table 4.3) show that the largest difference in
normalized fluorescence intensity between a sample containing the fluorophore (p-TPh or
p-QPh) and 30 mM DT-BP adduct with 10-7 M BP and one without BP is achieved in
DCM. The next best solvents, which do not affect the photochemistry of the adduct,
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appeared to be ethyl acetate, benzene, and cyclohexane. All of these solvents have
similar rates of evaporation to DCM. As a result the use of solvents with similar
functional groups and properties were explored as possible solvent choices for
implementation onto a chip.
Table 4.3. p-QPh fluorescence “turn-off” photoamplification assay results in selected
solvents
Solvent

Difference*

Photoamplification
Negatively Effected

Adipodinitrile
Dichloromethane
Ethyl Acetate

0.42
0.61
0.38

yes
no
no

t-Butyl Benzene

0.18†

no

1,2-Dichlorobenzene

0.04†

yes

Cyclohexane
Acetone
t-Butanol

0.31
0.08
0.12

no
no
no

Benzene

0.32

no

Pristane

0.23

†‡

no

*Difference maximum between normalized intensity values for a
sample with 10-7 M BP and No BP
†
10-6 M BP was used
‡
A BP adduct with an alkyl tail was used for solubility

C.1. The design and use of esters as a solvent for photoamplification
Due to the favorable result in Table 4.3 for ethyl acetate the use of an ester as a
solvent for photoamplification was explored. It was necessary to make the solvent
denser, increase the boiling point, and not compromise the viscosity. Figure 4.4 shows
several examples of the solvents which were prepared and purified by distillation, for
which the experimental boiling points and densities are reported in Table 4.4. While
increasing the ester tail length successfully increased the solvents boiling point it did not
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always provide a solvent with a density higher than 1 g/mL (2b), which is necessary as
the analyte (protein) to be use in the assay will be in an aqueous buffer. By introducing
bromine to the molecule (compare 2b to 3b) both the boiling point and density of the
solvent were increased.

The problem with bromine substitution is that the solvent

becomes more viscous. This led to the use of fluorocarbon groups which are expected to
make the solvents less viscous (but can also compromise the solubility of the adduct) and
could also increase the boiling point and density (compare 2b to 6 and 8 to 9).

Figure 4.4. Synthesized esters tested as solvents for photoamplification
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Table 4.4. Boiling points and densities for compounds in Figure 4.4.
Compound #

Boiling Point °C

2b
3a
3b
3c
4
5
6
7
8
9
10

95
95
143
148
152
110
61
70
60
90
75

Distillation
Pressure
290 mTorr
150 mTorr
200 mTorr
500 mTorr
200 mTorr
140 mTorr
500 mTorr
200 mTorr
18 mmHg
18 mmHg
18 mmHg

Density (g/mL)
0.94
1.58
1.64
1.08
1.84
1.45
1.65
1.38
0.97
-

Once solvents that have a high boiling point, and a density higher than 1 g/mL
were identified, they were tested for the photoamplification assay using p-QPh.
Unfortunately, the reasonable fluorescence intensity difference between a sample with
BP and without seen in ethyl acetate (0.38) did not translate into similar results for any of
these solvents, which all had differences less than 0.10 for samples with 10-6 M BP vs. no
BP. As a result the use of these solvents was abandoned.

C.2. Evaluation of ionic liquids as solvents for photoamplification
In recent years ionic liquids (IL’s) have become popular as a new class of solvents
for various organic reactions,[70,71] including photochemical reactions.[72,73] These
unique solvents are commonly referred to as designer solvents as their unique properties
– a large liquidus range, lack of measurable vapor pressure, tunable density, viscosity and
salvation strengths, and high thermal, chemical and electrochemical stability – allow
them to be optimized for specific applications.[70,71] When one considers the influence
of solvent on photochemical reactions, such as the ratio between homolytic vs. heterolytic
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bond cleavage in alkyl halides, the cage effect on radical recombination, and the
competition between energy vs. electron transfer processes, it would be ideal to identify
one which has tunable properties.

For this reason, and the fact that identifying a

conventional hydrophobic, low viscosity solvent, which would not compromise the
detection limit, appeared to be unattainable, the use of IL’s as a solvent for this assay was
considered.
In 2002 Narayana and co-workers explored the use of IL’s as a medium for
photochemical reactions, including energy and electron transfer reactions.[72] They
utilized a 1-alkyl-3-methylimidazolium salt and determined that the major features of
carrying out photochemical reactions in IL’s was (1) they have remarkable low oxygen
solubility ([O2] < 0.2 mmol/L compared to DCM [O2] < 10.7 mmol/L), (2) triplet states
live longer in IL’s, (3) they decrease the association time for charge transfer complexes,
and (4) diffusion is slowed making diffusion controlled processes about two times slower
in IL’s. While points (1-3) could be helpful for our application, (4) may hinder BP ability
to quench the fluorophore, which has to be tested experimentally. Six IL’s were prepared
(Figure 4.5) to test their ability as a solvent for this assay.
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Figure 4.5. Ionic liquids tested as solvents for photoamplification
Pulse field gradient 19F NMR was used to determine the diffusion coefficient (see
Table 4.1 for representative measurements) of 4-trifluoromethylbenzophenone in each
solvent. 13 and 15 quenched the fluorophores, p-QPh and p-TPh, without BP being
present, eliminating their use. In solvents 11 and 12 the diffusion of BP was found to be
two slow to effectively quench the fluorophore even at concentrations of 0.01 M BP. The
diffusion of BP was found to be slower in 14 and 16, in keeping with Narayana’s
findings. Experimental results showed that at a concentration of 0.01 M BP 50% of pQPh fluorescence was quenched. Additionally, photocleavage experiments indicated that
after 15 min of irradiation at 365 nm more than 50% of DT-BP adduct had cleaved, but
that the production of benzopinacole is higher in the IL’s than in other standard organic
113

solvents. These findings lead to the conclusion that while IL’s may help facilitate the
photocleavage reaction they cannot be used because (1) they quench the fluorophore and
(2) they slow down diffusion of BP, lowering the detection limit of the assay.

C.3. Revisiting the use of DCM
Based upon the results presented above it became quite obvious that DCM was
going to be our gold standard as far as the detection limit of this assay was concerned.
Using DCM provided us with the ability to use a recrystallizable adduct – DT-BP adduct
– and a detection limit on the order of 10-7 M (18 ppb) BP, with the possibility of going
even lower to 10-8 M (1.8 ppb) of BP. Unfortunately, we continued to return to the
problem of fast evaporation at room temperature. The one thing not probed so far was
running the assay under aqueous buffer, and thus if this prevented evaporation we may
still be able to utilize DMC as the solvent.
DCM was placed in a capillary under water and left to evaporate overnight, the
layers stayed in place with water on top. No evaporation was seen when there was at
least 5 mm of water between DCM and air. When DCM was placed in a test tube and
water was added it seemed to create two vertically divided columns (Figure 4.6 gives a
visual representation). This partitioning was even more apparent when a buffer (0.02 M
PBS, pH 7.5) was added, even though DCM has a density of 1.33 g/mL. This lead to the
use of carbon tetrachloride (CCl4) (bp = 77 °C, D = 1.59 g/mL). CCl4 did not show
partitioning problems with the buffer and gave similar results to DCM when used as the
solvent for the fluorescence assay. Therefore, by running the assay under water we allow
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for the use of solvents which evaporate quickly in air, making it possible to run the assay
in DCM and CCl4.

Figure 4.6. Visual representation of the partitioning between DCM and water observed
in a test tube.

D. Application of Adduct and Solvent Optimization Studies to the Coumarin 6
“Turn-Off” Assay
While the C6 fluorescence “turn-off” assay is different from the one utilizing poligophenylenes as far as the method of quenching, it is very much the same in its solvent
requirements. Initial results in DCM, for solutions containing C6 at 10-5 M and 30 mM
DT-BP adduct, showed an astounding normalized fluorescence intensity difference
between samples containing 10-8 M BP and no BP of 0.65 (Figure 4.7). We later learned
that coumarins have a large bathochromic shift in fluorescence upon the buildup of HCl
in solvents such as CCl4 and DCM (Figure 4.8), something that happens during
irradiation at 365 nm (Figure 4.9). This build-up of HCl leads to non-reproducible results
which could not be solved by using a wet solvent. As a result the solvent needed to be
changed to one which retained the properties of DCM without building up excessive
amounts of HCl.
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Figure 4.7. Detection limit for the photoamplified fluorescence quenching of C6 by
benzophenone in DCM using recrystallized DT-BP adduct.
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Figure 4.8. Control experiment to determine the effect of HCl on coumarin 6 [10-5 M]
fluorescence emission in DCM.
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Figure 4.9. Bathochromic shift of C6 fluorescence in DCM due to the build up of HCl
during irradiation at 365 nm in the prescence of 30 mM DT-BP adduct and10-6 M BP.

D.1. Towards the use of chlorinated alkyls as solvents for the photoamplification assay
We set out to identify other chlorinated solvents which may have the same
solubilizing abilities as DCM, are commercially available, have densities of about 1
g/mL, do not produce an abundance of HCl upon irradiation at 365 nm, and have higher
boiling points (≥ 100 °C).

We initially identified 1-chlorocyclohexane, 1,3-

dichlorobutane, 1,4-dichlorobuate (1,4-DCB), and 1,5-dichloropentane (see Table 4.5 for
properties).
After distilling all solvents the fluorescence quenching assay was carried out.
Each solvent was vortexed with water for 30 seconds and then a solution containing
2x10-5 M p-QPh and 30 mM DT-BP adduct recrystallized 8 times was prepared and
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divided into 2 samples. The sensitizer, BP, was added to one of them at a concentration
of 10-5 M.

The other sample did not contain any added sensitizer.

The initial

fluorescence intensity of each sample was recorded and then they were all irradiated at
365 nm using a carousel reactor. The emission intensity of each sample was recorded at
regular intervals and normalized to give the maximum difference shown in Table 4.5.
Table 4.5. Coumarin fluorescence “turn-off” photoamplification assay results in
chlorinated alkanes
Density (g/mL)

0.90

Boiling Point °C
40

1-Chlorocyclohexane

0.70

142

1.00

1,3-Dichlorobutane
1,4-Dichlorobutane

0.57
0.50

134
162

1.12
1.16

1,5-Dichloropentane

0.14

65/10 mmHg

1.06

Solvent

Difference*

Dichloromethane (wet)

1.32

*Difference maximum between normalized emission intensity
values for a sample with 10-5 M BP and No BP

The results show that 1-chlorocyclohexane, 1,3-dicholobutane, and 1,4-DCB are
reasonable solvents for this application. Because the density of 1,4-DCB is higher than
for the other two solvents it is preferred for this assay. The detection limit of BP in bulk
solution is 10-6 M (180 ppb) in 1,4-DCB. Based upon these results I believe C6 is a
better choice as the fluorophore for this assay, as the excitation and emission maxima are
both in the visible region while those of p-QPh are in the UV. In addition, the time it
takes the assay to complete is sixty minutes or less, whereas the same assay using p-QPh
takes up to three hours to complete in some cases.
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E. Experimental
E.1. General
Common solvents were purchased from AAper Alcohol and used as is, except for
THF and hexanes. THF was refluxed over and distilled from potassium benzophenone
ketyl prior to use. Hexanes was distilled over calcium hydride before use. All reagents
for which a synthesis is not referenced in the text or described here were purchased from
Alfa Aesar, TCI America, Fisher Scientific, AK Scientific, ChemImpex, or Aldrich. All
reagents were used without purification unless otherwise noted. All NMR spectra were
recorded at 25 °C on either a Varian Mercury 400 MHz instrument, or a Bruker Biospin
500 MHZ instrument, in CDCl3 with TMS as an internal standard (unless noted
otherwise). Column chromatography was performed on silica gel, 32-63μ mesh, the
eluent is noted in the procedure.

E.2. Pulse field gradient (PFG) NMR
19

F PFG NMR was used to determine all diffusion coefficients for solvents in

Table 4.1.

Each sample contained 4-trifluoromethylbenzophenone (50 mg) and the

solvent to be analyzed (0.6 mL). In cases where the benzophenone used was not soluble,
CDCl3 was used to dissolve it (0.1 mL), before adding it to the solvent for which the
diffusion coefficient was being determined.
The diffusion measurements (PFG-LED technique) were carried out with Varian
Mercury 400MHz spectrometer equipped with Performa I PFG module and PFG-capable,
4 nuclei autoswitchable probe. The PFG module is capable of forming PFG pulses up to
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21 G/cm strength, which was sufficient to drive the signal amplitude of free probe
molecules to zero.

We used slightly modified watersLED sequence (with water-

suppression turned off completely). This is a stimulated spin-echo technique. The echo
amplitude is related to the diffusion coefficient by the following expression:
A = Ao exp[-(γδG)2 (Δ−δ /3)Ds]
γ - magnetogyric ratio, 2.5181 x 104 1/G s
δ - length of pulsed field gradient (s)
G - gradient strength (G)
Δ - diffusion time = δ + gstab1 + pulse width + diff
Ds - diffusion coefficient
For each NMR the PFG strength (variable gzlvl 1) was arrayed from 100 to 2000
while other relevant parameters were held constant: gt1 = 0.005 ms ( = δ), pw = 20 μs,
led = 0.017 ms, diff = 0.10 to 0.20 ms depending on viscosity of the solvent, gstab1 =
0.0005 ms, gt2 = 0.003 ms.

E.3. Solubility tests
All solubility tests in Table 4.2 were carried out by dissolving a quantity of adduct
equal to 30 mM in 1 mL of the solvent used. Heat was used to try and dissolve adducts
which were not soluble at room temperature. Each sample was then left sitting for 1
week to determine whether the adduct crystallized from the solvent or remained in
solution.
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E.4. General information regarding photoreactions
Photoreactions were carried out using an in house built 365 nm five LED reactor
outfitted with a 300-400 nm long pass filter. For each photoreaction discussed a bulk
solution of fluorophore and adduct was prepared and divided to the appropriate number
of samples. Benzophenone was added to each sample, from a stock solution, at the
appropriate concentration. The concentrations of each reagent in the photoreactions are
stated in the text where the reaction is presented. All solvents were evaluated using two
samples containing fluorophore and adduct as stated above. One contained 10-5 M BP
and one no BP. All bulk solution photoreactions were carried out in quartz fluorescence
spectroscopy cells from NSG precision cells.

E.5. General method for the synthesis of 4-alkylbenzophenones
Method 1 – Suzuki coupling: In a pressure vessel to the appropriate 1-alkene (20
mmol) was added 9-BBN (0.5 M in THF, 52 mL, 26 mmol). The reaction mixture was
heated at 90 °C with stirring for 18 hrs. Water (0.4 mL) was added and this mixture was
pured into a flask containing 4-bromobenzophenone (2.61 g, 10 mmol), Pd(PPh3)4 (0.1
eq.) and K3PO4 (6 eq). The reaction mixture was refluxed 18 h with stirring and then
filtered. The filtrate was removed under vacuum to give the crude product which was
purified by gel filtration (silica gel eluted with 5% EtOAc in hexane). After removing the
solvent under vacuum the small amount of remaining alkene was removed by high
vacuum pump to give pure 4-alkylbenzophenone.
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Method 2 – Grignard reaction: In a three neck RB flask, with a condenser and addition
funnel attached, under nitrogen 3 crystals of iodine were added to Mg turnings (1.7 g, 42
mmol) in 15 mL of dry THF and stirred for 5 min. Neat 1-bromo-4-alkylbenzene (4
mmol) was added and stirred until the iodine color faded and heat began to evolve from
the reaction. The remaining 1-bromo-4-alkylbenzene (36 mmol) in dry THF (15 mL)
was added dropwise over 5 minutes. After reflux stopped the reaction mixture was
heated slightly until all Mg dissolved. The mixture was then cooled to 0 °C and 4alkylbenzaldehyde (40 mmol) in THF (15 mL) was added dropwise over 5 minutes. A
slightly purple color prevailed until the addition was complete.

The reaction was

removed from the ice bath and reacted at room temperature with stirring for 3.5h and then
refluxed for 30 min. Ethanol (10 mL) was added to react with any remaining Grignard
reagent and then the reaction was quenched with saturated NH4Cl (10 mL), and washed
with DCM (2 x 40 mL). The organic solvent was collected and dried over sodium sulfate
and removed under vacuum. Impurities were removed on high vacuum to give the
benzhydrol containing 20% benzophenone which was dissolved in DCM (100 mL) and
PCC (8.1 g. 37.5 mmol) was added. The reaction was stirred overnight at room
temperature. Ether (50 mL) was added to the reaction mixture and the precipitate was
filtered off. The organic layer was removed under vacuum and the resulting residue was
dissolved in hexane:ether (1:1). The precipitate was filtered off and the organic solvent
was removed. The residue was dissolved in hexane:ethyl acetate (20:1 - 25 mL) and
purified by gel filtration using this solvent as the eluent (500 mL). Impurities were
removed under high vacuum with a heat gun to give pure 4,4-dialkylbenzophenone.
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4-propylbenzophenone (17a): 12.8 g, 89% yield, 1H NMR (400 MHz, CDCl3) δ 7.797.81 (ddd, 2H, J = 1.6, 2.9, 7.1 Hz), 7.71-7.76 (m, 2H), 7.54-7.62 (m, 1H), 7.46-7.50 (tt,
2H, J = 1.3, 6.6 Hz), 7.26-7.31 (d, 2H, J = 8.5 Hz), 2.66-2.69 (m, 2H), 1.58-1.74 (m, 2H),
0.92-0.99 (t, 3H, J = 7.3 Hz). (NMR tpg27231_product)

4-butylbenzophenone (17b):

1

H NMR (400 MHz, CDCl3) δ 7.79-7.82 (ddd, 2H, J =

1.9, 3.3, 7.1 Hz), 7.73-7.76 (m, 2H), 7.56-7.60 (m, 1H), 7.46-7.50 (tt, 2H, J = 1.3, 6.6
Hz), 7.26-7.31 (d, 2H, J = 8.5 Hz), 2.68-2.72 (m, 2H), 1.61-1.69 (m, 2H), 1.34-1.44 (td,
2H, J = 7.3, 14.7), 0.93-0.97 (t, 3H, J = 7.3 Hz). (NMR tma25059_c1fr5)

4-pentylbenzophenone (17c): 1H NMR (400 MHz, CDCl3) δ 7.79-7.81 (d, 2H, J = 7.1
Hz), 7.73-7.75 (d, 2H, J = 7.9 Hz), 7.55-7.60 (t, 1H, J = 7.4 Hz), 7.46-7.50 (t, 2H, J = 7.8
Hz), 7.25-7.27 (d, 2H, J = 8.0 Hz), 2.69-2.75 (dd, 1H, J = 6.3, 13.3 Hz), 2.43-2.48 (dd,
1H, J = 8.2, 13.3 Hz), 1.20-1.85 (m, 6H), 0.91-0.95 (t, 3H, J = 7.5 Hz).

(NMR

tma25074_fr5)

4-hexylbenzophenone (17d):

1

H NMR (400 MHz, CDCl3) δ 7.73-7.81 (d, 2H, J = 8.1

Hz), 7.73-7.75 (d, 2H, J = 8.1 Hz), 7.56-7.60 (t, 1H, J = 7.4 Hz), 7.46-7.50 (t, 2H, J = 7.7
Hz), 7.26-7.30 (d, 2H, J = 8.0 Hz), 2.67-2.71 (m, 2H), 1.56-1.67 (m, 2H), 1.26-1.40 (m,
6H), 0.88-0.91 (t, 3H, J = 6.7 Hz). (NMR gam26002_fr15)
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4-octylbenzophenone (17e): 1.85 g, 50% yield, 1H NMR (400 MHz, CDCl3) δ 7.797.80 (d, 2H, J = 6.9 Hz), 7.73-7.76 (d, 2H, J = 8.2 Hz), 7.56-7.60 (t, 1H, J = 7.4 Hz),
7.46-7.50 (t, 2H, J = 7.5 Hz), 7.26-7.30 (m, 2H), 2.68-2.71 (m, 2H), 1.62-1.69 (dt, 2H, J =
7.5, 15.1 Hz), 1.28-1.33 (m, 10H), 0.87-0.90 (t, 3H, J = 6.8 Hz).

13

C NMR (400 MHz,

CDCl3) δ 196.51, 148.21, 137.96, 135.04, 132.11, 130.31, 129.93, 128.31, 128.18, 36.03,
31.85, 31.17, 29.42, 29.29, 29.22, 22.65, 14.09.

(NMR tpg27047_pure and

tpg27047_13C)

4-dodecylbenzophenone (17f): 2.69 g, 77% yield, 1H NMR (400 MHz, CDCl3) δ 7.737.80 (d, 2H, J = 7.6 Hz), 7.73-7.75 (d, 2H, J = 8.1 Hz), 7.56-7.59 (t, 1H, J = 7.5 Hz),
7.46-7.49 (t, 2H, J = 7.6 Hz), 7.26-7.29 (d, 2H, J = 8.2 Hz), 2.66-2.70 (m, 2H), 1.59-1.65
(m, 2H), 1.25-1.42 (m, 18H), 0.86-0.89 (t, 3H, J = 6.7 Hz). (NMR tpg27026_pure)

4,4-diethylbenzophenone (17g): 5.85 g, 62% yield, 1H NMR (400 MHz, CDCl3) δ
7.70-7.73 (d, 4H, J = 8.1 Hz), 7.23-7.28 (d, 2H, J = 8.0 Hz), 2.58-2.74 (q, 4H, J = 7.6
Hz), 1.24-1.28 (t, 6H, J = 7.6 Hz). (NMR tpg27168_pure)

4-ethyl-4’-propylbenzophenone (17h): 5.6 g, 63% yield, 1H NMR (400 MHz, CDCl3) δ
7.72-7.75 (dd, 2H, J = 3.1, 8.0 Hz), 7.27-7.31 (t, 2H, J = 8.6 Hz), 2.71-2.77 (q, 2H, J =
7.6 Hz), 2.65-2.69 (m, 2H), 1.61-1.73 (m, 2H), 1.26-1.31 (t, 3H, J = 7.6 Hz), 0.91-0.99 (t,
3H, J = 7.3 Hz). (NMR tpg27175_rm)
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E.6. General method for the synthesis of dithiane adducts
A generic method by Corey and Seebach was modified and used to prepare the
desired dithiane adducts.[55] The appropriate dithiane (5.1 mmol) was dissolved in
freshly distilled THF (30 mL) and placed under nitrogen. n-Butyllithium (4.3 mL, 6.8
mmol) was added at room temperature while stirring and the resulting mixture was stirred
for 10 minutes. The desired benzophenone (3.4 mmol) was dissolved in freshly distilled
THF (10 mL) and added to the anion mixture with stirring. The reaction was left 2 hours
at room temperature. The reaction mixture was quenched with a saturated solution of
ammonium chloride and the aqueous layer was extracted twice with ethyl acetate. The
combined organic layer was dried over anhydrous sodium sulfate. The solvent was
removed under vacuum, and the residue was purified by column chromatography 6 times
(silica-gel, ethyl acetate/hexanes) or recrystallization 8 times (DCM in hexanes). The 2alkyl-1,3-dithiane adducts were described in chapter 2, (2a-e) along with the 5-alkyl-1,3dithianes which are used here (Chapter 2 compounds 3-7).

(1,3-dithian-2-yl)diphenylmethanol (1a):

1.8 g, 60% yield, 1H NMR (500 MHz,

CDCl3) δ 7.56-7.63 (d, 4H, J = 7.2 Hz), 7.30-7.37 (d, 4H, J = 7.5 Hz), 7.22-7.27 (m, 2H),
3.28 (s, 1H), 2.84-2.99 (m, 4H), 2.04-2.12 (m, 1H), 1.82-1.90 (m, 1H).

(NMR

tpg17851_rc_2)

(5,5-diethyl-1,3-dithian-2-yl)diphenylmethanol (1bn=2): 1H NMR (400 MHz, CDCl3) δ
7.55-7.57 (d, 4H, J = 7.4 Hz), 7.30-7.33 (t, 4H, J = 7.6 Hz), 7.21-7.25 (t, 2H, J = 7.3 Hz),
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1.64-1.70 (q, 2H, J = 7.5 Hz), 1.35-1.41 (q, 2H, J = 7.5 Hz), 0.83-0.80 (t, 3H, J = 7.5 Hz),
0.74-0.78 (t, 3H, J = 7.5 Hz). (NMR mpc24059_clm)

(5,5-dibutyl-1,3-dithian-2-yl)diphenylmethanol (1bn=4):

1

H NMR (400 MHz, CDCl3)

δ 7.55-7.57 (d, 4H, J = 8.0 Hz), 7.30-7.33 (t, 4H, J = 7.7 Hz), 7.21-7.25 (m, 2H), 1.531.62 (m, 2H), 1.26-1.34 (m, 6H), 1.04-1.21 (m, 4H), 0.88-0.90 (m, 6H).

(NMR

mpc24107_II48)

(5,5-dipentyl-1,3-dithian-2-yl)diphenylmethanol (1bn=5): 0.12 g, 27% yield, 1H NMR
(400 MHz, CDCl3) δ 7.55-7.57 (d, 4H, J = 8.4 Hz), 7.30-7.33 (t, 4H, J = 7.8 Hz), 7.217.25 (t, 2H, J = 7.3 Hz), 1.07-1.33 (m, 16H), 0.86-0.90 (t, 6H, J = 6.9 Hz). (NMR
tpg27059_pure)

(5,5-dioctyl-1,3-dithian-2-yl)diphenylmethanol (1bn=8): 1H NMR (400 MHz, CDCl3) δ
7.54-7.56 (d, 4H, J = 8.0 Hz), 7.29-7.33 (t, 4H, J = 7.6 Hz), 7.21-7.24 (t, 2H, J = 6.9 Hz),
1.05-1.35 (m, 20H), 0.87-0.90 (t, 6H, J = 6.6 Hz). (NMR mpc24149_66)

(1,3-dithian-2-yl)(4-ethylphenyl)(phenyl)methanol (1cn=2) :

1

H NMR (500 MHz,

CDCl3) δ 7.55-7.58 (d, 2H, J = 7.2 Hz), 7.46-7.49 (d, 2H, J = 8.3 Hz), 7.30-7.33 (t, 2H, J
= 7.5 Hz), 7.22-7.25 (t, 1H, J = 7.3 Hz), 7.14-7.16 (d, 2H, J = 8.1 Hz), 3.25 (s, 1H), 2.862.92 (m, 4H), 2.59-2.64 (q, 2H, J = 7.5 Hz), 2.05-2.11 (m, 1H), 1.79-1.90 (m, 1H), 1.181.21 (t, 3H, J = 7.6 Hz). (NMR tpg27203_rm)
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(1,3-dithian-2-yl)(phenyl)(4-butylphenyl)methanol (1cn=4):

1

H NMR (500 MHz,

CDCl3) δ 7.58-7.60 (d, 2H, J = 7.3 Hz), 7.48-7.50 (d, 2H, J = 8.2 Hz), 7.34-7.37 (t, 2H, J
= 6.0 Hz), 7.25-7.29 (m, 1H), 7.14-7.16 (d, 2H, J = 8.0 Hz), 3.31 (s, 1H), 2.83-2.95 (m,
4H), 2.59-2.64 (m, 2H), 2.03-2.10 (m, 1H), 1.80-1.91 (m, 1H), 1.55-1.64 (m, 2H), 1.291.42 (m, 2H), 0.91-0.95 (t, 3H, J = 7.3 Hz). (NMR tma25063_evapdithiane)

(1,3-dithian-2-yl)(phenyl)(4-pentylphenyl)methanol (1cn=5) :

1

H NMR (500 MHz,

CDCl3) δ 7.78-7.81 (dd, 2H, J = 1.4, 8.4 Hz), 7.73-7.75 (d, 2H, J = 8.4 Hz), 7.56-7.60 (m,
2H), 7.46-7.50 (t, 1H, J = 7.5 Hz), 7.25-7.27 (d, 2H, J = 8.4 Hz), 2.67-2.74 (m, 4H), 2.422.48 (dd, 2H, J = 8.2, 13.3 Hz), 2.03-2.10 (m, 1H), 1.16-1.73 (m, 8H), 0.91-0.95 (t, 3H, J
= 7.4 Hz). (NMR tma25070_fr50)

(1,3-dithian-2-yl)(phenyl)(4-octylphenyl)methanol (1cn=8):

0.49 g, 70% yield, 1H

NMR (500 MHz, CDCl3) δ 7.55-7.57 (d, 2H, J = 7.4 Hz), 7.45-7.47 (d, 2H, J = 8.2 Hz),
7.30-7.33 (t, 2H, J = 7.8 Hz), 7.22-7.26 (t, 2H, J = 7.2 Hz), 7.11-7.13 (d, 2H, J = 8.1 Hz),
3.24 (s, 1H), 2.83-2.95 (m, 4H), 2.53-2.57 (m, 2H), 2.05-2.12 (m, 1H), 1.78-1.90 (m,
1H), 1.54-1.60 (m, 2H), 1.20-1.35 (m, 10H), 0.85-0.88 (t, 3H, J = 6.4 Hz). (NMR
tpg27067_pure)

(1,3-dithian-2-yl)(phenyl)(4-dodecylphenyl)methanol (1cn=12): 0.45 g, 68% yield, 1H
NMR (400 MHz, CDCl3) δ 7.58-7.60 (d, 2H, J = 7.3 Hz), 7.48-7.50 (d, 2H, J = 8.2 Hz),
7.34-7.37 (t, 2H, J = 6.0 Hz), 7.25-7.29 (m, 1H), 7.14-7.16 (d, 2H, J = 8.0 Hz), 3.24 (s,
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1H), 2.84-2.93 (m, 4H), 2.53-2.57 (m, 2H), 2.05-2.10 (m, 1H), 1.84-1.87 (dtd, 1H, J =
4.7, 10.3, 20.1 Hz), 1.54-1.57 (m, 2H), 1.20-1.35 (m, 18H), 0.83-0.88 (t, 3H, J = 6.9 Hz).
(NMR tpg27031_pure)

(5,5-dipentyl-1,3-dithian-2-yl)(4-octylphenyl)(phenyl)methanol (1d R2n=8, R4n=5):
0.43g, 78% yield, 1H NMR (400 MHz, CDCl3) δ 7.54-7.56 (d, 2H, J = 7.8 Hz), 7.43-7.45
(d, 2H, J = 8.1 Hz), 7.29-7.32 (t, 2H, J = 7.7 Hz), 7.20-7.24 (t, 1H, J = 7.0 Hz), 7.10-7.12
(d, 2H, J = 8.1 Hz), 3.38 (s, 1H), 2.53-2.61 (m, 4H), 1.53-1.60 (m, 4H), 1.12-1.28 (m,
22H), 0.85-0.90 (m, 9H). (NMR tpg27060_product)

(5,5-dibutyl-1,3-dithian-2-yl)(4-octylphenyl)(phenyl)methanol (1d R2n=8, R4n=4):

1

H

NMR (400 MHz, CDCl3) δ 7.54-7.56 (d, 2H, J = 7.5 Hz), 7.43-7.45 (d, 2H, J = 8.0 Hz),
7.29-7.33 (t, 2H, J = 7.7 Hz), 7.20-7.24 (t, 1H, J = 7.3 Hz), 7.10-7.12 (d, 2H, J = 8.1 Hz),
3.38 (s, 1H), 2.53-2.65 (m, 4H), 1.54-1.61 (m, 4H), 1.10-1.32 (m, 18H), 0.85-0.94 (m,
9H). (NMR mpc24152_C11)

(1,3-dithian-2-yl)bis(4-ethylphenyl)methanol (1e R2n=2, R3n=2):

1

H NMR (400 MHz,

CDCl3) δ 7.46-7.48 (d, 4H, J = 8.1 Hz), 7.14-7.16 (d, 4H, J = 8.1 Hz), 3.21 (s, 1H), 2.842.94 (m, 4H), 2.59-2.64 (q, 4H, J = 7.6 Hz), 2.06-2.17 (m, 1H), 1.80-1.89 (m, 1H), 1.181.22 (t, 6H, J = 7.6 Hz). (NMR tpg27180_rc3x)
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E.7. Synthesis of Acetates as Solvents
E.7.1. 2,2-Diethylpropane-1,3-diyl dialkyl esters
2,2-Diethyl-1,3-propanediol (10.0 g, 0.076 mol) was added to pyridine (50 mL).
The desired anhydride (0.17 mol) was added and the reaction was stirred at reflux for 4
hours.

The reaction was poured into 10% aq. HCl (150 mL), extracted with

dichloromethane (2 x 100 mL), the organic layer was collected, dried over anhyd. sodium
sulfate, and removed under vacuum. The clear oil was then distilled under vacuum to
give the dialkyl ester.

2,2-diethylpropane-1,3-diyl diacetate (2a): 27.83 g, 62% yield, distilled 75 °C, 380
mTorr, density: 1.05 g/mL,

1

H NMR (400 MHz, CDCl3) δ 2.05 (s, 6H), 1.32-1.37 (q,

4H, J = 7.6 Hz), 0.81-0.85 (t, 6H, J = 7.6 Hz). (NMR tpg17927_ds2)

2,2-diethylpropane-1,3-diyl dipropionate (2b): 7.57 g, 40% yield, distilled 95 °C, 290
mTorr, density: 0.94 g/mL, 1H NMR (400 MHz, CDCl3) δ 2.31-2.36 (q, 4H, J = 7.6 Hz),
1.33-1.38 (q, 4H, J = 7.6 Hz), 1.12-1.16 (t, 6H, J = 7.6 Hz), 0.82-0.85 (t, 6H, J = 7.5 Hz).
(NMR tpg17902_ds2)

2,2-diethylpropane-1,3-diyl bis(2,2,3,3,3-pentafluoropropanoate) (6):
yield, distilled 61 °C, 500 mTorr, density: 1.45 g/mL,

1

H NMR (400 MHz, CDCl3) δ

1.39-1.44 (q, 4H, J = 7.5 Hz), 0.86-0.90 (t, 6H, J = 7.6 Hz).
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6.5 g, 40%

19

F NMR (376 MHz, CDCl3

with C6F6 as standard) δ -86.15 (s, 6F), -124.78 (s, 4F). (NMR tpg17932_ds2 and
tpg17932_19F)
2,2-diethylpropane-1,3-diyl bis(2,2,3,3,4,4,4-heptafluorobutanoate) (7): 6.27 g, 64%
yield, distilled 70 °C, 200 mTorr, density: 1.65 g/mL,

1

H NMR (400 MHz, CDCl3) δ

1.39-1.44 (q, 4H, J = 7.5 Hz), 0.86-0.90 (t, 6H, J = 7.6 Hz).

19

F NMR (376 MHz, CDCl3

with C6F6 as standard) δ -88.6 (m, 6F), -126.2 (m, 2F), -127.78 (m, 2F), -134.8 (s, 4F).
(NMR tpg17915_pure and tpg17915_19F_rf)

E.7.2. 2,2-bis(bromomethyl)propane-1,3-diyl dialkyl esters
The appropriate anhydride or acid chloride (0.12 mol) and 2,2-bis(bromomethyl)1,3-propanediol (15.0 g, 0.057 mol) were added to pyridine (65 mL) and stirred at reflux
overnight. The salt was filtered and washed with dichloromethane (2 x 100 mL). The
filtrate was washed with 10% aq. HCl (150 mL) and the organic layer was collected,
dried over anhyd. sodium sulfate and removed under vacuum. The resulting oil was
distilled under vacuum to give the product.

2,2-bis(bromomethyl)propane-1,3-diyl diacetate (3a): 4.3 g, 33% yield, density: 1.58
g/mL,

1

H NMR (400 MHz, CDCl3) δ 4.15 (s, 4H), 3.64 (s, 4H), 2.09 (s, 6H). (NMR

tpg17906_ds2)
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2,2-bis(bromomethyl)propane-1,3-diyl dipropionate (3b): 8.2 g, 58% yield, density:
1.64 g/mL, 1H NMR (400 MHz, CDCl3) δ 4.16 (s, 4H), 3.51 (s, 4H), 2.34-2.39 (q, 4H, J
= 7.6 Hz), 1.14-1.17 (t, 6H, J = 7.6 Hz). (NMR tpg17907_ds2_pure)

2,2-bis(bromomethyl)propane-1,3-diyl dibutyrate (3c): 15 g, 52% yield, distilled 75
°C, 18 mmHg, 1H NMR (400 MHz, CDCl3) δ 4.01 (s, 6H), 2.31-2.37 (q, 6H, J = 7.6 Hz),
1.12-1.16 (t, 9H, J = 7.6 Hz), 1.02 (s, 3H). (NMR tpg17895_product)

E.7.3. Synthesis of 3-chloro-2,2-dimethylpropyl alkyl esters
3-chloro-2,2-dimethyl-1-propanol (12.0 g, 0.098 mol) was added to pyridine (40
mL). The appropriate anhydride (0.12 mol) was added and the reaction was stirred at
reflux for 4 hours. The reaction was poured into saturated aq. sodium bicarbonate (200
mL) and extracted with dichloromethane (100 mL). The organic layer was washed with
10% aq. HCl (150 mL x 2), sat. sodium bicarbonate (50 mL), and collected and dried
over anhydrous sodium sulfate.

The solvent was removed under vacuum and the

resulting oil was distilled under vacuum to give the product.

3-chloro-2,2-dimethylpropyl 2,2,3,3,3-pentafluoropropanoate (8): 2.27 g, 26% yield,
distilled 60 °C, 17 mmHg, density: 1.34 g/mL,
2H), 3.42 (s, 2H), 1.08 (s, 6H).
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1

H NMR (400 MHz, CDCl3) δ 4.23 (s,

F NMR (376 MHz, CDCl3) δ 19.46 (d, 6F), -18.67 (s,

4F). (NMR tpg17913_pure and tpg17913_19F_rm1)
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3-chloro-2,2-dimethylpropyl propionate (9): 8.72 g, 50% yield, density: 0.97 g/mL,
1

H NMR (400 MHz, CDCl3) δ 3.93 (s, 2H), 3.43 (s, 2H), 2.33-2.39 (q, 2H, J = 7.6 Hz),

1.14-1.17 (t, 3H, J = 7.6 Hz), 1.03 (s, 6H). (NMR tpg17909_ds3_pure)

E.7.4. Synthesis of all other esters as solvents
2-methyl-2-(propionyloxymethyl)propane-1,3-diyl

dipropionate

(4):

1,1,1-

Tris(Hydroxymethyl)ethane (10 g, 0.083 mol) was added to pyridine (60 mL). Propionic
anhydride (12.2 mL, 0.29 mol) was added and the reaction was stirred at reflux for 4
hours. The reaction was poured into 10% aq. HCl (150 mL x 2) and extracted with
dichloromethane (200 mL).

The organic layer was collected, dried over anhydrous

sodium sulfate, and removed under vacuum. The crude oil was distilled under vacuum
(152 °C, 200 mTorr) to give the product as a clear oil (14.62 g, 61% yield, Density:1.08
g/mL). 1H NMR (400 MHz, CDCl3) δ 4.01 (s, 6H), 2.31-2.37 (q, 6H, J = 7.6 Hz), 1.121.16 (t, 9H, J = 7.6 Hz), 1.02 (s, 3H). (NMR tpg17903_ds2)

3-bromo-2,2-bis(bromomethyl)propyl propionate (5):
Pentaerythritol Tribromide (10 g, 0.030 mol) was added to pyridine (40 mL). Propionic
anhydride (12.2 mL, 0.12 mol) was added and the reaction was stirred at reflux for 4
hours. The reaction was poured into saturated aq. sodium bicarbonate (200 mL) and
extracted with dichloromethane (100 mL). The organic layer was washed with 10% aq.
HCl (150 mL x 2) and sat. sodium bicarbonate (50 mL) before being collected, dried over
anhydrous sodium sulfate, and removed under vacuum. The crude oil was distilled under
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vacuum to give the product as a clear oil (6.43 g, 56 % yield, 1.84Density:).

1

H NMR

(400 MHz, CDCl3) δ 4.20 (s, 2H), 3.54 (s, 6H), 2.36-2.41 (q, 2H, J = 7.6 Hz), 1.15-1.17
(t, 3H, J = 7.6 Hz). (NMR tpg17908_ds3_pure)

Neopentyl pivalate (10): Pivalyl chloride (21 mL, 0.17 mol) and neopentyl alcohol (15
g, 0.17 mol) were added to pyridine (35 mL) and stirred at reflux overnight. The salt was
filtered and washed with dichloromethane. The filtrate was washed with 10% aq. HCl
(150 mL) and the organic layer was collected, dried over anhydrous sodium sulfate and
removed under vacuum. The crude oil was distilled under vacuum (75 °C, 18 mmHg) to
give the pure product (15 g, 52% yield).

1

H NMR (400 MHz, CDCl3) δ 3.57 (s, 2H),

1.21 (s, 9H), 0.94 (s, 9H). (NMR tpg17892_product)

E.8. Synthesis of ionic liquids
General

synthesis

of

bis(trifluoromethanesulfonyl)imides:

The

appropriate

tetraalkylammonium bromide (8.9 mmol) and LiNTF2 (2.56 g, 8.9 mmol) were dissolved
in acetone (50 mL) and reacted at room temperature for 24 hours. The reaction mixture
was filtered through Celite 512, and the solvent was removed under vacuum. The
resulting residue was extracted with dichloromethane and filtered to remove the solid.
The organic layer was filtered 2 times and the solvent was evaporated. The clear lightly
yellow liquid was dissolved in acetonitrile and stirred with carbon for 1 h. The carbon
was filtered off and the filtrate was purified by gel filtration (neutral alumina, eluted with
100 mL acetonitrile) to give the desired product.
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methyltrioctylammonium bis(trifluoromethanesulfonyl)imide (11):

4.25 g, 74%

yield, 1H NMR (400 MHz, Acetone) δ 3.46-3.50 (m, 6H), 3.23 (s, 3H), 1.80-1.92 (m,
6H), 1.27-1.39 (m, 30H), 0.85-0.89 (t, 9H, J = 6.9 Hz).

(NMR tpg17791_rm and

tpg17791_13C)
dimethyldioctylammonium bis(trifluoromethanesulfonyl)imide (12):

6.8 g, 95%

yield, 1H NMR (400 MHz, CDCl3) δ 3.19-3.22 (m, 4H), 3.02 (s, 6H), 1.60-1.75 (m, 4H),
1.27-1.35 (m, 20H), 0.87-0.90 (t, 6H, J = 6.8 Hz).

13

C NMR (400 MHz, CDCl3)

δ 124.56, 121.37, 118.18, 116.18, 115.00, 64.72, 50.96, 31.68, 29.03, 29.00, 26.09, 22.64,
14.08, 1.68. (NMR tpg17806_1H and tpg17806-C13)

tetrabutylammonium bis(trifluoromethanesulfonyl)imide (14): 6.22 g, 99% yield, 1H
NMR (400 MHz, CDCl3) δ 3.18-3.22 (m, 8H), 1.61-1.69 (m, 8H), 1.42-1.51 (m, 8H),
1.03-1.07 (t, 12H, J = 7.3 Hz). (NMR tpg17821_product)

1-hexyl-3-methylimidazolium bis(trifluoromethanesulfonyl)imide (15): See reference
[70].

tetrahexylammonium bis(trifluoromethanesulfonyl)imide (16): 5.64 g, 97% yield,
1

H NMR (400 MHz, CDCl3) δ 3.15-3.19 (m, 8H), 1.59-1.69 (m, 8H), 1.31-1.47 (m, 24H),

0.92-0.96 (t, 12H, J = 6.9 Hz).

13

C NMR (400 MHz, CDCl3) δ 124.85, 121.66, 118.46,
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116.72, 115.26, 58.77, 31.14, 25.86, 22.43, 21.86, 13.86, 1.86. (NMR tpg17820_product
and tpg17820_13C)
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Chapter 5: Design and Fabrication of a “Chip” and Imager for the Detection of
Photoamplified Fluorescence Quenching.
In Chapters 3 and 4 two versions of the fluorescence “turn-off” assay were
successfully developed. The first uses either the p-oligophenylene p-terphenyl (p-TPh) or
p-quaterphenyl (p-QPh) as the fluorophore, which is quenched by the release of
benzophenone (BP) during photoamplification.

The second method relies upon the

conversion of a robust fluorophore, 7-diethylaminocoumarin, to one which is short lived
and quickly photobleached, 7-ethylaminocoumarin, via a reaction catalyzed by BP. The
coumarin reaction was identified only recently, within the last 8 months, therefore much
of the work to design and fabricate a chip was carried out using the first quenching
methodology which utilizes p-oligophenylenes as the fluorophore. Thus, when we began
looking for an imager we were planning to image the fluorescence of p-TPh or p-QPh, for
which λex = 280 nm or 297 nm, and λem = 345 nm or 376 nm respectively. The use of
fluorophores which emit in the UV (below 400 nm) thus limited our imager design to
devices which were sensitive to these wavelengths. The first attempt at designing an
imager was to build a scanner which utilized a photomultiplier tube (PMT) as the
detector. Next we considered the use of a charge-coupled device (CCD) camera on
which the “chip” is imaged from above. Once the coumarin quenching reaction was
discovered we created our own FL imager, for which the design is similar to a FL
microscope.
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A. Identifying a “Chip”
Before evaluating a scanner/imager a “chip” must be designed.

The most

expedient way to obtaining a “chip” is to utilize a substrate or material which is cheap
and quick. The cheapest and quickest way to make your own “chip” is to utilize a glass
microscope slide and create spots or wells for analysis. Each spot should contain all the
necessary elements for photoamplification, except the sensitizer. The “chip” should also
provide a compartmentalization strategy which (1) allows for free 3-dimensional
collisional quenching in solution and (2) provides a structural element suitable for a
pixilated spatially addressable array. In addition, we must be able to immobilize the
ligands onto the surface of the chip with existing technology. Currently the printing of a
bioanalytical parallel library onto chip surfaces is carried out by contact or piezo
activated ink-jet printing to provide a uniform distribution of the library onto the “chip”.

A.1. Utilizing an organogelator
In order to provide a structural element, which compartmentalizes individual
wells resulting in a spatially addressable array, but does not interfere with diffusion of the
quencher in solution, organogels were utilized. Dialkylureas (Figure 5.1) were utilized
for this purpose and are well described as low molecular weight organogelators
(LMOG’s) in the literature.[74,75] These urea based gelators self-assemble through
intermolecular hydrogen bonds to form a helical lattice into which guest molecules, like
n-alkanes, fit to form aggregates which provide the structural lattice of the gel. The
nature of these aggregates depends on the cooling temperature, type of gelator, and its
137

alkyl chain length (Figure 5.2). These gelators are also reported to form organogels in
multiple solvent types, such as hexane, n-octane, silicone oil, ethanol, toluene, DMSO,
CCl4, etc.[74]

Figure 5.1. Dialkylureas tested as organogelators.

Figure 5.2. Polarizing optical micrographs of gels comprised of dipropylurea (top row),
and dipropylthiourea (bottom row) in silicone oil. Different cooling methods were used
(a) fast cooling, (b) moderate cooling, and (c) slow cooling. Black space bars are 200
μm. These images were taken from reference [74].
3-5% of N-n-octadecylurea (1b) produced stable organogels in t-butylbenzene (tBuPh) (Figure 5.3a) which did not affect fluorescence, nor greatly diminish the diffusion
of benzophenone, as measured by PFG NMR (Table 5.1).
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The photoamplified

fluorescence quenching of p-terphenyl by benzophenone was studied (Figure 5.3b and
5.4). The results mimicked those seen in our previous solution studies (Chapter 4),
showing successful amplified quenching of the fluorophore which is not affected by the
organogel.

(a)

(b)

Figure 5.3. (a) Stable 4% N-n-octadecylurea organogel prepared in t-BuPh containing
10-5 M p-TPh, 10-6 M benzophenone, and 10-2 M MDT BP Adduct. (b) Organogels
irradiated for 100 minutes (left) control with only 10-5 M p-terphenyl, 10-6 M
benzophenone, (right) photoamplified fluorescence quenching with 10-5 M p-terphenyl,
10-6 M benzophenone, and 10-2 M MDT BP Adduct.
Table 5.1. Diffusion coefficients of 4-trifluoromethyl-benzophenone for organogels
made in t-BuPh as determined by PFG 19F NMR.
Diffusion Coefficient (cm2 s-1)

% N-n-Octadecylurea
0

6.50 x 10-6

2

5.32 x 10-6

4

5.60 x 10-6

6

5.34 x 10-6
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Figure 5.4. Normalized fluorescence quenching of p-terphenyl (2 x 10-5 M) due to
photoamplification of quencher – benzophenone (BP) - in 4% N-n-octadecylurea
organogels, made in t-BuPh containing 10-2 M MDT BP adduct, with no BP, 10-8 M BP,
and 10-6 M BP. Controls of p-terphenyl (2 x 10-5 M) alone and with BP (10-6 M) showed
no interference between the gel and fluorescence as well as no significant fluorescence
quenching without photoamplification.
The problems with the commercially available organogelator (1b) were (1) the
opacity led to all spots looking dark on an imager and (2) the stability of the gels. Over
the course of one or two days the gels separated into two phases, the fibers of the gel and
the solvent. To circumvent these problems we synthesized and tested various urea based
gelators (1c-h) only to find that they either did not form gels in the desired solvents,
Chapter 4, or that these gels separated in the same manner as those prepared from (1b).
This lead to a search for a new organogelator which would form clear transparent gels in
CCl4, a dichloroalkane, or an alkane.
A new dicholesteryl-based gelator was identified (Figure 5.5)[76] and two
variations were synthesized. (2) utilized an alanine spacer between succinic acid and
cholesterol while (3) utilized phenylalanine. This new dicholesteryl-based gelator forms
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a stable and transparent organogel in CCl4 (Figure 5.6) and decane which remains intact
and is stable for at least a week. In addition the gelator does not interfere with the
photoamplified fluorescence quenching assay in bulk organogel (Figure 5.7). The gelator
was tested for evaporation from a microscope slide in CCl4 and dodecane.

CCl4

evaporated from the gel within four minutes while dodecane did not evaporate after 1
hour. When the chip was placed under water, to prevent evaporation of the solvent from
the gel spots, the gel did not always remain adhered to the glass surface and at the
interface with water turned white, probably due to crystallization of the gelator or
intercalation of water into the gel structure. As a result it was deemed necessary to
provide an additional structural element as part of the chip.

H
O
O
H

H
O

O

H
N

N
H

H
O

O

H
2
(3) phenylalinine in place of alanine

Figure 5.5. Dicholesteryl-L- alininate succinic amide gelator (2).
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H

Figure 5.6. Organogel of (2) in CCl4.
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Figure 5.7. Photoamplification of benzophenone in a CCl4 dichloesteryl-based
organogel. The organogel was prepared with 30 mM DT-BPA and 2x10-5 M p-QPh. To
one sample was added 10-5 M (1.8 ppm) BP. Both samples were irradiated using five 365
nm Nichia LED’s.

A.2. AnodiscsTM
In order to continue using a commercially available product Anodiscs, sold as
AnaporeTM aluminum oxide membranes (Figure 5.8) were tested. Anodiscs come in
three diameters: 47, 25, and 13 mm each. They are 60 μm thick and have one of three
pore sizes: 200, 100, and 20 nm. Our initial studies were done with Anodiscs having 200
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nm pores, which is a pore density of 10 pores per μm2. Each pore is calculated to hold
1.88 μm3. Anodiscs provide a unique opportunity for massive 3D amplification (within
the pore) without sacrificing the surface area of the chip (the exposed surface area of
solvent per pore is ~ 0.063 μm2). In addition they have a fluorescence background 7
times lower than flat glass surfaces.[77]

The use of anodiscs should enable

miniaturization of the chip design while improving the statistical sampling and
mechanical properties of the chip.

Figure 5.8. AnodiscTM images: (left) full Anodisc shown, (right) electron microscope
image of the anodisc pore structure. Taken from reference [77].
Before the Anodiscs could be utilized as a “chip” diffusion of BP had to be tested.
An AnodiscTM was loaded with decane containing 2x10-5 M p-QPh by dipping it into the
solution and 0.1 M BP was spotted onto the disc using a capillary. The diffusion of BP
was then visually monitored under UV light over the course of four hours. When a single
spot is placed in the center of the Anodiscs it doubles in size. When 8-10 spots of BP
were placed around the Anodiscs they diffused to cover the entire disc after 3 hours. The
use of anodiscs was thus ruled out as the pores do not appear to be sealed and BP diffuses
easily between them.
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A.3. Glass microcapillary arrays
Due to the facile diffusion of BP through the pores in Anodiscs a more sound pore
structure was needed to prevent amplification of one pixel from spilling over into
adjacent pixels. Currently there are a few companies which can provide microcapillary
arrays made of glass. One such company is INCOM USA©. These arrays can be cut to
almost any dimensions and come with one of several pore sizes (diameters of 25, 50, 100,
200 μm, etc.) In addition they can be made from different glass types, including clear or
black doped glass. INCOM provided us with several arrays having a pore diameter of
100 μm (Figure 5.9). Pores are hexagonally packed and have a pore density of 780 pores
per mm2, each pore holds ~0.04 μL. The glass array provides a unique opportunity for
massive 3D amplification (within the pore) without sacrificing the surface area of the
chip (the exposed surface area of solvent per pore is ~ 0.008 mm2).

Figure 5.9. Photograph of a microcapillary array chip provided by INCOM USA© (left).
Image of an empty microcapillary array taken on a Mead Deep Sky Imager 2 Pro CCD
camera (right).
The microcapillary arrays can be quickly filled by capillary action.

Several

attempts were made to fill the arrays with dicholesteryl organogel in decane. It was
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found that when the critical gelation temperature (temperature at which all gelator
dissolves in solution) was reached the pores were filled by simply placing the chip into
solution and heating it for several minutes. Upon removing the array from the hot gel
solution it was washed with hot solvent to remove excess gelator from the exterior. The
array was then viewed under a stereoscope to verify that all pores were filled. We found
that when the gelator was present above 0.5% in solution it crystallized out of the gel,
inside the pores of the array, upon cooling to form the organogel. When the gelator was
present below 0.5% in solution no organogels was formed upon cooling in the array. At
this point the use of organogels was abandoned in favor of using solvent, as the
microcapillary array alone could provide the structural element necessary for a pixilated
array.
The micro arrays were filled via capillary forces by simply placing the array into a
solution of solvent without immersing the top of the array. Upon removal from the
solvent the arrays were then placed upon a glass microscope cover slip to “read” them.
This proved problematic as the solvent seemed to leave the pores due to reverse capillary
action as a result of the array coming into contact with the glass cover slip. To prevent
this it became necessary to seal one end of the arrays once they had been filled. We
explored two options to accomplish this: (1) sodium silicate, and (2) polyvinyl alcohol
(PVA).
In order to prevent destroying the arrays provided by INCOM, simple capillaries
were used to test their ability to seal one end onto a glass cover slip with sodium silicate.
Upon heating, sodium silicate forms a glass which has a high tendency to bubble if it
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becomes too hot. We found that it was very difficult to prevent bubbles and fractures in
sodium silicate and thus decided to concentrate on using PVA.
Powdered PVA was dissolved in hot water and boiled until a thick syrup formed.
When spread onto a microscope cover slip and allowed to dry the syrup forms a thin
transparent film. This film is capable of sealing the end of a capillary against the cover
slip and is resistant to organic solvents, but will dissolve in the presence of water. While
this film does seal the pores of the microcapillary array from INCOM, it is hard to
remove from the ends of all pores upon cleaning of the array.

For this reason a

disposable (single use) “chip” was prepared.

A.4. Designing an inexpensive and disposable array
These arrays or “chips” (Figure 5.10) were assembled by filling a glass rod with
cement epoxy and then placing capillaries within (4 in x 1.5 mm OD x 0.86 mm ID). The
rods were then cut to smaller “chips” of which the ends could be polished to 0.3 μ. Each
array could be reused up to 5 times before the epoxy began to visibly decay. These
arrays were sealed onto a glass microscope cover slide by a layer of PVA. This was
confirmed by inspection under a stereoscope. The use of these “chips” will be further
discussed during development of the imager.
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Figure 5.10. Disposable array containing 12 pores

B. Designing an Imager
B.1. The design of an LED scanner which utilizes a PMT detector
A LED scanner was built (Figure 5.11) which utilized a PMT, outfitted with an
appropriate filter to collect light at/near the emission maximum of the fluorophore, as the
detector. The voltage should directly reflect the intensity of emission at the maximum.
The excitation source is a 300 nm LED purchased from Sensor Electronic Technology,
Inc. To direct the light a 310 nm 45° single edge dichroic mirror from Semrock© was
used which has a reflection band from 255-295 nm and a transmission band from 315600 nm. The beam then passed thru a focusing lens and a pinhole to make it narrower.
The scanner saved three numbers for each “point” it recorded: the x and y coordinate and
voltage signal.
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Figure 5.11. Picture and schematic diagram of the LED scanner.
To test the scanner two spots were applied to a microcapillary array chip, one
contained p-QPh (2x10-5 M) and 1,3-dithiane ethylbenzophenone adduct (DT-EBP
adduct) (30 mM) in decane and the other was exactly the same with BP (10-5 M). The
spots were placed on separate sides of the chip so that they did not meet. The scanner
was aligned so the excitation source was aimed through the spot without BP and the
voltage was recorded. They x,y-coordinates were then used to move the chip so that the
light excited the spot containing BP , the spots voltage was recorded. The chip was then
irradiated at regular intervals, and the voltage of each spot was recorded by moving
between them with the x,y-coordinates at the end of each irradiation period. The results
(Figure 5.12) show a difference of FL intensity, which is equivalent to the voltage
intensity, of 0.1 V, indicating that the scanner is capable of reading the “chip”.
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Figure 5.12. Photoamplified FL quenching on a microcapillary array where each spot
has p-QPh (2x10-5 M) and DT-EBP adduct (30 mM) in decane one contains BP (10-5 M)
(black) and one does not (red) (left). Difference in the normalized intensity between the
spot with no BP and the one with BP (No BP- BP) (right). ΔInorm = (I-Ifinal)/(Iinitial-Ifinal).
While this scanner was fully capable of reading the difference in voltage between
two large spots on the microarray, the resolution became a problem when smaller “spots”
were used. The resolution of the scanner was limited by how small the excitation source
could be made. We purchased copper apertures from Edmund optics© with diameters of
10, 20, and 50 μm to try and narrow the excitation beam. The result was a lack of
photons to excite a small spot of fluorophore. In order to increase the number of photons
present a 266 nm laser was utilized as the excitation source, as the initial excitation beam
would be much smaller and provide an excess of photons.

B.2. Design of an laser scanner which utilizes a PMT detector
A laser scanner was built (Figure 5.13) which utilized a PMT, outfitted with an
appropriate filter to collect light at/near the emission maximum of the fluorophore, as the
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detector. The voltage should directly reflect the intensity of emission at the maximum.
The excitation source is a 266 nm solid state laser which uses the second harmonic of 532
nm. A 45° 266 nm laser line mirror from Edmund optics© was used to direct the beam
thru a focusing lens and onto the chip above the PMT lens. The scanner saved three
numbers for each “point” it recorded: the x and y coordinate and the voltage signal. An
“in house” program then converted the voltage to a color map to visualize the spots on
the chip. Each progression of the x,y-coordinate in one direction is equal to 2 μm. An
image of the laser beam was then taken using a CCD camera and the lens over the PMT
tube. By measuring the number of pixels equal to the crosswidth of the beam we
determined the width to be ~100 μm (Figure 5.14).

Figure 5.13. Schematic diagram of 266 nm laser scanner

100 μm

Figure 5.14. CCD image of the laser beam.
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We used the scanner to “image” a microscope cover slip containing small spots of
p-TPh in adipodinitirle (used for its extremely slow evaporation at room temperature),
applied with a capillary. The sample was placed on the laser scanner which was set to
read the area where the spots were applied, giving Figure 5.15. While the imaging of the
“chip” was successful it was extremely slow, taking more than 1 hour. We needed a
faster way to image the chips for which the resolution would be high enough to image
spots 100 μm or smaller if the INCOM arrays were to be used.

Figure 5.15. Color map of spots containing 2x10-5 M p-TPh in adipodinitrile on a glass
microscope cover slip.

B.3. Using a CCD camera to image the microarray
A Mead Deep Sky Imager 2 Pro monochromatic CCD camera was purchased and
set up according to Figure 5.16, with the excitation source above the “chip”. To test the
imager for its ability to detect fluorescence and to detect quenching by BP the INCOM
chip was loaded with a solution containing 2x10-5 M p-QPh and a picture was taken. A
capillary was then used to spot 1 mM BP onto the surface. The results (Figure 5.17)
show that quenching of the fluorophore can be easily detected by the CCD camera.
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Figure 5.16. CCD imager which excites fluorophore from above.

Figure 5.17. CCD image of microcapillary array filled with CCl4 + 2x10-5 M p-QPh
(right) and then spotted with 10-5 M BP (left).
We then utilized the single use “chips” prepared above (A.4.) to show that FL
quenching takes place in a solution and that the FL difference between a solution seeded
with BP and one without BP could be detected (Figure 5.18). The chip was prepared so
that all three pores contained 2x10-5 M p-QPh and 30 mM DT-BP adduct, but only one of
these pores contained 10-5 M BP. The fluorophore was excited from above with a 300
nm LED and an initial image was captured. The chip was then irradiated using one 365
nm LED and at various time intervals a new image was captured to monitor the
quenching of fluorescence. While the results do show that the pore seeded with BP lost
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fluorescence faster than the other two, they also show uneven pore sizes and non-uniform
excitation of the pores. In addition the results were not reproducible. We believe that
this may be because we are exciting the fluorophore from above and imaging from
below. Therefore, much of the light we are using to image the chip is affecting the image
that we take. Thus, it would be better to excite the fluorophore from below and image it
from below, as is done on a FL microscope.

Figure 5.18. FL quenching of p-QPh by photoamplification on a single use chip. Pores
were loaded according to the guide (left). All pores contained 2x10-5 M p-QPh and 30
mM DT-BP adduct. Only one pore was seeded with 10-5 M BP.

B.4. The design and use of a fluorescence imager based upon the fluorescence
microscope
Fluorescence microscopes have become an important tool in fluorescence
imaging, but they remain extremely expensive. It is our goal to develop a low cost
imager so utilizing a FL microscope is not possible. For our purposes the three integral
153

parts of the microscope are the CCD, the lenses, and the fluorescence filter block, which
contains a dichroic mirror and the excitation and emission filters (Figure 5.19). It is this
block that allows one to excite the fluorophore and image from the same direction. An
empty block was purchased along with the necessary dichroic mirror and filters. In
addition, inexpensive plano-convex (PCX) lenses were added to the filter block. A
spacer was then added to keep the sample (chip) at the focal length of the lens. The
previously purchased Mead Deep Sky Imager 2 Pro CCD camera was mounted below the
fluorescence filter block and an LED was added as the excitation source to create the
imager (Figure 5.20)

Figure 5.19. Fluorescence filter block taken from reference [78].
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Figure 5.20. Inexpensive FL imaging device which utilizes a fluorescence filter block
and CCD camera. The figure shows placement of the chip which will be irradiated from
above with an irradiation LED. The image at right is the filter block built in the lab.

In order to determine the most effective focal depth (volume) of fluorophore in
the chip, to maximize fluorescence intensity, increasing amounts of a solution of C6 at
10-5 M was added to each capillary (1 mm ≅ 1 μL). The results (Figure 5.21) show that
increasing the path length up to 5 mm does improve the fluorescence intensity of the
image, but beyond this the intensity is not affected. This also shows that amplification
should improve the signal to noise ratio, because upon photoinitiation the path length of
solution containing fluorophore should begin to decrease due to quenching, making the
wells where sensitizer is present less intense.
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Figure 5.21. Effect of path length on FL intensity as imaged by the CCD camera. The
top number is the average pixel intensity per spot while the bottom number is the number
of μL C6 solution added to each pore. Maximum intensity is reached at about 5 μL.
Initial photoamplification experiments were run using the single use chip
described above. Using PVA a chip was sealed onto a holder made of a glass rod (22
mm diameter x 1 in tall) glued to a glass microscope cover slip. Each well was then
filled with a solution of either (A) C6 (10-5 M), (B) C6 (10-5 M) with DT-BP adduct (30
mM) and BP (10-5 M), or (C) solution B without BP, and the chip was covered with DI
water to prevent evaporation. The chip was then placed on top of the imager, a picture
was taken, and it was irradiated. Images were taken at equal time intervals to monitor the
progression of the quenching due to photoamplification (Figure 5.22).
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Figure 5.22. Photoamplification of benzophenone in 1,4-dichlorobenzene on a single use
chip irradiated from above with a 365 nm LED. (A) C6 (10-5 M), (B) C6 (10-5 M) with
DT-BP adduct (30 mM) and BP (10-5 M), or (C) solution B without BP. Before
irradiation (left), after 150 minutes irradiation (right).
The results show that the pores containing solution (B) went dark faster than A
and C as a result of fluorescence quenching by benzophenone produced during
photoamplification. This shows that a sample with BP is distinguishable from a sample
without it. Irradiation to obtain this result took 150 minutes, compared to 30-40 in bulk
solution. Additionally, this result was not reproducible in the majority of experiments.
In those where it could be reproduced the time it took to “turn-off” pores where BP was
seeded varied from 45 to more than 200 minutes. We believe that this is due to uneven
irradiation of the chip from above. When irradiating fluorescence cells during bulk
irradiation they are irradiated from the side while rotating the samples to ensure an even
distribution of photons.

Irradiation from above seems to cause a new problem in

providing this even distribution.
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To correct this problem we returned to irradiating the sample from the side by
creating a “mini” photoreactor above the imager (Figure 5.23).

Doing this also

necessitates leaving the sides of the capillaries exposed (they could not be covered by
epoxy) in order to irradiate. We also returned to using closed capillary tubes to assemble
the “chip” (Figure 5.24), believing it would be easier. The chip is now assembled around
a rod by using heat shrink tubing to hold it all together. The rod can then be screwd into
the motor to load the chip onto the scanner.

Figure 5.23. FL imager modified to include a “mini” photoreactor on top and its
schematic diagram. Top right shows the “mini” reactor made on top of the imager
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Figure 5.24. Chip to be used with imager in Figure 5.23 which contains 10 capillary
pores assembled around a rod which screws into the motor.
To test this new imager, and determine its detection limit, photoamplified
quenching of C6 was carried out in 1,4-DCB. Each pore contained either (A) 10-5 M C6,
(B) 10-5 M C6 and 30 mM DT-BP adduct, (C) 10-5 M C6, 30 mM DT-BP adduct, and 104

M BP, (D) 10-5 M C6, 30 mM DT-BP adduct, and 10-5 M BP, (E) 10-5 M C6, 30 mM

DT-BP adduct, and 10-6 M BP, or (F) 10-5 M C6, 30 mM DT-BP adduct, and 10-7 M BP.
The chip was then loaded onto the motor, imaged, and rotated while being irradiated with
one 365 nm LED outfitted with a 300-400 nm long pass filter. At various time intervals
irradiation was stopped and another image was taken. The results (Figure 5.25) show that
solutions seeded with 10-4 M BP and 10-5 M BP are different from those with 10-6 or 10-7
M BP and no BP. Thus, the visual detection limit is 10-5 M BP, while intensity analysis
shows a difference in normalized fluorescence intensity between a pore containing 10-4
M, 10-5 M, or 10-6 M BP and one without BP, after 25 minutes of irradiation, or 80%,
65%, and 25% respectively.
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Figure 5.25. Photoamplified fluorescence quenching of C6, using seeded BP solutions,
in a mini reactor using capillaries sealed at one end. (A) 10-5 M C6, (B) 10-5 M C6 and
30 mM DT-BP adduct, (C) 10-5 M C6, 30 mM DT-BP adduct, and 10-4 M BP, (D) 10-5 M
C6, 30 mM DT-BP adduct, and 10-5 M BP, (E) 10-5 M C6, 30 mM DT-BP adduct, and
10-6 M BP, or (F) 10-5 M C6, 30 mM DT-BP adduct, and 10-7 M BP.
The image taken before irradiation (Figure 5.25) shows significant differences
between the fluorescence intensity of some of the individual pores, ie: they are not all
equal. This is likely due to an unequal distribution of the four LED’s used as the
excitation source. This was solved by using a lens to focus the LED’s.
In this chapter an inexpensive imaging method, which we have developed, based
upon a FL microscope and a “mini” reactor chip in which to carry out our biotin-avidin
molecular recognition studies, has been described. The imager easily allows for the
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visible detection of seeded 10-5 M BP (1.80 ppm, 50 pmoles, 9.1 ng), while carrying out
an intensity analysis allows for the detection of 10-4 M (500 pmoles), 10-5 M (50 pmoles),
or 10-6 M (5 pmoles) BP after 25 minutes of irradiation (Figure 5.25 above).

C. Experimental
C.1. General
Common solvents were purchased from AAper Alcohol and used as is, except for
THF and hexanes. THF was refluxed over and distilled from potassium benzophenone
ketyl prior to use. Hexanes was distilled over calcium hydride before use. All reagents
for which a synthesis is not referenced in the text or described here were purchased from
Alfa Aesar, TCI America, Fisher Scientific, AK Scientific, ChemImpex, or Aldrich. All
reagents were used without purification unless otherwise noted. All NMR spectra were
recorded at 25 °C on either a Varian Mercury 400 MHz instrument, or a Bruker Biospin
500 MHZ instrument, in CDCl3 with TMS as an internal standard (unless noted
otherwise). Column chromatography was performed on silica gel, 32-63μ mesh and the
eluent is noted in the procedure.

C.2. Pulse field gradient (PFG) NMR
19

F PFG NMR to determine all diffusion coefficients for solvents in Table 5.1 was

done on a Varian Mercury 400 MHz instrument using a PFG sequence adapted from the
WaterSLED experiment.

Each sample contained 4-trifluoromethylbenzophenone (50

mg), the noted % gelator and the solvent to be analyzed (0.6 mL).
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C.3. General information regarding photoreactions
Photoreactions in fluorescence cells were carried out using an in house built 365
nm five LED carousel reactor outfitted with a 300-400 nm long pass filter. For each
photoreaction discussed a bulk solution of fluorophore (10-5 M) and adduct (30 mM) was
prepared and then divided to the appropriate number of samples. Benzophenone was
then added to each sample, from a stock solution, at the appropriate concentration. The
concentrations of each reagent in the photoreactions are stated in the text where the
reaction is presented if they are not stated here. All bulk solution photoreactions were
carried out in quartz fluorescence spectroscopy cells from NSG precision cells.

C.4. General information regarding scanners amd imagers
Photoreactions carried out on chips were irradiated using one or two 365 nm
LED’s from Nichia Corporation. The excitation source for the LED scanner was a 295
nm

UVTOP

LED

purchased

from

Sensor

Electronic

Technology,

Inc.

(UVTOP295TO39HS) and utilized a 45° single-edge dichroic beamsplitter centered at
310 nm with a reflection band from 255 – 295 nm and a transmission band from 315-600
nm (FF310-DiO1-25x36) to direct the excitation source. The laser scanner was built with
an Opto Engine LLC 5 mW 266 nm solid state laser (MPL-F-266nm) run by a DPSSL
driver. A TECHSPEC® ND:YAG laser line 45° mirror from Edmund optics was used to
direct the laser beam onto the sample (NT47-980). The PMT for both scanners was
connected to a solid state electrometer, which acted as the amplifier, and a high volt
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power supply.

The x,y-coordinates were Vextra model PK245-01AA 2 phase

coordinates run by a Velmex VMX stepping motor controller.
The CCD camera used for all imagers was a Mead Deep Sky Imager 2 Pro with a
Sony ICX429ALL interline monochromatic CCD solid state image sensor. The effective
pixels were 7.4x5.95 mm with a pixel size of 8.6x8.3 μm. The fluorescence filter block
was from a Zeiss Axiovert 100 microscope. The filters and dichroic mirror for C6, pQPh, and 7-diethylaminocoumarin-3-carboxyamide were purchased from Semrock. For
C6 a 45° single-edge dichroic beamsplitter centered at 495 nm with a reflection band
from 442 – 488 nm (reflects all light at wavelengths below this band) and a transmission
band from 502-730 nm was used (FF495-DiO2-25x36). The excitation source was four
400 nm Ultraviolet LEDs purchased from LED Supply (L3-0-U5TH15-1) which were
used without an excitation filter. A 515 nm short pass emission filter was used. For pQPh, a 45° single-edge dichroic beamsplitter centered at 310 nm with a reflection band
from 255 – 295 nm (reflects all light at wavelengths below this band) and a transmission
band from 315-600 nm was used (FF310-DiO1-25x36). The excitation source was a 295
nm

UVTOP

LED

purchased

from

Sensor

electronic

Technology,

Inc.

(UVTOP295TO39HS), which was used without an excitation filter. A 295 nm short pass
emission

filter

was

used

(FF01-292/15-25).

For

7-diethylaminocoumarin-3-

carboxyamide, a 45° single-edge dichroic beamsplitter centered at 409 nm with a
reflection band from 344 – 404 nm (reflects all light at wavelengths below this band) and
a transmission band from 415-570 nm was used (FF409-DiO2-25x36). The excitation
source was a 365 nm Nichia LED (used for irradiation previously), which was used
163

without an excitation filter. A 465 nm short pass emission filter was used (FF01-465/3025). The lenses for all filter bocks were purchased from Edmund Optics©. For both
coumarins TECHSPEC® PCX uncoated lenses were used that were 25x40 mm (NT45278) and 25x25 mm (NT45-097). For p-QPh the same 25x25 mm lens (NT45-097) was
used on the emission side but a fused silica TECHSPEC® PCX 25x38 mm lens (NT48273) was used on the excitation end.

C.4.1. General information regarding the fluorescence analysis of images obtained
on the CCD imaging device.
Each image was opened in Adobe Photoshop and a circle was drawn around the
image of the first pore using the marquee tool. The mean pixel intensity value (from 0 to
255) was determined by the histogram tool for all pixels inside the marquee tool circle.
The mean pixel intensity was recorded in Excel where the fluorescence was normalized
as Inorm = (I/Istd)/I0, where I is the pixel intensity of the pore being normalized, Istd is the
intensity of the pore containing fluorophore only in a given image, and I0 is (I/Istd) for the
same pore from the image at t=0. Following normalization the intensity difference
between samples could be determined.

C.5. Preparation of PVA
Poly(vinyl alcohol) with a typical molecular weight of 89,000-98,000 was
purchased from Aldrich (Item # 341584). It was then dissolved in water with heating and
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water was removed until the weight of solution was equal to 0.3 g PVA/ 1 g water. This
solution was then stored at room temperature in a sealed container.

C.6. Preparation of chips
Single use chips were assembled by filling a glass rod with cement epoxy and
then filling them with capillaries (4 in x 1.5 mm OD x 0.86 mm ID). The rods were then
cut to smaller “chips” and the ends were polished to 0.03 μ by Brian Burks in the
Department of Engineering. A layer of PVA was painted onto the surface of a glass
microscope cover slip and the chip was pushed into this PVA layer and left to dry
overnight. After inspection under a stereoscope, to verify that all pores were sealed, each
pore was filled with the solution of interest using a Hamilton 10 μL gas-tight syringe.
Sealed capillary “mini” reactor chips were prepared by drawing OD: 1.5 x ID:
0.86 mm capillary tubes from AM Systems glass to a 15 m point on a Sutter Instrument
Co. flaming brown micropipette puller model #P97 using a 3 mm box filament with
program P=500 (Heat = 515, Vel = 20, Del = 1). The 15 m end was then flame sealed for
approximately 20 seconds and the capillaries were cut to 2.5 cm in length. 10 sealed
capillaries were assembled around a center rod and then bound by heat shrink tubing to
create a chip. Each pore of the chip was filled with the solution of interest by hand using
a Hamilton 10 μL gas-tight syringe. The buffer was then added to the top of the solution
by putting the tip of the syringe just below the solvent line and then injecting the buffer
solution.
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C.7. Preparation of dithiane adducts of benzophenone
All dithiane adducts of benzophenone used in this chapter were previously
described in either Chapter 3 or Chapter 4.

C.8. Preparation of organogelators
N,n-octadecylurea and N-butylurea were purchased from TCI America. All other
gelators were synthesized.

C.8.1. Urea based organogelators
To alkylamine (5 mmol) dissolved in THF (50 mL), NEt3 (1 mL) was added.
This mixture was stirred at room temperature for 10 minutes before adding alkyl
isocyanate (5 mmol) in THF (20 mL). Additional THF (25 mL) was added. The reaction
was then left for 6h with stirring at room tempurature. 5% aq. HCl (60 mL) was added
and the product was collected by vacuum filtration. After drying at ambient temperature
overnight the remaining water and triethylamine were removed under high vacuum to
give the product which was tested as a gelator.

1,3-dioctadecylurea (1c): 1H NMR (500 MHz, CDCl3) δ 3.12-3.17 (q, 4H, J = 7.1 Hz),
1.47-1.53 (m, 12H), 1.24-1.29 (m, 52H), 0.86-0.90 (t, 6H, J = 6.9 Hz). (NMR
tpg27213_rm)
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1-hexyl-3-octylurea (1d): 1H NMR (500 MHz, CDCl3) δ 3.14-3.19 (q, 4H, J = 6.2 Hz),
1.47-1.53 (m, 4H), 1.20-1.34 (m, 16H), 0.89-0.91 (t, 3H, J = 6.9 Hz), 0.88-0.90 (t, 3H, J =
7.0). (NMR gam26026)

1-hexyl-3-dodecylurea (1e):

1

H NMR (500 MHz, CDCl3) δ 3.12-3.16 (q, 4H, J = 7.1

Hz), 1.45-1.51 (m, 4H), 1.20-1.34 (m, 24H), 0.87-0.89 (t, 3H, J = 6.9 Hz), 0.86-0.989 (t,
3H, J = 7.0). (NMR gam26025)

1-octyl-3-tetradecylurea (1f): 1H NMR (500 MHz, CDCl3) δ 3.12-3.16 (t, 4H, J = 7.1
Hz), 1.47-1.51 (m, 4H), 1.20-1.34 (m, 36H), 0.86-0.89 (t, 6H, J = 6.7 Hz). (NMR
tpg27155_pure)

1-octyl-3-hexadecylurea (1g): 1H NMR (500 MHz, CDCl3) δ 3.15-3.19 (q, 4H, J = 7.0
Hz), 1.48-1.62 (m, 4H), 1.20-1.34 (m, 40H), 0.89-0.92 (dt, 6H, J = 3.4, 7.0 Hz). (NMR
gam26029)

1-tetradecyl-3-dodecylurea (1h): 1H NMR (500 MHz, CDCl3) δ 3.15-3.15 (q, 4H, J =
7.0 Hz), 1.48-1.52 (m, 4H), 1.20-1.34 (m, 44H), 0.89-0.92 (t, 6H, J = 7.0 Hz). (NMR
gam26023)
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C.8.2. Dicholesteryl succinic amide gelators:
cholesteryl-ala-Boc (2i):

Boc-ala-OH (13 mmol) and Cholesterol (13 mmol) were

dissolved in DCM (250 mL dried over CaH). The solution was maintained at 0° C. DCC
(13 mmol) and DMAP (1.3 mmol) were added and the reaction mixture was stirred at 0°
C for 4 h. The mixture was filtered and the filtrate was washed with 5% aq. HCl (2 x 100
mL), 5% aq. NaOH (2 x 100 mL), and water (100 mL). The organic layer was removed
under vacuum and the product was purified by column chromatography (silica gel eluted
with THF:Hexane (1:6)) to give a white solid as the product (4.43 g, 62% yield).

1

H

NMR (500 MHz, CDCl3) δ 5.39-5.40 (d, 1H, J = 4.7 Hz), 5.08-5.09 (d, 1H, J = 7.4 Hz),
4.64-4.70 (tdd, 1H, J = 4.2, 7.1, 11.5 Hz), 4.25-4.32 (m, 1H), 2.32-2.34 (d, 2H, J = 7.0
Hz), 1.96-2.05 (m, 2H), 1.81-1.88 (m, 2H), 1.70-0.95 (m, 22H), 1.46 (s, 9H), 1.38-1.40
(d, 3H, J = 7.2 Hz), 1.04 (s, 3H), 0.93-0.94 (d, 3H, J = 6.5 Hz), 0.87-0.89 (dd, 6H, J = 2.3,
6.6 Hz), 0.70 (s, 3H). (NMR tpg27280, 11)

cholesteryl-ala (2ii): (2i) (14.4 mmol) was dissolved in dioxane (40 mL) and lowered to
0° C. 4M HCl in Dioxane (64 mL) was added and the reaction was stirred at 0° C
warming to room temperature. The reaction was poured over ice after 4 hours. The
product was collected by filtration and dried to give the product (4.6 g, 70% yield). 1H
NMR (500 MHz, CDCl3) δ 5.39-5.40 (d, 1H, J = 4.7 Hz), 5.40 (s, 1H), 4.62-4.69 (m,
1H), 3.50-3.54 (m, 1H), 2.33-2.34 (d, 2H, J = 8.0 Hz), 1.98-2.04 (m, 2H), 1.81-1.91 (m,
2H), 1.70-0.95 (m, 22H), 1.34-1.35 (d, 3H, J = 7.0 Hz), 1.04 (s, 3H), 0.93-0.94 (d, 3H, J
= 6.5 Hz), 0.87-0.89 (dd, 6H, J = 2.3, 6.6 Hz), 0.70 (s, 3H). (NMR tpg27286, 31)
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dicholesteryl-L- alininate succinic amide gelator (2): (2ii) (11.4 mmol) and succinic
acid (5.70 mmol) were dissolved in dry THF (150 mL) at 0° C. DCC (11.4 mmol) and
DMAP (1.14 mmol) were added and the reaction was left for 3 hours at 0° C and then
warmed to room temperature over 1 h. The mixture was filtered and the filtrate was
removed under vacuum. The resulting white solid was washed with hot methanol while
stirring 3 times and collected by filtration to give the prodcut (1.36 g, 11.5% yield). 1H
NMR (500 MHz, CDCl3) δ 6.37-6.38 (d, 2H, J = 7.6 Hz), 5.40 (s, 2H), 4.64-4.67 (ddd,
1H, J = 5.3, 10.9, 16.5 Hz), 4.56 -4.61 (m, 1H), 2.24-2.35 (m, 8H), 1.98-2.05 (m, 4H),
1.81-1.91 (m, 6H), 1.70-0.95 (m, 42H), 1.40-1.42 (d, 3H, J = 7.2 Hz), 1.04 (s, 3H), 0.930.94 (d, 3H, J = 6.4 Hz), 0.88-0.89 (dd, 6H, J = 2.1, 6.6 Hz), 0.70 (s, 3H). (NMR
tpg27288, 11)

cholesteryl-phe-Boc (3i): Prepared the same as (2i) (11.2 g, 67% yield). 1H NMR (500
MHz, CDCl3) δ 7.27-7.30 (m, 3H), 7.15-7.16 (d, 2H, J = 6.9 Hz), 5.36-5.37 (m, 1H),
4.97-4.99 (d, 1H, J = 8.2 Hz), 4.58-4.64 (ddd, 1H, J = 4.9, 11.3, 16.2 Hz), 4.51-4.55 (dd,
1H, J = 6.1, 14.0 Hz), 3.04-3.11 (m, 2H), 2.19-2.29 (m, 2H), 1.99-2.02 (m, 2H), 1.811.86 (m, 4H), 1.70-0.95 (m, 23H), 1.42 (s, 9H), 1.00 (s, 3H), 0.91-0.92 (d, 3H, J = 6.5
Hz), 0.85-0.87 (dd, 6H, J = 2.3, 6.6 Hz), 0.67 (s, 3H). (NMR tpg27290, 11)

cholesteryl-phe (3ii): Prepared the same as (2ii) (0.77 g, 90% yield).

1

H NMR (500

MHz, CDCl3) δ 7.29-7.32 (dd, 2H, J = 4.5, 10.0 Hz), 7.20-7.26 (m, 3H), 5.36-5.37 (d,
1H, J = 5.1 Hz), 4.9-4.65 (ddd, 1H, J = 5.4, 11.1, 16.6 Hz), 3.67-3.70 (dd, 1H, J = 5.6, 7.7
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Hz), 3.04-3.08 (dd, 1H, J = 5.6, 13.5 Hz), 2.85-2.89 (dd, 1H, J = 7.8, 13.5 Hz), 2.19-2.28
(m, 2H), 1.95-2.02 (m, 2H), 1.79-1.87 (m, 4H), 1.70-0.95 (m, 23H), 1.01 (s, 3H), 0.900.92 (d, 3H, J = 6.5 Hz), 0.85-0.87 (dd, 6H, J = 2.3, 6.6 Hz), 0.67 (s, 3H). (NMR
tpg27294)

dicholesteryl-L- phenylalininate succinic amide gelator (3): Prepared the same as (2)
(0.41 g, 50% yield). 1H NMR (500 MHz, CDCl3) δ 7.25-7.32 (m, 3H), 7.16-7.18 (d, 2H,
J = 6.9 Hz), 6.39-6.40 (d, 2H, J = 7.8 Hz), 4.79-4.83 (dd, 1H, J = 6.2, 13.8 Hz), 3.51-3.52
(d, 2H, J = 5.5 Hz), 3.06-3.14 (m, 4H), 2.50-2.51 (m, 4H), 2.21-2.31 (m, 4H), 1.98-2.05
(m, 4H), 1.84-1.88 (m, 6H), 1.70-0.95 (m, 48H), 1.02 (s, 3H), 0.93-0.94 (d, 3H, J = 6.5
Hz), 0.88-0.90 (dd, 6H, J = 2.3, 6.6 Hz), 0.67 (s, 3H). (NMR tpg27295, 31)
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Chapter 6: Detection of a Molecular Recognition Event by Photoamplified
Fluorescence Quenching
In Chapters 1 – 5 a new photoinduced amplified fluorescence quenching
methodology for ultra-high sensitivity fluorescence "turn-off" assays has been described.
At the core of this approach is the self-amplified release of a sensitizer from its masked
state (DT-BP adduct). Each component of this assay – the fluorophore, solvent, and
masked sensitizer – has been optimized both independently and jointly. We have shown
that the assay can achieve a detection limit of 10-7 M (18 ppb) of sensitizer in bulk
solution, a 100,000 fold amplification.[5,64]
I have also designed and fabricated an imager and microcapillary chip for use
with this methodology.

This imager is inexpensive and is adapted from current

technology which is widely accepted for fluorescence imaging. We have shown that the
visible detection of 50 pmoles BP (9.1 ng, 10-5 M) is possible with this new imager, and
that 5 pmoles of BP (910 picograms, 10-6 M) can be detected by analyzing the
fluorescence intensity of a chips pores.
The Kutateladze group has previously shown that a molecular recognition event
can trigger photoframentation, and that a photofragmentation event can set off a
progression of photochemical events (photoamplification).[4,51] Thus, we must now ask
if a molecular recognition can set off not just one photofragmentation, but set off a
cascade of fragmentations leading to photoamplification, detecting a molecular
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recognition event through the use of our new photoinduced amplified fluorescence
quenching methodology. If such a binding event does trigger photoamplification it will
provide a yes or no signal for the presence of the receptor’s ligand in the pore where
quenching takes place (Figure 6.1).

Figure 6.1. The pores are loaded with organogel containing fluorophore (blue) and the
masked sensitizer (30 mM). The ligands are printed on the gel surface (A). The target
("receptor"), carrying the sensitizer (red) is applied. Binding of the receptor to the ligand
leads to penetration of the lipophilic sensitizer through the gel surface (B). Irradiation at
365 nm results in initiation of photofragmentation by the sensitizer, unmasking
benzophenone in its immediate vicinity (C). The unmasked benzophenone is free to
diffuse throughout the pore volume, leading to the release of more benzophenone,
resulting in massive photoamplification and quenching. Taken from reference [5,64].
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A. Biotin-Avidin Molecular Recognition Pair
The biotin-avidin recognition pair is widely used in bioanalytical and
biotechnological applications because of its high affinity constant (7 x 1014 M-1), which
leads to a stable biomolecular construct. Each avidin is tetrameric providing four binding
sites for biotin.[79]

Biotin-avidin binding is commonly employed to prove that

molecular recognition based sensors [80,81] and immunoassays [82] work. This, in
addition to the fact that avidin is easily conjugated to a sensitizer capable of initiating
photoamplification, is why we have chosen to utilize this pair for the proof of concept
experiments for this assay.
The affinity constant of 7x1014 M-1 is for biotin-avidin binding in solution. At
interfaces the reported affinity constant is between 1010 and 1011 M-1.[79] In previous
studies, in aqueous buffers,[83] on vesicle surfaces,[84] on alkylthiol monolayers,[85] on
optical fiber tips,[86] and for use in single molecule imaging,[79] the ratios of biotin to
avidin used range from 10:1 to 1:10. The actual concentrations of biotin vary from
2.0x10-7 M to 1 mM, with avidin concentrations for binding ranging from 9.0x10-7 M to
9x10-4 M. Thus, the amounts of biotin and avidin needed vary widely by application. In
our case we will be trying to detect avidin, thus it would be appropriate to utilize an
excess of biotin, while minimizing the avidin concentrations.

A.1. Determination of appropriate biotin-avidin concentrations for binding.
Calculations were carried out to determine the number of lipid molecules needed
to cover the surface at the interface of organic solvent and buffer. The capillaries being
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used have an ID of 0.86 mm, which would give a surface area (SA) of the solvent/buffer
interface equal to 0.58 mm2. It is reported that the approximate area of
dipalmitoylphosphatidylcholine (DPPC), the lipid which biotin is capping during these
studies, is 65 Å2 or 6.5x10-13 mm2.[87] This translates to 8.93x1011 molecules per pore to
cover the surface, which is a total concentration of 2.97x10-10 M in 5 μL of solution. 1,2dipalmitoyl-sn-glycero-3-phosphoethanolamine-N-(cap biotinyl)(sodium salt) (biotin
capped lipid) was thus at a concentration capable of forming a monolayer at the
solvent/buffer interface.
The first step towards using biotin-avidin binding to initiate photoamplification is
to determine the necessary starting concentrations for binding to occur. To do this
avidin-fluorescein conjugate was purchased and diluted to a concentration of 3x10-8 M in
0.02 M PBS buffer, pH 7.5. The biotin-capped lipid was then diluted in 1,4-DCB at
varying concentrations from 9.5x10-9 to 9.5x10-5 M. The solution containing biotin was
injected into a capillary sealed at one end (OD 1.5 x ID 0.86 mm) and then avidin in
buffer was loaded on top of the biotin solution using a Hamilton syringe. The capillary
was then placed sideways above the CCD imager (described in Chapter 5) and images
were taken at regular time intervals to determine the incubation time needed for biotinavidin binding to occur (results for 9.5x10-5 M biotin in Figure 6.2). The results showed
that when 9.5x10-5 M biotin capped lipid was present avidin bound to it at detectable
levels within 2 hours. The FL intensity of the bound avidin-fluorescein conjugate band
continued to increase up to 20 hours.
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Figure 6.2. CCD images of a capillary containing 1,4-DCM with 9.5x10-5 M biotin
capped lipid below 0.02 M PBS pH 7.5 with 3.0x10-8 M avidin-fluorescein conjugate to
determine the time necessary for biotin and avidin to bind. Incubation times are (A) 0
minutes, (B) 2 hours (C) 4 hours, and (D) 20 hours.
Next, we needed to determine whether avidin was capable of “pulling” the biotin
capped lipid through the aqueos layer. Thus a similar experiment to the one described
above was set up, except that a second layer of 1,4-DCB was added above the aq. buffer
containing biotin. The results (Figure 6.3) show that no detectable amount of bound
biotin-avidin is found at the second solvent-buffer interface after 2 hours. After 18.5
hours there appears be a small amount of avidin present at this interface, but this is
insignificant as the entire assay (including incubation) takes no more than 6 hours.
Finally, before moving on to utilizing biotin-avidin recognition for initiating
photoamplified fluorescence quenching, it was necessary to determine whether a lower
concentration of avidin could be detected.

The same experiment preformed above

(Figure 6.3) was repeated with 3.0x10-9 M avidin, a concentration ten times lower. The
results in (Figure 6.4) show that bound avidin is detectable at this concentration. At this
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lower avidin concentration there is also no detectible avidin at the second solvent/buffer
interface after 18.5 hours. Hopefully, this concentration of avidin is an indicator for the
detection limit of biotin-avidin binding to initiate photoamplification in our assay.

Figure 6.3. CCD images of a capillary containing 1,4-DCM with 9.5x10-5 M biotin
capped lipid below 0.02 M PBS pH 7.5 with 3.0x10-8 M avidin-fluorescein conjugate
covered with empty 1,4-DCB to determine if avidin can pull the biotin capped lipid thru
solution. Incubation times are (A) 0 minutes, (B) 60 minutes, (C) 120 minutes, and (D)
18.5 hours.

Figure 6.4. CCD images of a capillary containing 1,4-DCM with 9.5x10-5 M biotin
capped lipid below 0.02 M PBS pH 7.5 with 3.0x10-9 M avidin-fluorescein conjugate
covered with empty 1,4-DCB to determine if avidin can pull the biotin capped lipid thru
solution. Incubation times are (A) 0 minutes, (B) 60 minutes, (C) 120 minutes, and (D)
18.5 hours.
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The use of excess biotin capped lipid (more than calculated for a single lipid
monolayer) appears to be necessary, as concentrations below 9.5x10-5 M failed to show
detectable binding of avidin-fluorescein conjugate. This is likely due to the solubility of
the biotin capped lipid in 1,4-DCB, which results in the need for more lipid to cover the
surface. The solubility of the biotin capped lipid was confirmed by 1H NMR where the
concentration of lipid did not decrease in the bulk NMR solvent (CDCl3) over 18.5 hours
in the presence of water. If the lipid preferred to form a monolayer then the integration
vs. a standard should have decreased, instead it remained the same. Taking this into
account we moved toward utilizing this molecular recognition pair to initiate
photoamplified fluorescence quenching.

B. Optimizing Photoamplified Fluorescence Quenching Initiated by the Binding of
the Biotin-Avidin Molecular Recognition Pair.
The first step in using biotin-avidin molecular recognition to initiate
photoamplification is to outfit avidin with a sensitizer.

Because xanthone is less

reducible than BP it is longer lasting and a better sensitizer for this purpose. 2-Bromo9H-xanthen-9-one (1) was synthesized, and methyl-10-undecenoate was added via
Suzuki-Miyaura coupling to give (3). (3) was hydrolyzed to give the free acid (4) which
was converted to its NHS ester (5) (Scheme 6.1). The NHS ester (5) was then coupled to
avidin to give (Av1) (Scheme 6.2) which was purified by a sephadex G-25 column, and
quantified by UV/Vis.
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Scheme 6.1. Synthesis of 11-(9-oxo-9H-xanthen-2-yl)undecanoic acid and its NHS ester
(5) for coupling to avidin.
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Scheme 6.2. Coupling of (5) to avidin to make (Av1).
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Conjugation of xanthone to avidin was verified by UV/Vis spectroscopy by
identifying xanthone in a fraction of purified avidin conjugate (Figure 6.5). The Solver in
Excel was used to carry out a least squares analysis between a model system ( a fit of the
sum of OD’s for free ketone and protein, at known concentrations) and the actual UV/Vis
spectrum of a fraction of the conjugated protein. The Solver determined the relative
contributions to the conjugate spectrum of the UV/Vis spectra of free ketone and avidin,
from which the ratio could be taken to determine the number of coupled xanthone
molecules per avidin.

Each avidin generally carried between 3 and 5 xanthones,

depending on the experiment and the fraction. Using the absorbance of xanthone at 365
nm the actual concentration of xanthone (ε365 = 635) was determined and from this the
approximate concentration of avidin was calculated for each fraction. Avidin for each
binding experiment was then diluted from these fractions.

1.2

Abs. (a.u.)
Avidin

1

0.8
Xanthone
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0.4
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200
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Figure 6.5. UV/Vis spectra of avidin-xanthone conjugate showing the prescence of
xanthone absorption at 350 nm. This sample was calculated to have 5 xanthone
molecules/avidin.
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The results from the above fluorescent binding study provided a starting point for
photoamplified quenching experiments. The same concentrations of biotin were used
with a higher concentration of avidin to be sure that plenty of sensitizer would be present
upon binding. The prepared avidin was then tested for initiation of photocleavage. Using
a sealed end capillary chip comparing pores containing C6 (10-5 M) and DT-BP adduct
(30 mM) in 1,4-DCB with either biotin capped lipid (9.5x10-5 M) or POPS (9.5x10-5 M)
as a control. The results showed no quenching of fluorescence after 2 hours indicating
that no photocleavage had taken place. This is likely due to the length of the linker (11aminoundecanoic acid) not being long enough for the sensitizer to penetrate the lipid
monolayer (the tails on the lipids are 16 carbons long). To extend the linker a second 11aminoundecanoic acid molecule was added giving (6), which was made into its NHS
ester (7) and coupled to avidin to give (Av2) (Scheme 6.3). (Av2) was then used for
photoamplification experiments.
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Scheme 6.3. Synthesis of 11-(11-(9-oxo-9H-xanthen-2-yl)undecanamido)undecanoic
acid and its coupling to avidin to give (Av2).

Using the new xanthone, with an extended linker, experiments were carried out
using the CCD imager and a sealed capillary “chip”. They show (Figure 6.6) that (Av2)
“sticks” to the solvent layer, in the absence of biotin, preventing detection of binding in
the absence of a lipid layer to keep avidin away from the solvent surface – pores B. This
“sticking” is likely due to an exposed lipophilic surface on avidin. In the presence of Lα-phosphatidylcholine (POPS) “sticking” appears to be prevented as the solvent layer is
no longer easily accessible – pores C. Pores A show that in the presence of both biotin
and avidin photoamplified quenching does take place.

While this is likely due to

molecular recognition, as the controls in the absence of avidin did not go dark, further
studies were needed in order to confirm the results.
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Figure 6.6. All solutions used in pores (A-E) contained C6 (10-5 M) and DT-BP adduct
(30 mM) in 1,4-DCB. To some pores was added the following: (A) biotin capped lipid
(9.5x10-5 M), (C) POPS (9.5x10-5 M), (E) POPS (9.5x10-5 M). Pores A, B, and C were
incubated with 0.01 M PBS pH 7.5 containing (Av2) (10-5 M), while all others were
incubated with 0.01 M PBS pH 7.5, for 4 hours prior to irradiation. Irradiation time is
noted on each image.
Experiments to confirm that biotin-avidin molecular recognition initiate
photoamplified fluorescence quenching were carried out in 0.7 mL fluorescence cells (1
cm x 2 mm). The amount of biotin capped lipid necessary, in 5 μL of solvent, to form a
monolayer over the solvent surface area in this cell is 1.7x10-6 M. Therefore, the use of
9.5x10-5 M biotin capped lipid should still provide more than enough biotin to cover the
surface of the solvent/buffer interface. These experiments should confirm: (1) biotinavidin recognition does initiate photoamplified quenching; (2) POPS prevents avidin
from sticking to the organic layer and initiating photoamplification in the absence of
biotin; (3) biotin, in the absence of avidin, cannot initiate photoamplification; and (4) the
avidin initiated photocleavage is detectable from photocleavage initiated by either selfcleavage or trace amounts of BP which may be present in the purified adduct.
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These experiments were carried out by preparing a solution of C6 (10-5 M)
containing DT-BP adduct (30 mM) in 1,4-DCB. To one half of this solution was added
biotin (9.5x10-5 M) and to the other POPS (9.5x10-5 M).

Four samples were then

prepared, (A) and (B) contained biotin while (C) and (D) contained POPS. (A) and (C)
were incubated with 0.01 M PBS pH 7.5 containing (Av2) (10-5 M) while (B) and (D)
were incubated with 0.01 M PBS pH 7.5. After taking an initial FL spectrum the samples
were then irradiated using five 365 nm LED’s from Nichia Corporation. Additional
spectra were taken at regular intervals during irradiation. The results (Figure 6.7) are as
expected. Biotin-avidin recognition does initiate photoamplification, giving a difference
in normalized intensity between (A) and (B) of at least 0.50 after 90 minutes of
irradiation. Additionally, POPS prevents avidin from sticking to the organic layer and
initiating photoamplification in the absence of biotin, but it does not prevent all insertion
of the sensitizer into the solvent layer. In the absence of avidin minimal photoamplified
quenching takes place, making avidin initiated photocleavage detectable from
photocleavage initiated by either self-cleavage or trace amounts of BP which may be
present in the purified adduct.
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Figure 6.7. (A-D) contain C6 (10-5 M) and DT-BP adduct (30 mM) in 1,4-DCB. To (A)
and (C) was added biotin capped lipid (9.5x10-5 M) while (B) and (D) contained POPS
(9.5x10-5 M). (A) and (B) were incubated with 0.01 M PBS pH 7.5 containing (Av2)
(10-5 M) while (C) and (D) were incubated with 0.01 M PBS pH 7.5 for 4 hours before
irradiation. (A) was the only sample which contained both biotin and avidin.

The above experiment was repeated using the capillary chip (Chapter 5) to show
that biotin-avidin molecular recognition can be detected on the CCD imager developed in
Chapter 5. The results (Figure 6.8) are very similar, showing that biotin-avidin binding
does result in photoamplified fluorescence quenching (pores A, Figure 6.8) detectable
from pores in which biotin and avidin were not incubated together before irradiation. If
the biotin, avidin, and lipid concentrations for this assay are optimized that the intensity
difference between pores of type A (Figure 6.8) and all other pores can be improved to
give a more definitive yes or no answer to a molecular recognition event than the one
shown.
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Figure 6.8. (A-D) contain C6 (10-5 M) and DT-BP adduct (30 mM) in 1,4-DCB. To
pores (A) and (C) was added biotin capped lipid (9.5x10-5 M) while pores (B) and (D)
contained POPS (9.5x10-5 M). (A) and (B) were incubated with 0.01 M PBS pH 7.5
containing (Av2) (10-5 M) while (C) and (D) were incubated with 0.01 M PBS pH 7.5 for
4 hours before irradiation. Pores (A) were the only ones which contained both biotin and
avidin. (FL) indicates only C6 (10-5 M) was present while (Empty) indicates the pore
held 1,4-DCB and buffer. Irradiation time is noted on each image.
While POPS appeared to prevent avidin from “sticking” to the solvent it did not
prevent some insertion of the sensitizer to initiate photocleavage. In addition the assay
needs to be developed so that biotin capped lipid (the ligand) can be printed onto the
surface of a pore. This means that the solution used in all pores should remain the same
(POPS must be a component) with the exception of the biotin capped lipid which is the
ligand to be printed.

To determine the effect of POPS on biotin-avidin molecular

recognition the experiment in Figure 6.7 was repeated in the presence of different ratios
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of POPS:Biotin. The results (Figure 6.9) show that the presence of POPS does decrease
or eliminate the ability for detection of biotin-avidin recognition depending on the ratio
of POPS:biotin when the concentrations of biotin and avidin remain the same as in
previous experiments. The best results obtained, in the presence of POPS, were for (C)
and (D) at 1.5 and 2 POPS: 1 biotin, giving a difference in the normalized fluorescence
intensity for [biotin – no biotin] of 0.16 and 0.35 after about 100 minutes of irradiation
respectively.
A photoinduced amplified fluorescence quenching methodology for a
fluorescence “turn-off” assay for the detection of biological targets and ligands has been
developed and tested by the molecular recognition pair of biotin and avidin.

In

experiments, both in fluorescence cells and on a chip, we could distinguish between
samples where both biotin and avidin were present and those where one or neither was
available, if POPS was used to prevent avidin from “sticking” to the solvent layer. While
an attempt was made to optimize the POPS concentration, to improve the detection limit,
further work needs to be done to finalize these optimizations, to optimize the
concentration of avidin, and to determine its detection limit. Following the completion of
these optimizations an utilizable photoamplified fluorescence “turn-off” assay for the
detection of biological targets and ligands will be completed.
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Figure 6.9. (A-H) contain C6 (10-5 M) and DT-BP adduct (30 mM) in 1,4-DCB. In
addition each cell contained the following: (A) biotin capped lipid (9.5x10-5 M), (B)
POPS (9.5x10-5 M) (C) biotin capped lipid (9.5x10-5 M) + POPS (9.5x10-5 M), (D) POPS
(9.5x10-5 M), (E) biotin capped lipid (9.5x10-5 M) + POPS (1.43x10-4 M), (F) POPS
(1.43x10-4 M), (G) biotin capped lipid (9.5x10-5 M) + POPS (1.9x10-4 M), and (H) POPS
(1.9x10-4 M). All samples were incubated with 0.01 M PBS pH 7.5 containing (Av2)
(10-5 M) for 4 hours before irradiation.
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C. Experimental
C.1. General
Common solvents were purchased from AAper Alcohol and used as is, except for
hexanes. Hexanes was distilled over calcium hydride before use. All reagents for which
a synthesis is not referenced in the text or described here were purchased from Alfa
Aesar, TCI America, Fisher Scientific, AK Scientific, ChemImpex, or Aldrich. All
reagents were used without purification unless otherwise noted. All NMR spectra were
recorded at 25 °C on either a Varian Mercury 400 MHz instrument, or a Bruker Biospin
500 MHZ instrument, in CDCl3 with TMS as an internal standard (unless noted
otherwise). Column chromatography was performed on silica gel, 32-63μ mesh and the
eluent is noted in the procedure.

C.2. General information regarding bulk photoreactions
Photoreactions in bulk solvent were carried out using an in house built 365 nm
five LED carousel reactor outfitted with a 300-400 nm long pass filter.

The

concentrations of each reagent in the photoreactions are stated in the text where the
reaction is presented.

C.3. General information regarding reactions on the CCD imager w/ “mini” reactor
Photoreactions carried out in capillary chips, described in Chapter 5, were
irradiated using two 365 nm LED’s from Nichia Corporation and imaged on the CCD
imager with a single 400 nm LED excitation source, a mini carousel reactor on top, and
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the fluorescence filter block was optimized for C6, all described in Chapter 5. The
capillaries used to prepare the chips were purchased from AM-Systems Inc. OD 1.5 mm
x ID 0.86 mm x 4 in.

C.3.1. General information regarding the fluorescence analysis of images obtained
on the CCD imaging device.
All images from the CCD imager in this chapter were analyzed visually. The
results were confirmed by opening each image in Adobe Photoshop and using the
marquee tool a circle was drawn around the image of the first pore. The mean pixel
intensity value (from 0 to 255) was determined by the histogram tool for all pixels inside
the marquee tool circle. The mean pixel intensity was recorded in Excel where the
fluorescence was normalized as Inorm = (I/Istd)/I0, where I is the pixel intensity of the pore
being normalized, Istd is the intensity of the pore containing fluorophore only in a given
image and I0 is (I/Istd) for the same pore from the image at t=0. Following normalization
the intensity difference between samples could be determined.

C.4. Preparation of dithiane adducts of benzophenone
All dithiane adducts of benzophenone used in this chapter were previously
described in either Chapter 3 or Chapter 4.

C.5. Preparation of compounds 1 – 7
2-bromo-9H-xanthen-9-one (1): Sodium metal (~2.4 g) was dissolved in methanol (60
mL). 4-bromophenol (10 g, 58 mmol) and 2-chlorobenzoic acid (9.2 g, 59 mmol) were
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added and methanol was removed under vacuum to give a cake like solid. Copper
powder (cat.) was added, the reaction was heated with an open flame (bunsen burner)
applied until dense white smoke spread over the entire solid. The reaction was cooled for
30 min. Concentrated sulfuric acid (100 mL) was added and the mixture was heated for 4
hours at 90 °C, cooled to room temperature, poured over ice, extracted with
dichloromethane (2 x 150 mL), and washed with 5% aq. NaOH solution. The organic
layer was collected, dried over anhydrous sodium sulfate, and removed under vacuum.
The resulting solid was purified by gel filtration (eluted by DCM) and the solvent was
removed to give the product (1.4 g, 9% yield). 1H NMR (400 MHz, CDCl3) δ 8.46-8.47
(d, 1H, J = 2.5 Hz), 8.32-8.35 (dd, 1H, J = 1.7, 8.0 Hz), 7.77-7.82 (ddd, 1H, J = 0.6, 2.5,
8.9 Hz), 7.73-7.76 (m, 1H), 7.48-7.51 (d, 1H, J = 8.5 Hz), 7.39-7.43 (m, 2H) (NMR
tpg27159).

methyl 11-(9-oxo-9H-xanthen-2-yl)undecanoate (3): To a pressure vessel containing
methyl-10-undecenoate (2.45 mL, 10 mmol) was added 9-BBN (0.5 M in THF, 22 mL,
10 mmol). The reaction mixture was heated to 85-90 °C with stirring for 18 hrs to
provide (2). After cooling to room temperature water was added (0.15 mL) to quench
unreacted 9-BBN, and this mixture was combined with (1) (1.4 g, 5.1 mmol), Pd(PPh3)4
(0.6 g, 0.5 mmol), and potassium phosphate tribasic (7 g) in a round bottom flask. The
reaction was heated at reflux for 18h, filtered, and the solvent was removed under
vacuum. The residue was dissolved in ethyl acetate and purified via gel filtration (eluted
with hexane:ethyl acetate (20:1)) to give the purified white solid (0.877 g, 41 % yield).
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1

H NMR (500 MHz, CDCl3) δ 8.34-8.36 (dd, 1H, J = 1.7, 8.0 Hz), 8.13 (s, 1H), 7.70-7.74

(ddd, 1H, J = 1.8, 7.1, 8.7 Hz), 7.54-7.57 (dd, 1H, J = 2.3, 8.6 Hz), 7.48-7.50 (d, 1H, J =
8.6 Hz), 7.41-7.43 (d, 1H, J = 8.6 Hz), 7.36-7.41 (ddd, 1H, J = 1.0, 7.1, 8.0 Hz), 3.66 (s,
3H), 2.71-2.75 (m, 2H), 2.28-2.31 (t, 2H, J = 7.6 Hz), 1.55-1.67 (qd, 4H, J = 7.6, 15.1
Hz), 1.25-1.35 (m, 12H). (NMR tpg27160A or tpg27160B)

11-(9-oxo-9H-xanthen-2-yl)undecanoic acid (4):

(3) (0.877 g, 2.2 mmol) was

suspended in MeOH (50 mL) with stirring. NaOH (2 g) dissolved in H2O (10 mL) was
added to the suspension. This mixture was refluxed for 4 h, poured over ice, and made
acidic using conc. HCl. The solid was collected via filtration to give the product (0.714
g, 86% yield). 1H NMR (500 MHz, CDCl3) δ 8.34-8.36 (dd, 1H, J = 1.6, 8.0 Hz), 8.14
(d, 1H, J = 2.2 Hz), 7.70-7.74 (ddd, 1H, J = 1.7, 7.2, 8.7 Hz), 7.54-7.57 (dd, 1H, J = 2.3,
8.6 Hz), 7.48-7.50 (d, 1H, J = 8.0 Hz), 7.41-7.43 (d, 1H, J = 8.5 Hz), 7.35-7.39 (t, 1H, J =
8.0 Hz), 2.71-2.75 (m, 2H), 2.33-2.37 (t, 2H, J = 7.5 Hz), 1.59-1.69 (m, 4H), 1.23-1.37
(m, 12H). (NMR tpg27161_pure)

11-(9-oxo-9H-xanthen-2-yl)undecanoic acid N-hydroxysuccinamide ester (5):

(4)

(0.75 g, 1.97 mmol), DIPEA (0.1 mL), DMAP (cat.), N-hydroxysuccinimide (0.45 g, 3.9
mmol), and EDC (1-(3-(dimethylamino)propyl)-3-ethylcarbodiimide hydrochloride, (0.60
g, 3.15 mmol) were dissolved in THF:CH2Cl2 (2:1, 75 mL) and stirred for 24 hours. The
solution was washed with water (60 mL) and saturated aq. sodium bicarbonate (60 mL),
followed by NaCl (60 mL). The organic layer was dried over anhydrous sodium sulfate
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and removed under vacuum to give the product (0.94 g, 99% yield). 1H NMR (500 MHz,
CDCl3) δ 8.34-8.36 (dd, 1H, J = 1.7, 8.0 Hz), 8.13 (d, 1H, J = 2.2 Hz), 7.70-7.74 (ddd,
1H, J = 1.7, 7.1, 8.6 Hz), 7.55-7.57 (dd, 1H, J = 2.2, 8.6 Hz), 7.48-7.50 (d, 1H, J = 8.5
Hz), 7.42-7.43 (d, 1H, J = 8.6 Hz), 7.36-7.39 (m, 1H), 2.85 (m, 4H) 2.71-2.74 (m, 2H),
2.58-2.61 (t, 2H, J = 7.5 Hz), 1.64-1.76 (m, 4H), 1.25-1.43 (m, 12H). (NMR tpg27486)

11-(11-(9-oxo-9H-xanthen-2-yl)undecanamido)undecanoic acid (6): (5) (1.31 g, 5.8
mmol) was dissolved in DMF (30 mL), 11-aminoundecanoic acid (2.36 g, 11.7 mmol),
NEt3 (0.2 mL), and DMAP (cat.) were added and the reaction was heated at 100 °C
overnight with stirring. The reaction was poured over ice and the product was collected
by filtration and purified by gel filtration (eluted with 7% MeOH in DCM) to give the
product (0.62 g, 20 % yield).

1

H NMR (500 MHz, CDCl3) δ 8.25-8.27 (d, 1H, J = 8.0

Hz), 8.04 (s, 1H), 7.67-7.70 (t, 1H, J = 7.8 Hz), 7.51-7.53 (dd, 1H, J = 1.9, 8.6 Hz), 7.447.46 (d, 1H, J = 8.5 Hz), 7.38-7.39 (d, 1H, J = 8.6 Hz), 7.31-7.34 (t, 1H, J = 7.5 Hz),
3.11-3.14 (t, 2H, J = 7.2 Hz), 2.65-2.68 (m, 2H), 2.20-2.23 (t, 2H, J = 7.5 Hz), 2.07-2.10
(t, 2H, J = 7.6 Hz), 1.51-1.62 (m, 8H),1.35-1.43 (m, 4H) 1.10-1.25 (m, 20H). (NMR
tpg27511, 31)

11-(11-(9-oxo-9H-xanthen-2-yl)undecanamido)undecanoic

acid

N-

hydroxysuccinamide ester (7): A mixture of (6) (0.5 g, 0.89 mmol), NEt3 (0.05 mL),
DMAP (cat.), N-hydroxysuccinimide (0.154 g, 1.3 mmol), and EDC (1-(3(dimethylamino)propyl)-3-ethylcarbodiimide hydrochloride, (0.204 g, 1.1 mmol) was
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dissolved in DMF (15 mL) and stirred for 24 hours. The solvent was removed under
vacuum. The product was dissolved in DCM and purified by gel filtration eluted with
DCM (50 mL) and then 10% MeOD in DCM (100 mL) to give pure product (0.135 g,
23% Yield). 1H NMR (500 MHz, CDCl3) δ 8.34-8.36 (d, 1H, J = 1.7, 8.0 Hz), 8.14 (d,
1H, J = 2.2 Hz), 7.70-7.74 (ddd, 1H, J = 1.7, 7.1, 8.6 Hz), 7.55-7.57 (dd, 1H, J = 2.2, 8.5
Hz), 7.49-7.50 (d, 1H, J = 8.4 Hz), 7.42-7.44 (d, 1H, J = 8.5 Hz), 7.36-7.39 (t, 1H, J = 7.5
Hz), 3.21-3.25 (dd, 2H, J = 7.0, 13.1 Hz), 2.71-2.74 (m, 2H), 2.58-2.61 (t, 2H, J = 2.5, 7.5
Hz), 2.13-2.16 (m, 2H), 1.70-1.76 (dt, 2H, J = 7.5, 15.2), 1.60-1.68 (m, 6H),1.46-1.50 (m,
2H) 1.22-1.43 (m, 22H). (NMR tpg27513_pure)

C.6. General procedure for avidin-xanthone conjugation:
Avidin (5 mg, 0.000074 mmol), purchased from Invitrogen or Pierce Biotechnology (now
ThermoScientific) was dissovled in PBS (0.01 M, pH 7.5, 1 mL). The appropriate
xanthone-NHS ester was dissolved in DMSO (5 mg/1 mL) and 0.1 mL of this solution
was added to the buffer containing Avidin. The resulting mixture was shaken gently
overnight at room temperature and purified on a Sephadex G-25 column (to 2.5 g of
Sephadex G-25, purchased from Aldrich, was added a 0.01 M PBS to make a slurry, this
slurry was poured into the appropriate column, the mixture was added and eluted with the
phosphate buffer). 16 fractions (1 mL each) were collected and tested by UV/Vis. The
conjugated avidin is generally found between fractions 3 and 8 containing the product
with an average of 3 to 5 xanthone molecules per avidin.
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The Solver in Excel was used to carry out a least squares analysis between a model
system ( a fit the sum of OD’s for free ketone and protein, at known concentrations) and
the actual UV/Vis spectrum of a fraction of the conjugated protein.

The solver

determined the relative concentrations of ketone and avidin present in the conjugate, from
which the ratio could be taken to determine the number of coupled xanthone molecules
per avidin. Each avidin generally carried between 3 and 5 xanthones, depending on the
experiment and the fraction. Using the absorbance of xanthone at 365 nm the actual
concentration of xanthone (ε365 = 635) was determined and from this the approximate
concentration of avidin was calculated for each fraction.

Avidin for each binding

experiment was then diluted from these fractions.

Analysis of avidin-(5) conjugation (Av1): Each avidin tetramer carries approximately 2
to 3 xanthone molecules. The concentration of xanthone was calculated to be 1.4x10-4
M, from this it was determined the approximate concentration of avidin was 8x10-5 M.
This fraction was diluted to the appropriate concentrations as indicated in the text before
use. Below is the fitting of OD’s for free avidin and free xanthone at 10-4 M to the actual
avidin-xanthone conjugate spectrum. (tpg27480)
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Analysis of avidin-(7) conjugation (Av2): Each avidin tetramer carries approximately 5
xanthone molecules. The concentration of xanthone was calculated to be 1.4x10-4 M,
from this it was determined the approximate concentration of avidin was 8x10-5 M. This
fraction was diluted to the appropriate concentrations as indicated in the text before use.
Below is the fitting of OD’s for free avidin and free xanthone at 10-4 M to the actual
avidin-xanthone conjugate spectrum. (tpg27518)
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C.7. General information regarding biotin-avidin binding experiments
The avidin-fluorescein conjugate used in the fluorescent binding studies was
purchased from Invitrogen and contained 4 moles dye/mole avidin. All reactions for
photoamplified fluorescence quenching by molecular recognition of biotin-avidin were
prepared at the concentrations described in the text. Biotin solutions were prepared from
a stock solution purchased from Avanti Polar Lipids at a concentration of 10 mg/mL in
CHCl3. POPS solutions were prepared from a stock solution purchased from Avanti
Polar Lipids at a concentration of 20 mg/mL in CHCl3.
All experiments in which biotin-avidin molecular recognition took place were left
at room temperature to allow for binding. In the fluorescence binding studies the times
are noted in the text. All other experiments were left for 4 hours unless otherwise noted
in the text.
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Chapter 7: Conclusion
The objective of my research was to develop a novel method which couples the
molecular recognition-triggered photoamplification chain in diaryl ketone adducts of
dithiane with a "turn-off" and/or “turn-on” fluorescence-based assay for the detection of
biological targets and ligands, regardless of their nature, through a molecular recognition
event. Throughout this dissertation several key steps to the development of such an assay
have been studied and optimized.

The most significant of these steps include: (1)

optimization of photochemistry as it applies to the development of an ultra-sensitive
photoamplified fluorescence turn-off assay, (2) implementation of the method in the
design and fabrication of chips for ultra-sensitive screening of microarrays, and (3)
integration of this microchip assay into a fluorescence based signal transducer for ultrasensitive detection of molecular recognition events. By addressing these key steps I have
shown that photoamplification of dithiane adducts of BP can be utilized in an ultrasensitive fluorescence assay for the detection of molecular recognition events.

A. Dithiane Adducts of Benzophenone
At the beginning of this project a better understanding of the photoamplification
of dithiane adducts of BP was obtained by studying the mechanism of fragmentation in
adducts of 2-alkyl substituted dithianes with BP. From this study it was determined that
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the quantum efficiency of cleavage steadily increases for adducts of dithianes substituted
with longer alkyl chains (Table 2.1).
The activation enthalpies (ΔH≠) were determined to be 4.7 kcal/mol for the MDTBP adduct and 1.5 kcal/mol for the EDT-BP adduct, which is in accord with the
activation energies obtained by Whitten for the thioindigo sensitized fragmentation in
vicinal amino alcohols.[59] Based upon methyldithianyl radical being more stable than
that of tert-butyl, which in turn is more stable than the unsubstituted dithiane-2-yl
radical[53], it is not unreasonable to assume that the apparent ΔH≠ of 4.7 and 1.5
kcal/mol correspond to fragmentation of the oxygen-centered radicals, releasing
methyldithianyl and ethyldithianyl radicals respectively. Therefore, we believe that the
reaction takes place via the O-centered radical mechanism and not via the original ‘Groblike’ mechanism in the case of adducts of benzophenone.
To support these findings computational and NMR studies of dithiane BP adducts
were undertaken. Computations show the lowest energy conformations for both methyl
and ethyl derivatives, the eMgO/eEgO conformers (Figure 2.3), had the smaller alkyl
substituent in the equatorial position, whereas the bulky benzhydryl group was axial, with
oxy-radical being gauche to methyl/ethyl (that is, anti to one of sulfur atoms). These
conformers have the lowest energies at both the minima and the transition states. Low
temperature NMR experiments confirm these results. In the methyl and ethyl derivatives
of the adduct the multiplets for the axial and equatorial protons H2C(3) and H2C(5) split
into two sets. If the rotation of the benzhydrol group has been stopped at this temperature
this would indicate that the most stable isomer is unsymmetrical.
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While the findings in Chapter 2 did do not rule out the ‘Grobe-like’ mechanism
for photofragmentation, they do provide further evidence that supports the alternative
oxygen-centered radical mechanism. Both the experimental and computational studies
show apparent enthalpies of activation for photoinduced fragmentation which are in
agreement, and indicate that the most stable conformation of the ethyl and methyl adducts
of BP are unsymmetrical.

B. Fluorophores for a “Turn On” or “Turn Off” Assay
The search for fluorophores to be used in both a “turn-on” and “turn-off”
fluorescence assay was undertaken. Three approaches to the design of a fluorescence
“turn-on” assay (Figure 3.1) were explored: (1) A fluorophore masked with dithiane
which recovers fluorescence upon cleavage; (2) A fluorophore conjugated to an adduct
carrying a quencher, which upon cleavage releases the quencher allowing for
fluorescence recovery; and (3) An adduct carrying self quenching fluorophores, that upon
release, recovers fluorescence. In the end none of these approaches was successful and
the focus of the project was directed toward identifying a fluorophore for and developing
a “turn-off” assay.
Because our adduct cleaves into two parts upon photofragmentation, BP and
dithiane, one or both of these parts must be capable of quenching the fluorophore. In the
case of the developed assay BP plays this role. Two fluorophores were identified which
meet the requirements for use in this assay (Chapter 2, B). The first, p-QPh is quenched
via collisional quenching with BP, leading to an effective turn-off assay. The problem
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with this assay is that the emission of p-OPh is in the UV region (λem max = 376 nm), and
most biological assays utilize fluorophores which emit in the visible spectrum.
7-Diethylaminocoumarin-3-carboxylic acid and coumarin 6 (C6) were later
identified as reliable fluorophores for the turn-off assay, both of which are quenched via a
de-ethylation reaction catalyzed by BP. After verifying that C6 does not interefere with
photoamplification we decided to pursue its use in the photoamplified fluorescence turnoff assay.

C. Optimizing the “Turn-off” Assay
The masked sensitizer – dithiane adduct of BP – and the solvent were optimized
for the turn-off assay.

The solvent was optimized for 7 key parameters: (1)

hydrophobicity; (2) solubility of the masked sensitizer; (3) method of purification for the
adduct; (4) quantum yields of fragmentation; (5) lack of interference with photochemistry
and fluorophore emission; (6) misciblity with aqueous physiological buffers; and (7)
diffusion of benzophenone – for which the diffusion coefficient was experimentally
determined in many solvents (Table 4.1).
Various adducts were prepared and modified with alkyl chains at several different
positions (Figure 4.1). The Φsens was experimentally determined to range from 0.12 to
0.18 depending on where the adducts are substituted. In addition, the solubility of each
adduct was tested in high boiling alkanes to determine their suitability if such a solvent
should be needed. Purification of the adducts was also undertaken, but as there is
currently no method to differentiate between a minute impurity of BP and very small
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amounts of direct (unsensitized) cleavage of the adduct, we cannot determine whether the
BP present is truly an impurity or if it is a product of cleavage and therefore will always
determine our detection limit. Therefore, the method by which purification takes place
has a large effect on the detection limit of the assay.
In the case of DCM (Figure 4.2) 10-7 M BP (18 ppb) was reproducibly detected.
This translates into a 100,000 fold amplification of the original sensitizer. This signal
amplification affords scientists the ability to detect a wide range of molecular binding
events. It not only improved the signal strength from those events which are already
detectable at reasonable limits in other such assays, but also affords the ability to identify
binding events which, without this amplification, would be difficult or even impossible to
detect.
A thorough study of solvents for this assay was then undertaken to try and
identify a solvent “type” which would allow for the use of a recrystallizable adduct.
Unfortunately, these solvents did not provide results anywhere close to those achieved in
DCM and their use was abandoned. Finally, ionic liquids were tested due to their unique
properties. Six IL’s were prepared (Figure 4.5) and tested for this assay only to conclude
that while IL’s may help facilitate the photocleavage reaction they cannot be used
because they quench the fluorophore and they slow down diffusion of BP, lowering the
detection limit of the assay.
DCM became our gold standard in regards to the detection limit of the “turn-off”
assay, thus we looked to chlorinated alkanes to try and solve our solvent problem. 1,4DCB was identified as a preferable solvent for this assay, for which the detection limit of
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BP in bulk solution is 10-6 M (0.1 μM, 180 ppb). This is considered to be a biologically
relevant concentration.

D. Designing a Chip and Imager
A variety of chips were designed and prepared which allowed for free 3dimensional collisional quenching in solution and provided a structural element suitable
for a pixilated spatially addressable array. Some of these chips utilized organogels to
provide the structural element while other were pre-formed and provided to us. As a
result we decided to pursue the use of a sealed end capillary chip.
Several imagers were designed and tested, but in the end we have developed an
inexpensive imaging device and method based upon a FL microscope, and a “mini”
reactor chip in which to carry out our biotin-avidin molecular recognition studies. The
imager developed easily allows for the visible detection of seeded 10-5 M BP (1.80 ppm).
We determined that increasing the path length up to 5 mm does improve the
fluorescence intensity of the image, but beyond this intensity is not affected. It has also
been showen that the imager can visibly distinguish between solutions seeded with 10-4
M BP, 10-5 M BP, and no BP, giving a visual detection limit of 10-5M BP. Further
analysis of the intensities of the pores gives a detectable difference in normalized
fluorescence intensity between a pore containing 10-4 M, 10-5 M, or 10-6 M BP and one
without BP, after 25 minutes of irradiation, of 80%, 65%, and 25% respectively. Thus,
we now have the chip and imager necessary to develop an on-chip method for
photoamplified fluorescence quenching initiated by a molecular recognition event.
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E. Detection of a Molecular Recognition Event
The final task was to implement this methodology for the detection of a molecular
recognition event – biotin-avdin binding. First, the minimum starting concentrations for
binding to occur were determined, using avidin-fluorescein conjugate and a biotin-capped
lipid in a capillary tube which could be imaged on our in-house built CCD imager. These
results showed that after 2 to 4 hours 3x10-9 M avidin binds to biotin, in solution at a
concentration of 9.5x10-5 M, at an easily detectable limit by fluorescence imaging.
Because of the solubility of the biotin capped lipid using lower concentrations was not
possible.
Utilizing this information, photoamplified fluorescence quenching initiated by
molecular recognition of the biotin-avidin pair was studied. In experiments, both in
fluorescence cells and on a chip, we can distinguish the fluorescence intensity of samples
where both biotin and avidin are present from those where only one or neither is present
on the condition that POPS was used to prevent avidin from “sticking” to the solvent
layer.

An attempt was made to optimize the POPS concentration to improve the

detection limit, showing that the concentration of POPS does affect molecular recognition
of biotin and avidn. Overall, these experiments showed promise that this assay does
work, and that molecular recognition of the biotin-avidin pair does initiate
photoamplified fluorescence quenching, which can be imaged on a chip by an
inexpensive CCD imager.
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F. Final Results and the Future
A

novel

method

which

couples

the

molecular

recognition-triggered

photoamplification chain in diaryl ketone adducts of dithiane with a "turn-off"
fluorescence-based assay for the detection of biological targets and ligands, regardless of
their nature, through a molecular recognition event has been developed. Each component
of this new photoinduced amplified fluorescence quenching methodology – the
fluorophore, solvent, and masked sensitizer – has been optimized. We have shown that
the assay can achieve a detection limit of 10-7 M (18 ppb) of sensitizer in bulk solution, a
100,000 fold amplification.

A proof of concept has been carried out that shows

molecular recognition of the biotin-avidin pair does lead to photoamplified fluorescence
quenching.
Work which remains to be completed includes optimization of the aspects related
to biotin-avidin binding and prevention of non-specific photoinitiation due to “sticking”
of avidin to the organic solvent or lipid layers.

This work should include further

optimization of the POPS concentration in relation to biotin in the lipid layer, and
optimization of the avidin concentration and determination of its detection limit.
Following the completion of these optimizations an utilizable photoamplified
fluorescence “turn-off” assay will be completed. This assay, carried out on a chip, will
be able to provide a yes or no result showing that a molecular recognition event between
a biological target and it ligand (known or unknown) has taken place.
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